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Abstract.
Human platelets die in vitro in a caspase-independent manner with features of
necrosis. Little is known about the factors affecting the mode of platelet death or
how death is brought about. The research programme described in this thesis
aimed to generate novel tools for the discrimination of live from dead platelets
and to evaluate the role of autophagy, temperature and sugar metabolism in the
demise of platelets in vitro. Two dyes, calcein and FM4-64 were found to be
useful for the evaluation of platelet viability. It was found that during in vitro
storage dead platelets formed metalloproteinase-dependent aggregates and
shed CD42b. Platelets died more slowly at ambient temperature than at 37°C.
Platelets did not rely on exogenous glucose for viability but hypoglycaemia
sensitised them to pro-apoptotic stimuli. Inhibitors of glycogen breakdown were
toxic to platelets, implicating glycogen in the maintenance of platelet viability in
vitro. Autophagy could not be implicated in the loss of platelet viability but data
suggested a role for crinophagy in the maintenance of platelet function.
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1 INTRODUCTION.
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1.1 Platelets - an overview.
Bizzozero described the platelet as a haemostatic cell in 1881 (Bizzozero, 1881). Using
intravital microscopy of guinea pig mesenteric venules he observed their change from
resting single cells to aggregates at sites of vascular injury. Interestingly, many of his
contemporaries did not believe his contention, favouring the notion that blood clots
were made only of fibrin. Ironically, the confirmation of his observations nearly fifty
years later did little to influence the scientific community that platelets had anything to
do with clot formation (Burk and Tait, 1926). However it has since become dogma that
platelets perform the crucial role of maintaining the integrity of our blood vessels.
Platelets are now arguably one of the best known of all human cell types.
Despite the enormous clinical and academic importance of platelets it is surprising that
little is known about their senescence and death. Platelet senescence both in vitro and in
vivo has been associated with an apoptotic-like phenotype (Brown et al., 2000; Pereira
et al., 2002; Clarke, 2002; Clarke et al., 2003) and loss of functional responsiveness to
collagen (Hirsh et al., 1968) and thrombin (Peng et al., 1994). Although it is known that
apoptosis leads to a prothrombogenic phenotype due to phosphatidylserine (PS)
exposure (Bombeli et al., 1997) the net result of these gains and losses of thrombotic
potential to haemostasis is unknown but an inability to remove senescent platelets from
circulation is likely to have a complex but overall negative effect on haemostasis and
platelet-mediated inflammatory responses.
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In evolutionary terms platelets are relatively modern cell types. They appear to have
evolved from nucleated haemocytes that are found within the haemolymph of lower
organisms such as invertebrates and the Horseshoe Crab Limulus polyphemus.
Vertebrates such as birds, fish and amphibia retain nucleated haemocytes (also known
as thrombocytes) and it is only mammals that are known to produce anucleate platelets.
Quite why mammals evolved anucleate, specialised cells such as platelets is unknown.
The typifying features of haemocytes include their ability to adhere, aggregate, retract,
undergo viscous metamorphosis (shape change), promote coagulation, promote vessel
contraction and phagocytose and degrade foreign material. Although the haemostatic
functions of haemocytes have been retained by mammalian platelets other features, such
as phagocytosis and anti-microbial activity, seem to have been retained only at a very
rudimentary level (Levin, 2002).
Human platelets are small (~3 x 0.5pm), numerous (-300,000.pi"1) anucleate sub¬
cellular fragments that have a lifespan in the human of approximately seven to ten days.
Circulating platelets are non-adhesive and discoid in shape and similar to that of the
nucleated Limulus haemocytes that preceded them 400 million years ago. Interaction of
platelets with exposed sub-endothelial matrix evokes changes to platelet surface
receptors that promote firm adhesion and a complex range of signalling cascades
leading to degranulation of storage granules which amplifies platelet activation,
promotes platelet-platelet interactions and enzymatic activity that culminates in the
plugging of damaged vessels and the cessation of haemorrhage. In abnormal situations
the inappropriate activation of platelets leads to thrombotic events, increased platelet
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deposition in unsuitable areas of the vasculature. Build up of platelets leads to vessel
occlusion, increasing the likelihood of ischemia, infarction, stroke and death.
Conversely, dysfunctional platelets are incapable of maintaining the integrity of the
vasculature and bleeding disorders ensue.
1.2 Platelet ultrastructure.
Although the smallest cell type found within mammals platelets contain a surprisingly
complete array of organelles and storage granules including mitochondria, lysosomes,
alpha granules (containing predominantly proteinasceous material); dense granules
(containing small molecules such as ADP, ATP, serotonin, calcium and magnesium); a
dense tubular system (analogous to the endoplasmic reticulum of nucleated cells); a
highly invaginated plasma membrane system known as the open canalicular system
(OCS) and large fields of glycogen. A microtubule coil at the platelet's widest radius
maintains their discoid structure (fig. 1). Platelets contain a very well characterised
cytoskeletal scaffold that undergoes rapid and massive reorganisation during activation
in order to bring about shape change, filopod and psuedopod extension during spreading
and aggregation (fig. 2).
1.3 Platelet production.
Platelets arise from progenitor cells called megakaryocytes (MKs). MKs differentiate
from pluripotent stem cells of the myeloid lineage and under several rounds of












Figure 1. Schematic of platelet ultrastructure.
Although platelets are devoid of a nucleus and Golgi-ER system they
contain many organelles, storage granules and cytoskeletal components.
These include mitochondria, alpha and dense granules, lysosomes an
open canalicular system that is in close association with the dense
tubular system and glycogen.
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Figure 2. Micrographs illustrating gross morphology of platelet
activation.
Platelets are discoid in their resting state but transform rapidly upon glass
or injured vasculature. Both filopod and psuedopod formation occurs, a
process known as 'spreading'. Activation of platelets in stirred suspension
leads to platelet-platelet interactions and aggregate formation. Bar =5pm.
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the process of platelet production from MKs is not clearly understood, however
development of megakaryocytes and progenitors is primarily under the control of a
single growth factor, thrombopoietin (TPO) (de Sauvage et al., 1996) whose cognate
receptor upon the megakaryocyte (and precursors) is cMpl (Gurney et al., 1994). The
sites of platelet production are typically the bone marrow but it is aslo possible that
platelets are formed in the lung and blood.
The formation of platelets from the mature megakaryocyte is an elaborate process of
compartmentalised apoptosis (De Botton et al., 2002; Clarke et al., 2003). The cell's
nuclear region and immediate cytoplasmic environment undergoes caspase-dependent
programmed cell death whereas a large portion of the organelle and storage granule-
containing cytoplasm is immune from the execution of this program. The remaining
plasma membrane system, cytosol and organelles (including the platelet's alpha and
dense granules) fragments into the subcellular particles known as platelets.
1.4 Platelet adhesion to sites of vascular Injury.
Platelet functionality is based on their ability to recognise areas of damaged vasculature,
remain adhered to them whilst attracting further platelets and promoting coagulation.
Two receptors are of key importance in the initial tethering of platelets at high shear
force to sites of vascular injury (fig. 3). Both link platelets to the matrix but do so by
slightly different means. GPVI is able to bind directly to exposed fibrillar collagen and
initiates the activation of further platelet receptors (most importantly the anbP3 integrin
complex) that enables firm adhesion. In contrast, GPIb-IX-V is able to bind vWF that is
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bound to collagen. Both receptors therefore mediate the binding of platelets to collagen,
one directly and one indirectly.
1.5 Glycoprotein Ib-IX-V.
The GPIb-IX-V complex is a heptameric complex consisting of four different proteins;
glycoprotein Iba; glycoprotein Ib|3; glycoprotein IX and glycoprotein V; (CD42a, b, c
and d, respectively) in the ratio 2:2:2:1 (fig. 4). The complex exists as linear arrays on
the surface of resting platelets but as clusters on the surface of activated platelets
(Hoffmeister et al., 2003). The complex mediates the platelet's adhesion to damaged
vessel walls at high shear force (Cranmer et al., 1999). The ligand most important for
high shear force interactions of platelets with vessel wall is von-Willebrand factor
(vWF), a multimeric protein integral to sub-endothelial matrix but which is found also
in plasma due to its secretion from activated platelets and Weibel-Palade bodies of
endothelial cells. The adhesion of platelets to vWF via the GPIb-IX-V complex initiates
platelet activation due to signalling events that lead to cytoskeletal rearrangements;
integrin activation and calcium mobilisation. Essentially, the receptor's interaction with
vWF represents a platelet 'braking system' that allows the platelet to exit from the rapid
flow of blood at sites of injury. Without this interaction few other platelet-vessel wall
interactions can occur, thus people that have defects in either vWF or the GPIb-V-IX
receptor have a bleeding disorder.





collagen / vWF via GPVI




and firm adhesion at site
of injury.
Subsequent to firm adhesion platelets
degranulate attractive molecules that recruit
further platelets leading to thrombus growth.
Figure 3. Platelet recruitment to sites of vascular injury.
Exposure of matrix proteins such as collagen and vWF allows resting
platelets to tether and roll via GPVI and GPIb-IX-V receptors. Signalling
events initiated by this interaction lead to integrin activation, further
platelet-matrix interactions and firm adhesion at the site of injury. Platelet
activation proceeds with degranulation of attractive molecules that recruit
platelets and promotes thrombus growth.















Figure 4. The Glycoprotein Ib-IX-V Complex.
Adhesion of platelets at high shear forces to vWF exposed at sites of
vascular injury is critically important for the initiation of vascular repair.
The GPIb-IX-V complex mediates this adhesion and initiates a signalling
cascade that promotes firm adhesion of platelets due to activation of
allbplll and a2pi integrins complexes that bind fibrinogen and collagen
respectively. GPIba and GPIbp are linked by disulphide links near their
plasma membrane spanning regions. The cytoplasmic domains of the
complex associate with 14-3-3 proteins, calmodulin and actin binding
protein.
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Thrombin is known also to bind the complex, an event that, although not activating
platelets directly, facilitates the proteolysis of the PAR-1 thrombin receptor (De Candia
et al., 2001).
Regulation of the GPIb-V-IX complex and its signalling capacity is mediated by at least
four mechanisms. Adhesion to vWF and thrombin is regulated by sulfation of tyrosine
residues within the ligand-binding domain. Secondly, GPIba is heavily glycosylated
beyond amino acid residue 282 in an area known as the sialomucin core. This
glycosylation appears to be important for the extension of the ligand-binding domain
outwards from the platelet's surface. Thirdly, although controversial, the complex is
thought to reside within localised areas of the platelet plasma membrane known as rafts
(Gousset et al., 2002; Shrimpton et al., 2002). This localisation is probably mediated by
the palmitoylation of GPip and GPIX close to their membrane spanning domains that
effectively anchors them within the rafts. Lastly, phosphorylation of serine 166 within
the cytoplasmic tail of GPip by cAMP-dependent kinase PKA appears to negatively
regulate cytoskeletal reorganisation (Bodnar et al., 2002). Phosphorylation of serine 609
within the cytoplasmic tail of GPIba (by an unknown kinase) appears to mediate the
formation of a signalling complex containing 14-3-32, that is essential for activation of
the anbP3 integrin complex (Andrews et al., 2003).
Changes to the external aspect of the GPIb-IX-V complex can be evoked by cold
storage (Hoffmeister et al., 2003) and appear to involve both the clustering of the
complex and exposure of beta-N-acetylglucosamine residues of N-linked glycans on
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CD42b; this leads to the recognition and subsequent phagocytosis by liver macrophages
of cold-stored platelets (Hoffmeister et al., 2003; Hoffmeister et al., 2003). The loss of
CD42b from the platelet surface is known to occur during activation (Michelson et al.,
1991), extended in vitro storage (Michelson et al, 1988), in response to plasmin
(Michelson and Barnard, 1990) and deliberate collapse of platelets' AT'm using
protonophore (Bergmeier et al., 2003). Changes to CD42b appear therefore to be
associated with a broad range of scenarios both in vivo and in vitro but as yet there is no
physiological role appointed to these changes other than the speculation it may
negatively regulate the binding of platelets to vWF and collagen (Furman et al., 2000)
or that it serves as a negative regulator of thrombin activity due to the liberation of
glycocalicin, the 130kDa proteolytic fragment abundant in plasma (Jamieson et al.,
1980).
The initial tethering of platelets to sites of vascular injury is followed by inside-out
signalling of the integrin aiibP3 and 0.2$ \ integrin complexes. Ligands for these
receptors include the RGD-containing proteins fibrinogen, fibronectin and vitronectin
but also vWF in the case of anbp3.
1.6 The aiibP3 integrin complex.
The anb and P3 integrins form a 1:1 Ca2+-dependent complex on platelets that
constitutes the receptor for RGD-containing proteins such as fibrinogen and fibronectin
(Brass et al., 1985). The complex is abundantly expressed (50,000 - 80,000 copies)
upon the platelet surface and is the most abundant receptor they possess. An
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intracellular pool of the complex exists within the a-granules which can be surface
expressed during degranulation. Platelet deposition on exposed collagen leads to
signalling cascades originating from the GPIb-IX-V and GPVI receptor complexes that
converge on the ocnbP3 and direct a conformational change that switch it from a low to a
high affinity state, facilitating the firm adhesion of platelets to the site of injury
(Peerschke et al., 1980). The occupancy of the integrin receptor by ligand induces
outside-in signalling that further promotes intraplatelet changes such as mobilisation of
calcium, cytoskeletal reorganisation and degranulation.
Mutations within the receptor or loss of the complex lead to a bleeding disorder termed
Glanzmann's Thrombasthenia. Most sufferers have loss of function mutations that lead
to the disorder however, a gain of function mutation that locks the receptor complex in
the high affinity state has also been described (Fullard et al., 2001).
An important note to make regarding this integrin complex is that it is a major target of
the anticoagulant activity of EDTA. Platelets exposed to EDTA lose the ability to
aggregate due to dissociation of the integrin complex (Grant and Zucker, 1978; Zucker
and Grant, 1978). Removal of EDTA and the subsequent replacement of calcium fail to
restore platelet aggregability unless the a-granule store of the receptor is expressed on
the platelet surface (Zucker and Grant, 1978). The effect of EDTA on platelets can be
observed within 10 minutes and is known to be temperature and pH dependent because
dissociation does not occur within this time if platelets are incubated below 37 C and
<pH 7 (Zucker and Grant, 1978). Ultrastructural changes associated with the loss of the
integrin complex lead to the formation a 'zipped-up' canalicular system (so called
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'Birbeck-like granules'), a phenotype that is thought to result from homotypic
interactions between anb (Gachet et al., 1992; Gachet et ah, 1993). An extracellular
calcium concentration of above 10"6M is sufficient for maintenance of the complex
(Fujimura and Phillips, 1983; Fitzgerald and Phillips, 1985).
1.7 Phosphatidylserine (PS) exposure.
PS exposure is an important response of platelets and erythrocytes to stimuli originating
at sites of vascular injury (Bevers et al., 1982). Increased exposure of PS allows the
binding to the cell surface of activated factor V (factor Va) that leads to prothrombinase
activity of factor Xa and the subsequent cleavage by thrombin of fibrinogen to form
fibrin.
In resting cells the maintenance of aminophospholipids such as PS and PE on the
endofacial side of the plasma membrane is mediated by ATP-dependent
aminophospholipid translocase activity which can be inhibited by increased intracellular
calcium concentrations, growth factor starvation and the tyrosine kinase inhibitor,
VO(4) " (Julien et al., 1995). It is thought that transbilayer movement of PS and PE to the
exofacial side of the membrane is mediated by inhibition of translocase activity and a
concomitant initiation of 'scramblase' activity. The gene encoding a human
phospholipid scramblase has been recently cloned (Zhou et al., 1997), however mice
deficient in the PLSCR-1 gene can still scramble PS, suggesting that other 'scrambling'
genes are available for this process (Zhou et al., 2002).
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Exposed PS can be detected by a number of biochemical assays including the
measurement of prothrombinase activity and the binding in the presence of calcium of
annexin V (Thiagarajan and Tait, 1990). The procoagulant response induced by
collagen (as a soluble monomer or as an immobilised 'fibrillar' form) is superior to that
caused by thrombin, ADP or immobilised fibrinogen, however there is clear synergy
between agonists (Thiagarajan and Tait, 1990; Heemskerk et al., 1997). It is interesting
to note that the gross morphology of collagen-activated platelets is dramatically
different to that of ADP or thrombin treated platelets. The typical response of platelets
to ADP or thrombin is shrinkage, granule coalescence and pseudopod formation
whereas platelet sphering, microparticle formation and PS exposure typify that induced
by collagen.
1.8 Degranulation.
After the initial tethering and development of firm adhesion platelets release the
contents of their storage granules. This process of exocytosis serves to amplify platelet
activation at the site of injury but also recruits resting platelets from circulation. It is an
elaborate process of cytoskeletal rearrangements and membrane fusion events that is far
from being fully understood (Reed et al., 2000). Platelets contain three major granules;
the alpha and dense granules and lysosomes. Alpha granules contain proteinaceous
material such as the fibrinogen, Factors V and XIII, von Willebrand Factor,
thrombospondin, IgG, albumin, alpha 2-antiplasmin and alpha 2-macroglubulin.
Furthermore the a-granule membrane expresses ccnbP3 integrin complex and P-Selectin
(Harrison and Cramer, 1993). Dense granules contain small molecules such as ATP,
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GTP, ADP, GDP, phosphate, serotonin, calcium and magnesium (Reed, 2002).
Lysosomes are more enigmatic granules and although containing many characteristic
acid hydrolases, their contribution to platelet activation and haemostasis is not
understood. The release of granule contents coincides with surface expression of the
integral membrane proteins, thus degranulation of alpha and dense granules and
lysosomes can be monitored by the appearance upon the platelet surface of P-selectin,
CD63 or Lamp2, respectively.
1.9 Changes associated with platelet senescence.
In vivo studies of platelet senescence often rely upon manipulation of platelet
populations so that 'older' populations are isolated from ever-dwindling populations of
circulating platelets (ablated megakaryopoietic models). This method of analysis forces
those platelets that remain in circulation to maintain the vasculature and possibly
driving the few remaining platelets into a state of perpetual activity that is abnormal
under physiological conditions. In contrast to this are models that rely on the clearance
of all platelets with subsequent analysis of 'young' platelet populations in comparison
to the normal population. Massive loss of platelets caused either by controlled bleeds or
immune clearance is likely to abnormally affect platelet production, although authors
using these techniques are aware of such artefacts it is difficult to interpret data in terms
of real changes due to a platelet's time in circulation. Many authors have assumed that
platelet heterogeneity is linked to their age, thus many have reported correlations
between platelet size, volume, density, function and biochemical character. There is no
doubt that these correlations exist but whether they are truly a reflection of a platelet's
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age is uncertain. It has also been argued that platelets are not manufactured to a template
and that any heterogeneity within a platelet population is likely to have arisen at the
point of production. A review of some key papers follows.
One of the earliest demonstrations that platelet senescence is associated with
dysfunction was documented nearly forty years ago by the injection of rabbits with
35S04 and collection of platelets 54 hours and 96 hours after administration of the
isotope (Hirsh et al., 1968). The isolated platelets were then aggregated and it was
found that the older platelets adhered less well to collagen than younger platelets. In an
independent clinical study of a patient lacking a plasma factor important for the
production of platelets (possibly thrombopoietin), Johnson et al collected and analysed
platelets during a 30-week period of repeated normal plasma transfusions. Platelet
production was monitored after the transfusion of normal plasma, with numbers rising
from <10000/pl to 200000 - 300000/p.l by day 4, peaked at >500000/pi by day 9 and
gradually fell back to baseline figures by day 21 to 23. This three-week production
period corresponds to one round of megakarocytopoiesis and thus platelets present on
day 4 were younger than those present towards the end of the treatment day 21.
Aggregation studies revealed that younger platelets responded better than old to low
concentrations of ADP (2pM) but no difference was seen in response to supra-maximal
doses of ADP (20pM) or collagen (500pg/ml), however platelet adhesion to glass was
significantly impaired in the old population. Clot retraction, ultrastructure and
prothrombin time were similar between young and old populations. Although this data
came from a single patient it suggests that functional heterogeneity in platelet
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populations is associated with platelet age but that these differences may only be seen in
vitro with subtle functional tests.
It has been observed that one of two convulxin (a collagen receptor agonist purified
from Tropical rattlesnake Crotalus terrificus venom) binding sites on GPVI was lost
from canine platelets as they aged in vivo and it was speculated that an extrinsic
pressure on platelets is realised during senescence (Alberio et al., 2002). Considering
the recent spate of publications regarding the ability of metalloproteinase activity to
mediate the shedding ofGPIba and also GPVI (Bergmeier et al., 2003; Bergmeier et al.,
2004; Bergmeier et al., 2004) it is possible that the result obtained in the canine system
reflects these in vitro data.
Megakaryocytes do not synthesise fibrinogen, therefore both megakaryocytes and
platelets released into the circulation have to acquire the protein by endocytosis and
storage within alpha granules. It is not surprising then to find that one group working
with a canine model of platelet ageing has found a positive correlation between
circulating platelet age and fibrinogen content (Heilmann et al., 1994).
Examination of the packed volume of equal numbers of rat platelets isolated on the
basis of density by centrifugation revealed that the densest platelets were approximately
2.4 times the volume of the light platelets (Karpatkin, 1972). The 'dense-large' platelets
exhibited increased responsiveness to both thrombin and epinephrine (as assessd by
ADP release) over and above the relative difference in volume and it was concluded that
these platelets were the youngest ones in circulation. Interestingly, the dense-large
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platelets contained 3.4 times the amount of glycogen and had six-fold greater rates of
glycogenolysis and glycogenesis when compared to light-small platelets (Karpatkin and
Charmatz, 1970). This data was suggested to be evidence that platelet ageing is
associated with reduced metabolic function and reduction of carbohydrate reserves that
would impact upon the activation process. These results were echoed by other groups
who demonstrated that larger platelets isolated from human volunteers contained (on a
per volume basis) more glycogen, ADP, ATP and surface sialic acid residues than
smaller platelets (Carty and Gear, 1986) and that mean volume of platelets positively
correlated with increased serotonin uptake and greater responses to agonists (Thompson
et al., 1982). However these authors found also that platelet volume did not correlate
with platelet age, leading to the conclusion that megakaryocytes produce platelets of
heterogeneous size, granule content and activatory abilities (Thompson et al., 1983) and
that larger platelets which would have a longer lifespan were 'more important' to
haemostasis than smaller ones. Interestingly, large platelets, although more reactive to
agonists such as ADP and thrombin, aggregated less rapidly than small platelets, a
finding in accordance with a later study's finding (Carty and Gear, 1986).
An examination of over 7000 electron micrographs of rabbit platelets suggested that,
after induction of thrombocytopenia by either neuraminidase or anti-platelet antibody
treatment, newly made young platelets had very few dense granules and were less dense
than older platelets (Mishory and Danon, 1978). The treatments used gave slightly
different platelet loss kinetics; antibody treatment led to rapid thrombocytopenia (within
9 hours) whereas neuraminidase caused a slower rate of platelet clearance (48 hours).
The platelets produced in response to antibody were larger than those produced after the
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2less acute thrombocytopenia caused by neuraminidase (310 +/-17.5pm -vs.- 240 +/-
6.8pm2, respectively). As platelet numbers recovered to normal levels the density of
platelets increased along with an increased frequency of dense granules and loss of
glycogen particles. The authors point out that the young-large platelets produced in their
models may not represent a true reflection of normal megakaryocytopoieis because of
the suggestion that sudden losses of platelets leads to larger platelets being made, thus
large platelet production could be a 'stress response'. The authors also point out that
differences between young and old platelets may reflect increased degranulation of
young platelets during collection and experimental procedure. These considerations
notwithstanding, platelet senescence in the rabbit appears to be associated with at least
increased density due to dense granule accumulation but decreased volume / size.
These contradictory results may infer that the processes and / or result of platelet
senescence are species-specific. Data to support of this conclusion comes from a study
that demonstrated that serotonin (5-Hydroxytryptamine (5-HT)) levels and platelet
density positively correlate with each other in human platelets but the exact opposite is
true in canine platelets (Pereira et al., 1999).
The use of the nucleic acid specific stain thiazole orange (TO), has enabled the labelling
of a 'young' population of platelets. After biotinylation the number of biotin-negative,
TO-positive platelets rises from 0.72% at 30 minutes to 5.4% at 24 hours, indicating
that TO stains newly synthesized platelets (Ault and Knowles, 1995; Dale et al., 1995).
These 'reticulated platelets' (RPs) constitute 6% and 7% of the canine and human total
circulating platelet populations, respectively (Dale et al., 1995; Rinder et al., 1998).
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The number of RPs (i.e. TO-positive) is dramatically increased from the normal level of
-4% to 42% in humans with immune thrombocytopenic purpura (ITP). This coincides
with the observation that platelets in ITP compared to controls have an increased
reactivity to the thrombin receptor agonist peptide (TRAP), suggesting that serious
bleeding disorders are avoided in ITP by the lower activation threshold of the platelets
(Rinder et al., 1998). However, large doses of TO can also label dense granules too and
may give false results (Robinson et al., 2000).
In summary, it is widely accepted that reduced adhesion to collagen and recalcitrance to
agonists is associated with platelet senescence, whereas morphological changes appear
to be more plastic and can be species specific. Thus, identification of older platelets on
the basis of size, density, volume or numbers of dense granules has not been
demonstrated unambiguously and data pertaining to differences between platelet
populations isolated thus should be treated with great caution, especially in view of the
probability that megakaryocytes produce platelets of morphological and biochemical
heterogeneity.
1.10 Platelet Death and The Storage Lesion.
It is clear from studies performed several decades ago that platelets in vivo within
organising arterial clots (Jorgensen et al., 1967; Nathaniel and Chandler, 1968; Davies
et al., 1975) exhibit morphology similar to those generated in vitro (Brown et al., 2000).
They appear to be highly degranulated and were observed to have 'gaps' in their plasma
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membrane, indicative of a necrotic end-point. Interestingly, the resolution of thrombus
in a porcine model was associated with both the absolute degeneration of platelets and
the increased occurrence of macrophages with what appeared to be phagocytosed
platelets and fibrin within them (Jorgensen et al., 1967). Further to these studies is the
in vitro observation that, within 40 minutes of ADP-induced thrombus formation,
leukocytes (primarily neutrophils, monocytes and eosinophils) had phagocytosed
platelets (Shirasawa and Chandler, 1971). These observations suggest two things; that
platelet death can be associated with haemostasis and that phagocytosis may be an
important factor in the repair of vascular wounds.
Platelet storage lesion (PSL) is a collection of biochemical, morphological and
functional changes that occur to platelets when stored ex vivo for the purpose of
transfusion. PSL, along with bacterial contamination of platelet concentrates, is a major
limiting factor in the shelf-life of platelet concentrates which is currently 5 days.
Although noted several decades ago the PSL has received little attention apart from in
the field of apheresis technology and platelet transfusion. Despite this fact a number of
groups have, both explicitly and implicitly, observed and discussed the loss in vitro of
platelet viability (Murphy and Gardner, 1971; Solberg et al., 1986; Seghatchian and
Krailadsiri, 2001; Bergmeier et al., 2003; Wadhawan et al., 2004).
PSL is characterised by loss of functional responsiveness of platelets to agonists;
leakage of lactate dehydrogenase; glycolytic toxin accumulation (Bertolini et al., 1993);
loss of plasma membrane integrity (Murphy and Gardner, 1971); loss of ATP, platelet
numbers and aggregate formation (Holme et al., 1987); degranulation (Rinder and
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Snyder, 1992); reduction of plasma pH; loss of CD42b (Michelson et al., 1988) and lack
of both recovery and survival upon transfusion of platelets into recipients (Rinder et al.,
2003).
Direct examination of apoptotic machinery has been performed by a limited number of
groups. During storage of platelets over a 5-day period it was observed that both
caspase-3 and caspase-9 proforms diminished concomitantly with increased amounts of
their active subunits that were immunodetectable at 17kDa and 32kDa, respectively.
Further analysis of anti-apoptotic proteins such as Bcl-2 and Bcl-Xi indicated that
although Bcl-2 levels remained constant Bcl-Xi levels decreased during storage at 37°C.
The loss of viability according to and inability to reduce MTS correlated with the
aforementioned changes to the apoptotic proteins, however none of these events could
be inhibited by incubation of the platelets with pan-caspase inhibitor zVAD.fmk or the
caspase-9 inhibitor zLEHD.fmk (Bertino et al., 2003). However another group
presented data contradicting the capsase-3 observation but confirming the capsase-9
data. It was also noted that PS was exposed on platelets during storage and that
cytoskeletal proteins were degraded in a caspase-independent but calpain-dependent
manner (Wadhawan et al., 2004) similar to that seen during microvesiculation of freshly
isolated platelets in response to the calcium ionophore A23187 (Wolf et al., 1999).
The superficial similarities between PSL and apoptosis have led some authors to use the
terms interchangeably with one and other (Leytin and Freedman, 2003) or discuss PSL
in terms of an apoptotic program (Fratantoni, 1992), however it is arguable that PSL
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results more from the accumulation of a metabolic toxin leading to necrotic lysis of
platelets rather than an elegantly executed program of cell death.
1.11 Metalloproteinases and platelets.
Metalloproteinases are a family of zinc and calcium-dependent endopeptidases that have
overlapping substrate specificities. They are characterised by N-terminal pre and pro
enzyme domains that are cleaved to form active enzyme and a highly conserved
catalytic domain connected via a hinge region to a hemopexin / vitronectin-like domain.
They are grouped into three major sub-groups; collagenases (MMP-1, 8,13 and 18);
gelatinases (MMP-2 and 9) and membrane type metalloproteinases (MMP-14, 15, 16,
17, 24 and 25). Their substrates are predominantly found within the extracellular matrix
(ECM) protein laid down by cells, especially those associated with the vasculature. This
links MMP activity with vascular remodelling and disease states such as cancer. Post-
translational regulation of MMP activity is complex. Tissue inhibitors of
metalloproteinases (TIMPs) bind to the conserved zinc-binding catalytic regions of
MMPs to bring about inhibition of activity, thus the relative balance of MMPs and
TIMPs determines the amount of MMP activity within a tissue (Kuzuya and Iguchi,
2003).
Platelets contain the gelatinases, MMP-2 and MMP-9 (Sawicki et al., 1997); TIMP-4
(Radomski et al., 2002) and release a trimolecular complex of MT1-MMP:TIMP-
2:MMP-2 (Kazes et al., 2000). The interplay between these proteins and their activities
not only upon their known substrates but more subtle aspects of platelet function serves
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to highlight the complexity of MMP regulation. Platelets release both proMMP-2 and
proMMP-9 during activation, however it appears that MMP-9 is released more readily
than MMP-2 in response to thrombin (Fernandez-Patron et al., 1999). Immunogold
studies of platelets revealed that MMP-2 (which colocalises with TIMP-4 (Radomski et
al., 2002)) is distributed throughout the cytosol of resting platelets and that activation in
response to collagen led to release of the protein with retention of immunoreactivity
upon the plasma membrane (Sawicki et al., 1998).
1.12 Hexokinase and cell death.
Hexokinase is the first enzyme in the metabolism of glucose and catalyses the
phosphorylation of glucose to form glucose-6 phosphate. Four distinct isozymes are
described in humans (Wilson, 2003). Types I and II have a short membrane-integrating
peptide sequence and are known to associate with the voltage dependent anion channel
(VDAC) in the mitochondrial outer membrane (Mulichak et al., 1998; Pastorino et al.,
2002) and also to other organelles such as the endoplasmic reticulum (Travis et al.,
1999). Therefore some hexokinase isoforms are intimate with proteins known to effect
certain aspects of the cell death machinery. Type III has no such membrane spanning
peptide but may be associated with the nuclear membrane as well as cytosol (Preller and
Wilson, 1992), Type IV is known also as glucokinase and is the predominant form
found in the liver.
In platelets the predominant form of hexokinase activity is that of type I, the majority of
which is particle bound rather than cytosolic (Rijksen et al., 1982). Impaired hexokinase
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activity has been associated with decreased platelet activation in response to thrombin
(Akkerman et al., 1984) and a reduced glycolytic flux was observed in thrombin treated
platelets from patients with Wiskott-Aldrich syndrome (Verhoeven et al., 1989).
In favour of the hypothesis that growth factors are primarily involved with the support
of glucose metabolism it was demonstrated that an IL-3-dependent cell line, upon
growth factor withdrawal, rapidly down-regulated the expression of GLUT1,
hexokinase II and phosphofructokinase (Vander Heiden et al, 2001). This effect could
be lessened by over-expression of the GLUT1 glucose transporter. The authors showed
also that altering glycolytic flux by reducing exogenous glucose concentration caused
Bax translocation to the mitochondria, release of cytochrome c to the cytoplasm and
apoptosis.
A further link between glucose metabolism and apoptosis was emphasised by the
observation that Bad, a pro-apoptotic member of the Bcl-2 family, could be regulated by
glucose-dependent phosphorylation and exist as part of a pentameric protein complex
along with protein phosphatase-1, Wave-1, PKA and glucokinase (Danial et al., 2003).
The authors of the report demonstrated that hypoglycaemia led to the dephosphorylation
of Bad and cell death. Interestingly, Bad appeared also to affect glucose utilisation by
modulating glukokinase activity, indicating that Bad, far from being just a harbinger of
death, functions to maintain cellular homeostasis. It is likely that many proteins with
functions in apoptosis will have appointed to them further functions distinct from their
role in cell death.
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1.13 Glucose metabolism in platelets.
Much of the pioneering work on metabolism in platelets was performed many decades
ago. It is clear that platelets are metabolically active sub-cellular fragments. Early
reports demonstrated that resting platelets require oxidative phosphorylation, however
this is possibly not true considering the probability that platelets would have been
activated by the harsh isolation conditions. The initial tethering of platelets to exposed
areas of vasculature is likely to be energy-independent (Misselwitz et al., 1987),
subsequently, platelets up-regulate the surface expression of GLUT3, their sole glucose
transporter (Sorbara et al., 1997; Heijnen et al., 1997) (fig. 1.6); an event that coincides
with many energy-dependent processes such as integrin activation, degranulation and
clot retraction (Holmsen et al., 1974; Akkerman, 1978). It is now generally accepted
that, at this energy-demanding time, platelets' ATP demand is met by oxidative
phosphorylation with glucose being supplied by extracellular environment but also
glycogen (Niu et al., 1996). Although platelets appear to bind insulin and have insulin
receptors (Hajek et al., 1979; Kahn et al., 1994) it is not clear what significance this
ability has to platelet biology because GLUT3 is not known to be regulated by insulin.
1.14 Glycogen.
Mammalian platelets possess glycogen (Zingoni, 1952; Scott, 1967; du Plessis and
Stevens, 2002; Field et al., 2001). It is clear that glycogen is used up during the energy-
demanding processes of activation and degranulation, but there have also been
comments by some authors that glycogen content is reduced in what are believed to be
older platelets (Ginsburg and Aster, 1972; Karpatkin, 1969; Karpatkin and Charmatz,
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1970). The control of glycogen content in platelets has been examined in some detail
due to the ease of isolation of platelets and their possession of functional glycogenic and
glyoclytic pathways. In contrast to muscle and liver glyogenolysis which is controlled
by the phosphorylation and activation of glycogen phosphorylase by cAMP-dependent
kinase PKA, platelets are thought to break down glycogen due to the activation of
phosphorylase directly by calcium (Karpatkin et al., 1970; Gear and Schneider, 1975)
and indirectly by calcium-calmodulin (Gergely et al., 1980). As with all metabolic
pathways, none exist in isolation and glycogenesis appears to be concomitantly down-
regulated by increased intra-platelet calcium levels that inhibit glycogen synthesis. Thus
platelets represent an unusual PKA-independent / calcium-dependent system of
glycogen metabolism that is distinct from that seen in muscle and liver. Another key
regulator of glycogen metabolism recently identified in platelets is Glycogen Synthase
Kinase 3 (GSK3) (Barry et al., 2003). The un-phosphorylated enzyme (present in
platelets as both GSK3a and GSKP) phosphorylates glycogen synthase to inactivate it
thereby shifting the equilibrium in cells towards glycogen breakdown. The effects of
GSK3 can be inhibited by lithium's ability to block the dephosphorylation of GSK3
(fig. 1.7) and maintain it in an inactive form (Zhang et ah, 2003; Chalecka-Franaszek
and Chuang, 1999); thus lithium might be expected to inhibit glycogen depletion in
platelets. In platelets inactivation of GSK3 is caused by phosphorylation by PI-3 Kinase
during platelet activation in response to collagen or thrombin. At first sight this appears
to be counter intuitive, but may be indicative of an uncoupling of GSK3 from glycogen
metabolism activity in platelets during activation. GSK is known to have varied effects
within cells and has been implicated in the regulation of apoptosis; responses to amino
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acid starvation; the development of cancer and metabolic diseases such as diabetes
(Frame and Cohen, 2001).
Caffeine and a novel caffeine-based drug CP-91149 are both effective inhibitors of
glycogen phosphorylase (fig. 1.7). Although structurally similar their mode of action is
different because they can act synergistically to bring about a reduction in
phosphorylase activity in vitro and it is believed they target distinct sites upon the
enzyme that affect enzyme-substrate interactions. Despite inhibiting phosphorylase,
caffeine has broad pharmacological effects on cellular processes. It can affect adenosine
receptor expression on platelets by initially causing down regulation with concomitant
recalcitrance to agonists followed by massive up-regulation of receptors with resultant
hypersensitivity to agonist (Varani et al., 1999; Paul et ah, 1993). CP-91149 is a novel
drug developed by Pfizer for the control of hyperglycaemia in diabetics (Martin et al.,
1998). It offers a lower dose inhibitory effect than caffeine (pM versus mM ranges,
respectively) and is effective in vivo at lowering hyperglycaemia in diabetic ob/ob mice
without causing hypoglycaemia (Martin et al., 1998) and is known to concomitantly
activate glycogen synthase (Aiston et al., 2001).



















Figure 1.6. Metabolism in platelets.
A very brief overview of the major glycolytic and glycogenolytic pathways
within platelets. Platelets are thought to possess the insulin independent
glucose transporter GLUT3, which can be up-regulated upon their
surface during activation. Transported glucose is phosphorylated by
hexokinase activity and is then bound for glycogen synthesis, glycolysis
and hexose monophosphate shunt.

















Figure 1.7. Glycogen metabolism.
Glycogen metabolism is regulated by both synthase and phosphorylase
activities. Inactivation of synthase occurs due to phosphorylation by
glycogen synthase kinase 3 (GSK3), whose activity is inhibited by
phosphorylation. Catabolism of glycogen is catalysed by phosphorylase,
whose activity is increased by binding calcium and / or by phosphorylase
kinase activity. Both caffeine and a novel caffeine analogue CP-91149
are able to inhibit phosphorylase activity and prevent glycogen
breakdown, whereas a catabolic equilibrium is prevented by increased
synthase activity evoked by lithium.
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1.15 Autophagy.
Although the presence in platelets of caspase 3 has been described by numerous authors
(Shcherbina and Remold-O'Donnell, 1999; Brown et ah, 2000) and activity of the pro-
form suggested by others (Piguet et al., 2001) there is no clear correlation between the
activity and in vitro death nor inhibition of its activity and platelet survival (Bertino et
ah, 2003; Wadhawan et ah, 2004). Therefore, it appears that platelets die in vitro
independently of caspase activation (Brown et ah, 2000; Wadhawan et ah, 2004).
Autophagic cell death is persistently associated with vacuolisation and destruction of
cytoplasmic contents including organelles leading to near complete catabolism and a
necrotic-like end point (Thummel, 2001; Lee and Baehrecke, 2001; Bera et ah, 2003).
Apoptosis is the best understood means of programmed cell death but it is not the only
one (Bursch et ah, 2000; Lockshin and Zakeri, 2002; Lockshin and Zakeri, 2004). The
identification of apoptosis relies, in part, on caspase-dependent changes (Samali et al.,
1999) to nuclear morphology (chromatin condensation and nuclear body formation
(Kerr et al., 1972) - something that can clearly not be done with platelets. Thus,
apoptosis by any classical description can never be securely appointed as the program of
death used by platelets.
The alternatives to apoptosis are not well described but involve both apoptotic and
necrotic-like end points that appear to be elicited by catastrophic changes in lysosomal
integrity (Boya et al., 2003) or extensive autophagic destruction of cytosol and
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organelles (Yuan et al., 2003). Interestingly these changes appear not only in
mammalian cells but those of lower species such as Drosophila melanogaster
(Thummel, 2001) and the single-celled protozoan parasite Leishmania donovani (Lee et
al., 2002) and therefore represent forms of cell death that, in evolutionary terms,
preceded apoptosis.
Autophagy is the bulk degradation of cytosol and organelles within the lysosomes and is
a constitutive process required for the homeostasis of organelles and protein complexes.
It is a process that can be up-regulated in response to glucagon (Deter et al., 1967) and
upon nutrient deprivation (Bergamini et al., 1994) and is regarded as an important
adaptive response that allows for the recycling of essential amino acids from non¬
essential cellular components and the rapid liberation of glucose from glycogen stores.
Although autophagy is associated with cell death it has not been defined clearly as the
cause or consequence of it (Bursch et al., 2000; Thummel, 2001). However, a very
recent report discusses the first genetic evidence that genes important for autophagy can
be, under certain circumstances, required also for the execution of cell death (Yu et al.,
2004).
The identification of autophagy has historically relied upon the observation at the
electron microscopic level of multi-lamellar bodies surrounding identifiable cellular
components (Ericsson, 1969). Work with the yeast Saccharomyces cerevisiae identified
17 genes necessary for the induction of autophagy in response to nitrogen deprivation
(Tsukada and Ohsumi, 1993). Of particular importance to the field has been the
identification of the pre-autophagosomal structure (Suzuki et al., 2001) whose
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formation precedes and is necessary for the formation of an autophagic vacuole
(Kirisako et al., 1999). One of the five ATG gene products that comprise the PAS,
Atg8p (a ubiquitin-like protein known as MAP1-LC3 or LC3 in mammalian cells
(Kabeya et al., 2000) appears to be unique to the autophagy machinery and its
accumulation is now used widely as a marker of autophagy not only in yeast but also
Dictyostelium (Otto et al., 2003) and mammalian cells (Tanida et al., 2002; Asanuma et
al., 2003).
Although autophagy is becoming less enigmatic as a cell biological process there are
sub-types of lysosomal / autophagic processes that remain poorly understood. Most
work has dealt with /wacro-autophagy, which is characterised by the de novo synthesis
of double membrane around target organelles / cytosol, but there exists also micro-
autophagy, chaperone-mediated autophagy (CMA), micro and macro-pexophagy
(Huang and Klionsky, 2002) and crinophagy (Dunn, 1994).
Micro-autophagy is characterised by the protrusion of the lysosomal membrane around
and the engulfment of local cytoplasm / organelles. Interestingly, this form of
autophagy is induced after the yeast Pichia pastoris is grown on methanol rather than
glucose. Peroxisomal enzymes are synthesised for the usage of methanol, however
when the yeast is transferred to glucose these enzymes and the peroxisomes are
selectively degraded within the yeast vacuole by a process of micro-autophagy (Yuan et
al., 1997; Yuan et al., 1999). Both pexophagy and micro-autophagy represent similar
systems of organelle destruction within the lysosome. Chaperone mediated autophagy
(CMA) relies on the presence within a target protein of the consensus sequence KFERQ
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which is recognised and bound by the cognate heat shock protein hsc73 (Dice et al.,
1990) the complex binds to the lysosome, a process apparently requiring cleavage of
Lamp-2 at the lysosomal membrane by Protective Protein / Cathepsin A (PPCA), and
then degraded (Cuervo et al., 2003). CMA is important in the destruction of certain
annexins (annexins II and VI but not V and XI) in response to serum starvation (Cuervo
et al., 2000) and it is noteworthy that approximately 40% of the enzymes involved in
glycolysis have KFERQ-like sequences.
Crinophagy is probably the least well understood but yet one of the most important
forms of autophagy in mammalian cells. The process involves the fusion of storage
granules directly with lysosomes and is an important mechanism maintaining granule
homeostasis in highly secretory cells such as the insulin secreting (3-cells in the pancreas
(Koike et al., 1982), hepatocytes (Lenk et al., 1991), prolactin-secreting mammatrophs
(Bernabe et al., 2001) and neurons (Boudier and Picard, 1976).
Although platelets have lysosomes it is not known what role they play in platelet
biology or haemostasis. Autophagic-like structures have been observed in circulating
platelets from patients with carcinoid syndrome (Lewis et al., 1976) and a patient with
Danon's disease (a lysosomal storage disease with normal acid maltase activity), was
noted to have both abnormal platelet function and accumulation of glycogen (Katsumi
et al., 1994). Therefore a precedent for autophagy with abnormal platelet function /
pathology is present in the literature. It is not known whether autophagy has any role in
the death of platelets and this form of cell death is examined in this thesis.
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1.16 Assessment of platelet viability.
One reason for the scant information regarding platelet death is that few markers are
available that allow for the rapid, objective discrimination of live from dead platelets.
Their anucleate nature prevents analysis of plasma membrane integrity with DNA-
interchelating dyes and their tiny size precludes the use of vital stains such as trypan
blue complemented with microscopy for scoring viability. While the viability of whole
platelet populations can be routinely assayed for by examining the release of lactate
dehydrogenase (LDH) (Holme et ah, 1987; Bode and Miller, 1989; Bertolini et ah,
1993), release of annexin-V (Krailadsiri et al., 1997) and changes in pH (Bertolini et al.,
1993) such data does not allow the isolation and study of individual platelets (Solberg et
ah, 1986; Li et ah, 2000). Ultrastructural identification of Tysed and balloon' platelets
has been used to evaluate the frequency of dead platelets in stored platelet concentrates
(PC) (Murphy and Gardner, 1971; Solberg et ah, 1986) but due to the obvious expense
and labour intensity of such work a marker of viability that can discriminate live from
dead platelets is highly desirable. Also, any such marker should be amenable for
inclusion into experiments involving live and dead platelets without having deleterious
effects on platelet biology.
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1.17 Summary and Overall Aims of Research Program.
Platelet populations display biochemical and morphological heterogeneity but it is
unlikely that this reflects age-related differences between platelets and is more likely a
result of the inconsistencies of platelet production. Platelet storage lesion has been
examined in some detail at the level of whole platelet populations or in the context of
transfusion recovery success and lifespan but reports examining the phenotype of
individual platelets, the surface changes that occur as a result of PSL or the factors
dictating the onset of PSL are scant. Annexin-V, a marker of cell death that has been
used to demonstrate platelet death is also widely exploited to demonstrate changes to
membrane asymmetry during activation in viable platelets.
• An initial step in this program of work is the confirmation and subsequent
confident identification of platelet death. This is to be performed by careful
morphological and functional analysis of unwashed platelets stored at 37°C.
• Secondly, a marker that allows the rapid discrimination of live from dead
platelets is to be sought.
• Thirdly, changes to the surface phenotype of dead platelets are to be studied.
• Fourthly, the mechanism ofplatelet death is to be examined.
• Lastly, it is important to understand why platelets are dying in vitro, therefore
factors controlling their survival are to be explored.
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2 MATERIALS AND METHODS.
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2.1 Reagents and Antibodies.
All stock chemicals were from Sigma unless otherwise stated. Adenosine diphosphate
(ADP), Formaldehyde, carbonyl cyanidem-chlorophenylhydrazone (CCCP), Hanks
buffered saline solution (HBSS), Dulbeccos modified Eagle's Media (DMEM),
prostacyclin (PGI2), Calcium ionophore (A23187) were all from Sigma (Dorset, UK);
Calcein-acetoxymethyl ester and A-(3-triethylammoniumpropyl)-4- (6-(4-
(diethylamino)phenyl)hexatrienyl) pyridinium dibromide (FM4-64); R-Phycoerythrin
400
and Alexa -conjugated Streptavidin; Lysotracker Red; Mitotracker Green; all Alexa-
conjugated antibodies and Alexa488-conjugated fibrinogen were from Molecular Probes
(Oregon, USA); Convulxin was from Pentapharm (Switzerland); Thrombin activated
agonist peptide (TRAP), Fibrillar Collagen solution was from Chronolog (Haverton,
USA), GM6001 and Dimethyl Sulphoxide (DMSO) were from Calbiochem (California,
USA). R-Phycoerythrin conjugated anti-human CD62P was from DakoCytomation
(Cambridgeshire, UK); R-Phycoerythrin anti-human CD42b, clone HIP1, was from BD
Pharmingen; Annexin-V conjugated to either FITC or RPE, FITC-conjugated anti-
Human otub was from Caltag Laboratories (California, USA). Sterile sodium citrate
solution (Phoenix Pharma (Gloucester, UK). Anti-human Lamp-2 antibodies (H4B4)
were supplied as a partially purified IgG supernatant from the University of Iowa
Hybridoma Bank.
2.2 Blood collection from humans.
Whole blood (40ml) was collected into 50ml plastic Falcon tubes containing 4ml of 3.8
% sodium citrate from healthy human volunteers. Blood was centrifuged at 350 x g for
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20 minutes in a swing-out rotor centrifuge. The resultant upper layer of platelet-rich
plasma was removed to a fresh 50ml capped plastic tube and maintained at room
temperature or at 37°C until processed for experimentation. A further aliquot was
removed to a 500pl Eppendorf, maintained at 37°C and used for estimation of platelet
numbers using a Coulter counter.
2.3 In vitro platelet culture.
Platelets were cultured at 37°C or room temperature unless otherwise stated. Platelets
were cultured as citrated platelet rich plasma (cPRP); as a washed suspension
(resuspended in calcium-free Hanks buffered saline solution (HBSS): MgS04 0.5g/l;
KCL 0.4g/l; KH2P04 0.06g/l; NaHC03 0.35g/l; NaCl 8g/l; Na2HP04 0.048g/l)) or as a
50-fold dilution of PRP. This dilution factor was chosen because it allowed platelets to
be analysed by flow cytometry without causing blockages caused by large aggregates
that formed during culture or activation. D-Glucose was added to a final concentration
of 5mM unless otherwise stated. 2ml or 0.5ml capped Eppendorf tubes were used as
culture vessels and were filled to capacity with platelet suspension. Cultures were
maintained in a water bath for the required periods of time as stated in the text with
twice daily inversion.
2.4 Platelet Aggregometry.
A gross measure of platelet function can be determined by increased transmission of
light through stirred platelet rich plasma challenged with agonists. The initial stages of
platelet activation involve cytoskeletal rearrangements that transform resting discoid
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platelets into irregularly shaped entities. This 'shape change' causes less light to pass
through the platelet suspension and is seen as an increase in absorbance on
aggregometry plots. Platelet activation proceeds with the switching of low affinity
adhesion molecules into their high affinity state; most importantly is the anbP3 integrin
complex, this complex binds fibrinogen (amongst other proteins) that acts as a bridging
molecule between activated platelets. As the frequency of platelet-platelet interactions
increases light passes more easily through the platelet suspension and increased light
transmission is recorded. High order activation causes degranulation, a process of
granule secretion and surface expression of P-Selectin (CD62P). Granule exocytosis
leads to increased extracellular ADP and serotonin that positively feedback to platelets
in autocrine and paracrine fashion to promote further activation and aggregation.
Maximal aggregation is set as the amount of light passing through a platelet-free
solution.
Although widely used for the assessment of platelet function it is important to mention
the limitations of aggregometry. Plasma fibrinogen will be cleaved by thrombin to form
fibrin. Fibrin meshes will trap within themselves any particles, be they platelets or inert
beads. Aggregation can appear to proceed towards maximal levels but in this
circumstance is not a reflection of platelet function but only of thrombin's effects on
fibrinogen. If thrombin is to be used as agonist platelets must be first washed from
plasma and resuspended in a fibrinogen free solution. Evidence of platelet function
where thrombin has been used as agonist and platelets were within plasma should
therefore be treated with great caution (Hoffmeister et al., 2003). Thrombin analogues
such as thrombin receptor agonist peptide (SFLLRN / TRAP) obviate these problems,
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as they have no enzymatic effect on fibrinogen but still stimulate platelet Protease
Activated Receptors (PARs) (Hui et al., 1992).
Temperature has also a profound effect on platelets' response to agonists. Reducing the
temperature below 37°C primes platelet responses so that their resting state is lost and
they aggregate more readily than if at 37°C. Aggregometer chart recordings of colder
platelets invariably show a reduced increased absorbance of light due to the platelets
already having shape change due to lower temperatures (i.e. they are in 'primed' state)
(see Appendix fig. 8.1).
All procedures were carried out in a Chronolog dual chamber aggregometer at 37°C
with temperature-equilibrated equipment and platelets unless stated otherwise. 500pl of
PRP or washed platelet suspension was added to siliconised glass aggregometry tubes
containing a steel stir-bar. Basal and maximal light transmissions were set with un-
activated platelets and platelet poor suspensate, respectively. Platelets were stirred at
1000 rpm, calcium was added back to 2mM and then agonist was added. On occasion
platelets were pre-incubated with pharmacological agents for times specified in the
figures. Aggregation proceeded for times as specified in the figures (from 2 minutes to
20 hours).
2.5 Platelet activation.
Platelets were activated with various agonists (ADP; Convulxin; Thrombin; Thrombin
receptor agonist peptide (TRAP); A23187) in the presence or absence of 2mM calcium
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chloride and / or other treatments as described in the text. Activation was allowed to
proceed with or without agitation for 10 minutes at 37°C whereupon the reaction was
stopped by the addition of 1 volume of 2% formaldeyhde in HBSS A or 10-fold dilution
of platelets in HBSS if live staining was subsequent to activation. For analysis of the
effects of Antimycin on platelet activation platelets were pre-incubated with or without
lOpg/ml Antimycin for 1 hour prior to activation.
2.6 In vitro Biotinylation of Platelet Surface Proteins.
PRP was incubated for 5 minutes with 0.1pg/ml prostacyclin then centrifuged at 1000 x
g for 5 minutes. The platelet pellet was resuspended in HBSS and incubated with
100pM NHS-Biotin for 30 minutes at 37°C in order to label exposed amine groups on
the platelet surface. Platelets were washed from the biotinylation solution as described
and resuspended in autologous platelet-poor plasma (prepared by centrifuging PRP at
13.5K rpm for 1 minute at room temperature). Biotinylation was confirmed by staining
platelets with fluorescently-conjugated streptavidin (see below).
2.7 In vivo biotinylation of murine blood cells.
The aging of a platelet population can be observed in vivo by biotinylating whole blood
and examining biotin-positive platelets at subsequent time points. Two methods allow
for the labelling of platelets one involves the infusion of biotin directly into the
bloodstream of the animal the other requires platelets to be removed, iabelled, washed
and transfused back into animals. After blood sampling the biotinylated platelets can be
identified by their ability to bind fluorescently conjugated streptavidin. The method is
Page 56 of 239
simple and has been employed in a variety of animal models e.g. dogs, mice rabbits and
monkeys (Dale et al., 1995; Peng et ah, 1994; Berger et ah, 1998; Michelson et ah,
2001; Franco et ah, 1994). Although there is widespread acceptance of the technique
others have reported an impaired ability of biotinylated human platelets to aggregate
(Magnusson et al., 1998).
Utilisation of this method has demonstrated that older platelets have an impaired
response to thrombin (as evidenced by the 1.78-fold increase in the EC50 required to
induce surface expression of P-Selectin) (Peng et al., 1994) that platelets accumulate
fibrinogen but not IgG as they age (Heilmann et al., 1994) and that platelet clearance, at
least in the mouse, is independent of CD62P (Berger et al., 1998). Interestingly,
although flow cytometry collects information regarding cells' refractivity and
defractivity (roughly translating as volume and granularity) no one has published any
data suggesting there are changes in these characteristics as platelets age in vivo,
suggesting that the changes to volume, dense granule and glycogen content associated
with aging have not been noticed by flow cytometry, or that these changes are not as is
currently believed due to senescence related processes.
The functional consequences of platelet biotinylation have been debated. Some
researchers have found that after in vitro labelling the aggregation of platelets in
response to lOpM ADP is impaired (Magnusson et al., 1998). However, this contrasts
other reports that suggest this is not the case (Heilmann et al., 1993; Ault and Knowles,
1995).
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NHS-Biotin was diluted with DMSO to a stock concentration of 40mg/ml. The stock
was diluted immediately prior to injection 4mg/ml with sterile saline or PBS. It is
important to note that the efficacy of biotinylation relies on rapid usage of this solution,
once the NHS-Biotin is introduced to water the succinyl group hydrolyses and free
biotin is liberated. This reaction is thought to last only a few minutes. The liberated
biotin reacts with free amine groups in its vicinity and is stable for many days. Mice
were injected intravenously (i.v) with 150pl of 4mg/ml NHS-Biotin (a total of 600pg of
NHS Biotin per mouse). A second injection was performed 1 to 4 hours later in order to
label any platelets that were sequestered within the spleen during the previous injection.
This method of biotinylation labels all circulating blood cells and is stable for the
duration of the platelets lifespan as assessed by its persistence upon red blood cells
without any loss of signal. One caveat that must be mentioned for this method is that
plasma proteins are also biotinylated and any cells using / accumulating such plasma
proteins on their surface will show a persistent signal when stained ex vivo with biotin-
specific probes.
2.8 Incubation of platelets with Annexin V.
Annexin-V is a member of a large family of proteins known to negatively affect
coagulation due to the their ability to compete with Factor Xa for exposed PS residues
on platelets (Thiagarajan and Tait, 1990). Therefore, although annexin-V binds to PS
exposed as a consequence of programmed cell death and necrosis, its use as a marker of
platelet viability is limited because of its ability to interact with viable platelets during
the shedding of microparticles (Stuart et al., 1995). Thus annexin-V positive platelets
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can be securely classed as dead only when corroborating phenotypic information at the
ultrastructural level is presented (Brown et al., 2000). It is important to note also that the
mechanism of PS exposure used during platelet activation appears to be distinct from
that used for PCD, thus annexin-V binding to platelets is not a bone fide marker of their
death (Martinez and Freyssinet, 2001). Its use with platelets also requires millimolar
levels of calcium that lead to calcium influx into platelets and activation when store-
mediated calcium entry / capacitative calcium entry has been initiated (Rosado and
Sage, 2000; Dobrydneva and Blackmore, 2001). Thus, there are limitations to its
usefulness for experimentation with mixed populations of viable and non-viable
platelets when low calcium levels are required for maintenance of the resting state.
Platelets were incubated for 5 minutes on ice with a 1:100 dilution of either FITC-
conjugated or RPE-conjugated Annexin-V in the presence of 2mM calcium chloride.
The platelet sample was then diluted 100-fold with cold calcium-free HBSS and
immediately analysed for green fluorescence by flow cytometry in a Coulter XL
benchtop flow cytometer using unstained platelets as an auto fluorescent control.
Annexin-V binding to platelets was discernible as a single log order (ten-fold) shift in
fluorescence signal. A widely used positive control for the assay are platelets that have
been activated in the presence of calcium ionophore A23187, which is known to cause
dramatic shedding of microvesicles and exposure of PS.
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2.9 Examination of platelet cardiolipin with 10-A/-nonyl acridine orange.
Nonyl acridine orange associates with cardiolipin (a phospholipid found exclusively in
mitochondria) and is thought to associate with mitochondria independently of their
energy state / membrane potential (Maftah et al., 1989). Therefore the dye has been
useful for the determination of mitochondrial biogenesis during cell cycle progression
(Leprat et al., 1990) estimation of mitochondrial mass (Pieri et al., 1993) and changes to
mitochondrial cardiolipin levels during aging (Maftah et al., 1994). Its use as a marker
of early cell death events involves its ability to detect the oxidation state of cardiolipin
(Nomura et al., 2000). The oxidation of cardiolipin, reduction of its synthesis or
interaction with caspase 8-cleaved tBid have all been shown to precede the release of
cytochrome c into the cytosol (Asumendi et al., 2002; Petrosillo et al., 2001; Shidoji et
al., 1999; Nomura et al., 2000; Ostrander et al., 2001; Lutter et al., 2000; Lutter et al.,
2001) suggesting that alteration of cardiolipin is an important and early determinant of
programmed cell death. Thus the inability of a cell to accumulate NAO is indicative of
changes to cardiolipin that may reflect either oxidation of the phospholipid or complete
loss of mitochondria. Caution is required when using NAO due to the fact that it is
sensitive to mitochondrial membrane potential, however it is not known if its failure to
be retained within mitochondria that have lost their membrane potential is due solely to
changes in AThn or due to concomitant changes to the biochemistry of cardiolipin
(Jacobson et al., 2002).
Platelets as a 1:500 dilution of PRP or washed concentration were incubated with
500pM solution ofNAO for 10 minutes at 37°C (a period of time that allowed maximal
loading of the dye as assessed by flow cytometry; see appendix fig. 8.3). Platelets were
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then analysed by flow cytometry for associated green fluorescence, which was two log
orders greater (100-fold) than unstained controls. For microscopy platelets were
incubated as a 1:50 dilution of PRP or washed platelets with 5nM NAO for 10 minutes
at 31°C. An aliquot of the sample (8pi) was then spotted onto a glass microscope slide
and gently cover-slipped. Excess fluid was removed using the corner of a tissue and
platelets were immediately viewed by epifluorescence microscopy.
2.10 Analysis of platelet viability using calcein-AM.
Calcein-acetoxymethyl ester is a non-fluorescent compound related to fluorescein that is
permeable to biological membranes. Diffusion of calcein-AM across the plasma
membrane introduces it to intracellular esterase activity that liberates free calcein, a
highly fluorescent and membrane-impermeable compound that is thus trapped within
the cell. Thus, the accumulation of calcein fluorescence within a cell relies on two
properties, esterase activity for the hydrolysis of the AM ester from calcein in order to
liberate free fluorescent calcein and an intact plasma membrane for the retention of the
free calcein. An inability to accumulate this dye is therefore indicative of cell death
relating either to loss of plasma membrane integrity or loss of esterase activity. As such,
calcein-AM is a useful marker of cellular viability and has been used to study cytotoxic
killing by T cells (Wang et al., 1993) the viability of Schwann cells (Decherchi et al.,
1997) and the detection of early apoptotic events in PC 12 and NIH3T3 cells (Gatti et
al., 1998). Although calcein has been used to label platelets for in vivo tracking of
thrombus formation it has not been used as a viability marker (Denis et al., 1998).
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For flow cytometric analysis of calcein-AM accumulation by platelets cPRP or washed
platelet suspension was diluted 500-fold in calcium free HBSS containing lOOnM
calcein-AM, incubated for 10 minutes at 37°C and then analysed for associated green
fluorescence. Calcein-AM did not significantly accumulate in platelets beyond the ten-
minute time-point. Preliminary experiments indicated that lOOnM calcein led to at least
a three hundred-fold increase in green fluorescence beyond the platelets' auto-
fluorescence. A similar (10-fold more platelets and 10-fold more calcein-AM)
methodology was followed for microscopic analysis of calcein accumulation.
2.11 Assessment of viability using FM4-64.
N - (3 - triethylammoniumpropyl) - 4 - (p-diethylaminophenyl - hexatrienyl) pyridinium
dibromide (FM4-64) is a lipophilic sytryl dye that has been used to label the vacuole in
yeast. It inserts into the plasma membrane and by an endocytic process that is both
energy and time dependent is trafficked to the vacuole (Vida and Emr, 1995). It has
been used with mammalian cells to specifically label the lysosomes of neutrophils
during phagocytosis of opsonised red blood cells (S. Grinstein pers comm. /
unpublished results) and to track exocytosis of synaptic vesicles from neurons
(Fernandez-Alfonso and Ryan, 2004). Due to independence of energy and temperature
for the initial insertion of the dye into plasma membranes but the dependence upon
energy, temperature and time for its trafficking, it was hypothesised that it may be
useful for differentiating viable from dead platelets by virtue of its maintenance at the
plasma membrane of dead cells but its endocytosis into viable cells. Thus when washed
Page 62 of 239
from the dye dead cells would have bright plasma membranes and viable cells would
have bright lysosomes.
For flow cytometric analysis of FM4-64 accumulation by platelets cPRP or washed
suspension were diluted 500-fold in calcium free HBSS containing 5pM FM4-64,
incubated for 10 minutes at 37°C and then analysed for associated red fluorescence by
flow cytometry or microscopy.
2.12 Analysis of platelet mitochondrial membrane potential using JC-1.
A mitochondrial stain used widely in the field of cell death research is 5,5',6,6' -
tetrachloro - 1,1',3,3'- tetraethylbenzimidazolyl - carbocyanine iodide (JC-1), a
membrane permeable organic cation that accumulates within the matrix of respiring
mitochondria (Smiley et al., 1991). Within the matrix JC-1 monomers stack to form
polymers, a process known as J-aggregation. Monomeric JC-1 emits fluorescence in the
green wavelength whereas staked JC-1 emits red fluorescence. This change in
fluorescence emission qualities allows for the ratiometric analysis of green to red
fluorescence and is a measure of mitochondrial membrane potential (ATm) (Cossarizza
et al., 1993). Treatment of cells with protonophores that disrupt ATm leads to the loss
of matrix JC-1 accumulation, consequent loss of red fluorescence and an increase in
green fluorescence. It is important to note that uptake by cells of JC-1 (like other
organelle-accumulating dyes) is dependent upon both ATm and plasma membrane
potential (ATp), thus cells with intact plasma and mitochondrial membrane potentials
have both red fluorescing mitochondria but also green fluorescence associated with
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cytoplasm. Loss of A^Pm but maintenance of AvFp therefore leads to reduced
mitochondrial-associated red fluorescence and increased cytoplasmic green
fluorescence. A number of caveats have arisen in the past few years regarding use of
this dye. It is thought that J-aggregation can occur spontaneously in solution and that
these aggregates can associate with cells yielding false positive results (pers. comm.
From the NIH List). It has been found that results gained with JC-1 and other, better
characterised, Afm-sensitive dyes such as tetramethylrhodamine do not necessarily
correlate with each other.
Platelets as 1:500 dilution of PRP or washed platelet suspension were incubated with
JC-1 solution (lpM) for 20 minutes at 37°C and immediately examine by flow
cytometry. Platelets with intact mitochondrial membrane potential display dual green
and red fluorescence whereas those without fail to accumulate JC-1 to their
mitochondrial matrices and thus do not contain red-fluorescing J-aggregates; such
platelets display higher green to red ratio of fluorescence. Gating on high red / low
green versus low red / high green platelets is discriminatory for platelets with and
without intact A^m, respectively (Cossarizza et al., 1993).
2.13 Examination of intraplatelet calcium (calcium^) with FLU03.
Fresh platelets or platelets stored in vitro for 24 hours were incubated as a 1:500
dilution of cPRP (in HBSS) for 30 minutes at 37°C with Fluo-3 at a final concentration
of 1 pM. Platelets were then analysed for green fluorescence using a Coulter XL bench-
top flow cytometer. Unstained platelets were used to establish autofluoresence, which
Page 64 of 239
was set to within the 1st log order of brightness. Increases in calcium® are detected as an
increase in green fluorescence which can be invoked by addition of agonists to platelet
suspensions. Results were expressed as mean fluorescence units (mfu).
2.14 Quantification of mitochondria within platelets.
Platelets were incubated for 30 minutes at 37°C in the presence of lOOnM Mitotracker
green and / or 200nM Lysotracker red. Platelets were allowed to spread on glass
coverslips for 10 minutes. Platelet mitochondria were seen as individual punctate
structures and do not share the 'string of beads' morphology characteristic of other cell
types. At least 50 platelets from sequential, non-overlapping fields of view were
quantified for the number of mitochondria.
2.15 Electron Microscopy.
Platelets in platelet rich plasma were fixed with an equal volume of 3% gluteraldehyde
in 0.1M sodium cacodylate buffer for at least 1 hour at 37°C. Fixed platelets were
pelleted, washed and processed for transmission electron microscopy with osmium
tetroxide, lead citrate, araldite embedding and 60nm sectioning. Samples were analysed
on a Philips CM12 transmission electron microscope.
2.16 Periodic Acid Schiff (PAS) staining of platelets.
Platelets were fixed with 1 volume of 2% formaldehyde at 37°C for 30 minutes, washed
from fixative by centrifugation at 500 x g for 5 minutes and resuspension in 14 volume
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of 0.5% periodic acid for 5 minutes at ambient temperature. Platelets were rinsed from
the acid solution by two washed (as described) with HBSS. The platelets were then
incubated with Schiff reagent (Vi original platelet volume) for up to 15 minutes or until
a colour change could be seen by eye. Platelets were washed from the reagent by one
wash in HBSS, resuspended in % volume ofHBSS. An aliquot of platelets was then
spotted onto a glass slide, cover-slipped and viewed under phase microscopy. Fields of
glycogen can be seen as red-purple bodies within megakaryocytes (Ogura et al., 1985)
and platelets (Woo et al., 2002).
2.17 SDS PAGE and Western Blotting.
Proteins from equal number of platelets per donor were lysed by boiling in Laemlli
buffer A. For analysis of hexokinase washed platelets in H2O were sonicated 5 times for
10 seconds each on ice to bring about incomplete destruction of membranes so that a
hard cetrifugation step performed at 13,000 rpm for 30 minutes at 4°C separated
membrane (pellet) from cytosolic fractions (supernatant). The respective fractions were
placed in one volume of Laemlli buffer A (for cytosolic fraction) or further treated with
1% Triton-X 100 in 100pi of PBS for 15 minutes on ice in order to liberate proteins
from membranes. Triton-treated pellet was re-centrifuged to obtain a supernatant
containing triton-solubilised proteins to which was added 1 volume (90pi) of Laemlli
buffer A.
Proteins were electrophoresed through either 6 or 12% acrylamide gels at 100V, blotted
onto a polyvinyl membrane at 400mA for lor 2 hours depending on whether one or two
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gels were being blotted. PVDF membranes were removed to 1% MeOH to fix proteins
to the membrane, rinsed in distilled water and transferred to Blocking Solution (BS) for
30 minutes at room temperature. Membrane was washed from the initial BS with three
5-minute washes in BS. Primary antibody was incubated with membranes for 1 hour at
RT to overnight at 4°C depending upon the antigen being detected. Non-specific
primary Ab was washed off the membrane as described above and secondary antibody
applied always as a 1:1000 dilution. Secondary antibody (Horse-raddish peroxidase
(HRP)-conjugated anti-(primary species) IgG) was incubated with the membrane for at
least 1 hour at RT, washed off as described and the blot was developed by incubation
with 0.01% 4-chloro-l-napthol solution in Tris-HCl (pH 7.5) with hydrogen peroxide as
substrate for HRP.
2.18 Zymography
Platelet protein samples were separated by size by SDS PAGE as described above,
however PAGE gels contained 1% gelatine. Gels were washed (2.5% [v/v] Triton X-
100) and incubated in digestion buffer (200 mM NaCl, 50mM Tris, 5 mM CaCf, 1.0
mM ZnCB, 0.02% [v/v] Brij-35, pH 7.6; all chemicals from Sigma) for 18 h at 37°C.
Gels were then stained in staining solution (0.5% [w/v] Coomassie blue R250 in 30%
[v/v] methanol/10% [v/v] glacial acetic acid in H2O for 3 h at 23°C, and destained
(staining solution without Coomassie blue) to reveal discrete regions of gelatin
degradation by gelatinases. A well-characterised sample of human amniotic fluid
collected at term during active labour was used as a positive control, which clearly
demonstrated the latent and active forms ofMMP-2 (72 and 66 kDa, respectively) and
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the latent form ofMMP-9 (92 kDa), and the minor bands the dimeric form ofMMP-9
(approximately 210 kDa) and the lipocalin-MMP-9 complex (125 kDa) (Riley et ah,
2001; Riley et ah, 2004). Platelets are known to contain both MMP-2 and MMP-9
(Fernandez-Patron et al., 1999).
2.19 Anthrone assay of platelet glycogen content.
Glycogen content of platelets was estimated using the method of Seifter et al (Seifter et
al., 1950). Platelets (1ml PRP) were pelleted by centrifugation at 13.5K rpm for 1
minute. After removal of the supernatant the pellet was resuspended in 500pl 30% KOH
and placed immediately at 100°C for 20 minutes, this step lyses platelets and destroys
glycolytic enzymes that would otherwise begin catabolism of glycogen. The boiled
solution was then diluted with 1ml of 100% EtOH in order to precipitate glycogen and
other glycoproteins which were centrifuged from their supernatant for 15 minutes at
4000 x g. The supernatant was removed and the resultant white pellet was dissolved in
500pl of H2O. Anthrone (1ml of a freshly prepared 0.2% solution in H2SO4) was added
to the dissolved glycogen and boiled for 10 minutes. A colour change from yellow to
blue / black occurs due to the reaction of anthrone with glucose monomers liberated by
acid hydrolysis from glycopeptides and glycogen. Absorbance of boiled solutions was
performed was read at 625nm using anthrone solution as a zero baseline reading and a
serial dilution of glucose as a standard curve (see appendix fig. 8.2). Since inception of
the assay many groups working on a diverse range of cell types have used it extensively
for the estimation of cellular glycogen (Carroll et al., 1956; Murphy and Gardner, 1971;
Chun and Yin, 1998; Muriel and Deheza, 2003).
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2.20 Isolation and culture of murine peritoneal macrophages.
Mice were sacrificed by dislocation of the cervical vertebrae. The peritoneal cavity was
injected through a 19-gauge needle with 5ml of ice cold sterile PBS. Whilst the needle
remained within the peritoneum the abdomen was gently squeezed several times in
order to mix the PBS around the cavity. As much of the injected solution was then
aspirated from the peritoneum and then transferred to 15ml Falcon tubes and the cell
suspension was held on ice until washing. Time of transfer from the animal housing
facility to the laboratory laminar flow cabinets was within 5 minutes. Cell suspensions
were washed by initially centrifuging cells at 4°C at 300 x g for 5minutes. The cell
pellet was then suspended in DMEM to a final concentration of lx 106cells/ml. Cells
were then seeded onto 24 well culture dishes (1ml of cell suspension / well) and allowed
to settle for 2 hours at 37°C. Non adherent cells were washed from the dish with three
rinses of pre-warmed DMEM. The remaining adherent cells are enriched in peritoneal
macrophages. This protocol is used extensively within and without this laboratory for
the enrichment of murine peritoneal macrophages.
2.21 Phagocytosis of platelets by mouse peritoneal macrophages.
To demonstrate that dead platelets could be recognised and phagocytosed by
macrophages peritoneal cells collected as described above were incubated with cell
tracker green labelled platelets (suspended in DMEM) that had been aged for 6 days at
37°C (a time point that was consistently associated with >90% platelet death).
Incubation was carried out at room temperature for 30 minutes. Cells were then stained
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with Hoechst 33342 to label nuclei, and lysotracker red (lOOnM). These dyes
accumulate quickly within their target organelles (within 5 minutes at RT) and allow the
discrimination of nuclear morphology (Hoechst) and phagolysosome localisation
(LTR). Platelets alone did not uptake the dyes to amounts remotely equivalent to the
macrophages and remained non-fluorescent in their respective channels (blue and red,
respectively). Thus, co-localisation of the green platelets with equivalently sized
LTR+ve structures within the macrophages confirmed intemalisation of platelets. Fresh,
viable platelets were used as controls and examined for their incorporation into
lysosomal compartment of macrophages. No phagocytic events were recorded with
fresh platelets indicating that macrophages relied on the development upon platelets of a
recognition signal that promoted their association and phagocytosis by macrophages.
2.22 Statistics.
The Paired Students T-Test was used to establish significant differences between means
with P values below 0.05 being deemed significant. For multiple parameter studies such
as time courses and comparisons between more than two means Analysis of Variance
(ANOVA) test was used. Means are always expressed with standard errors of the mean
(+/-SEM).
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3.1 Abstract.
Platelet death and its consequences for haemostasis are poorly understood. In
an attempt to understand events associated with platelet death a number of
novel vital stains were identified as useful tools for the assessment of platelet
viability. Predictably, platelets incubated over time at 37°C lost the ability to
aggregate, activate integrins and degranulate in response to agonists. Electron
microscopy revealed a necrotic-like endpoint for platelets stored in vitro.
Platelets lost the ability to accumulate Calcein-AM and the cardiolipin-specific
stain 10-A/-nonyl acridine orange but concomitantly became able to bind the
styryl lipophilic dye FM4-64. All stains appeared to discriminate a platelet sub-
population that displayed morphological characteristics of cell death such as
cytoplasmic condensation and reduced forward and side scatter by flow
cytometry. Platelet death appeared to be analogous to the platelet storage
lesion and the phenotype of platelets within thrombi in vivo.
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3.2 Results.
3.2.1 Platelets lose functional responsiveness to agonists during in vitro
storage at 37°C.
It is accepted widely that platelet storage and senescence are associated with loss of
function. To confirm that platelets were losing functional responsiveness during in vitro
storage they were subjected to tests of both degranulation and integrin activation as
assessed by increased surface expression of CD62P and fibrinogen binding (fig 3.1A
and B, respectively) in response to TRAP. Both assays indicated a progressive loss of
function during storage in vitro; CD62P expression in response to 20pM TRAP was
reduced by approximately 50% at 48 hours of storage, whereas fibrinogen binding was
reduced by over 80% by the same time («=3, P<0.01 for both assays). Furthermore,
aggregation in response to calcium ionophore, A23187 (lOpM) (fig. 3.2) indicated a
progressive and significant reduction in the platelets' ability to aggregate during storage
with complete loss of aggregability achieved by 96 hours of incubation (P<0.01).
3.2.2 Annexin-V binds a sub-population of in vitro-aged platelets.
Annexin-V has been used to identify dead cells, to establish platelet death in vitro
(Brown et al., 2000) and to identify senescent platelets in vivo (Pereira et al., 2002). In
this work fresh platelets did not bind annexin-V whereas a sub-population of platelets
aged in vitro for 24 hours did (P<0.01) (fig. 3.3), however there was no difference in
results for platelets incubated in PRP and those washed and incubated in calcium-free
HBSS (P=0.336; n=4 different donors).
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3.2.3 Ultrastructural changes.
Platelets freshly isolated from human donors were discoid, contained discrete granules,
glycogen particles, uniformly electron-dense cytoplasmic material and mitochondria
(fig. 4A). Overnight incubation at 37°C led to the appearance of a sub population of
platelets that displayed varying degrees of plasma membrane integrity (from fully intact
to grossly degenerate). Some granules within these platelets were apparently retained in
an intact form without signs of degranulation / plasma membrane fusion, whereas others
appeared to have fused with one and other. Cytoplasm was collapsed into clumps. These
platelets were phenotypically similar to the Tysed and ballooned' platelets observed
previously in stored platelet concentrates (Solberg et al., 1986) and within mural
thrombi formed in vivo (fig. 3.4.C) (Jorgensen et al., 1967; Davies et al., 1975) or as a
result of in vitro aging (Brown et al., 2000). The remaining platelets retained their
resting morphology and had no signs of activation (fig 3.4.B).
3.2.4 10-Nonyl acridine orange (NAO) fails to accumulate in a sub-
population of in vitro aged platelets.
NAO specifically associates with cardiolipin and was used to assess the presence in
platelets of mitochondria independently of their membrane potential. The dye at 500pM
accumulated within fresh platelets within 10 minutes of incubation at 37°C, whereas
platelets incubated for 24 hours contained a sub-population that showed morphological
signs of cell death (spherical rather than discoid shape, condensed cytoplasm and large
vacuolated areas) that were unable to accumulate the dye (fig. 3.5.A). Cytometric
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Figure 3.1. Platelets lose the ability to express CD62P and bind
Fibrinogen in response to TRAP during in vitro storage at 37°C.
Freshly isolated or in v/'fro-aged platelets were activated with 20pM TRAP
in the presence of Alexa488-conjugated fibrinogen, fixed and examined for
surface expression of CD62P (A) and fibrinogen binding (B). A significant
decrease in both parameters is observed by 24 hours of storage and
further decreases by 48 hours. n=3 different donors; +/-SEM; *P<0.01
from day 0.
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Figure 3.2. Platelets lose the ability to aggregate in
response to calcium ionophore, A23187 during in vitro
storage at 37°C.
Freshly isolated or in vitro-aged platelets were activated with
10pM A23187 in the presence of 2mM calcium chloride and
allowed to aggregate for 5 minutes. /?=3; +/-SEM; *P<0.01.















Figure 3.3. Platelets become able to bind Annexin-V during in vitro
storage at 37°C.
Platelets were incubated at 37°C for 24 hours as PRP or washed and
suspended in calcium-free HBSS. Platelets were stained with annexin-V
in HBSS containing 2mM CaCI2 in an iced water bath for 5 minutes and
analysed by flow cytometry for positive events using unstained platelets
as an autofluorescent control. rt=4; +/-SEM; *P<0.01 from Time 0.
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Figure 3.4. The death of platelets is associated with a necrotic
morphology.
Platelets were freshly isolated (A) or incubated as platelet rich plasma for
24 at 37°C (B), fixed with 3% gluteraldehyde and processed for TEM. A
micrograph from Jorgensen et al.,(Jorgensen et al., 1967) illustrates the
similarity between in vitro aged platelets and platelets within an
experimentally induced porcine arterial thrombus (arrowheads, C).
Original magnification in A and B x17,000. Micrographs are
representative of many platelets from several donors.
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analysis of platelets revealed that 3.8 +/-1.7% of freshly isolated platelets failed to
accumulate the dye. During storage the NAO"VE subpopulation became increasingly
common and rose to 15.2 +/-3.1% at 24 hours; n=3 different donors; p<0.01 (fig.
3.5.B.i). Back-gating on the NAO"VE population revealed that these platelet events had
reduced forward and side scatter compared to NAO+VE events (fig 3.5.B.ii).
3.2.5 Dead platelets fail to accumulate calcein-AM but bind FM4-64.
Freshly isolated platelets incubated in the presence of lOnM (for cytometry) or lOOnM
(for microscopy) calcein-AM became fluorescent within 10 minutes (fig. 3.6.A).
Washed platelets and platelets in diluted PRP accumulated calcein to a similar level as
un-manipulated platelets. By microscopy it was clear that calcein was able to
accumulate in the platelets' cytoplasm but also to discrete (but as yet unidentified)
granules (fig. 3.6A). Incubation of platelets as cPRP, diluted cPRP (dcPRP) or washed
and suspended in calcium-free HBSS at 37°C led to the appearance of a subpopulation
of platelets that could no longer accumulate calcein. There was no change in the ability
of the main platelet population to accumulate the dye (fig. 3.7) indicating that platelets'
ability to accumulate the dye is lost abruptly rather than gradually. Morphological
examination by microscopy indicated that these calcein"VE platelets shared
characteristics with the lysed and balloon platelets seen at the TEM level. The calcein"VE
platelets were spherical and had collapsed cytoplasm with residual material and
granules associated with the periphery of their plasma membrane.
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As part of a separate study examining the role of the lysosomes in platelet biology it
was noted that although freshly isolated platelets poorly accumulated the yeast vacuole
marker FM4-64 the calcein~VE platelets were ten-fold more brightly stained with the
dye. The dye appeared to be inserted into the plasma membrane of dead platelets with
some staining associated also with residual cytoplasmic material (fig. 3.6). Bivariate
analysis of aged platelets indicated that the calcein"VE platelets were FM4-64+VE and that
no other sub-population existed (fig. 3.7.A).
Activation of fresh platelets with 20pM ADP or 50ng/ml convulxin in the absence of
stirring indicated that the platelets' activation status did not affect the accumulation into
platelets of calcein nor did it allow the insertion of FM4-64 into platelets (fig. 3.8.A, B
and C).
3.2.6 Calcein-VE / FM4-64+VE platelets fail to bind fibrinogen or exhibit a
calcium response when stimulated with convulxin.
The morphological data collected at the light and electron microscopic level indicated
that a population of dead platelets arose during in vitro storage at 37°C. Although there
was correlation between this morphology and changes to the platelets' ability to
accumulate calcein and NAO or allow the insertion of FM4-64 into their plasma
membrane, it was necessary to demonstrate loss of function in these platelets. To
establish that these platelets could no longer activate integrins nor evoke calcium
response they were stimulated with convulxin after staining with FM4-64.
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Figure 3.5. Platelets displaying signs of death fail to accumulate
NAO.
Platelets were aged in vitro at 37°C for 24 hours and stained with 500pM
nonyl-acridine orange for 10 minutes. Incubation of platelets with NAO
defines two populations that either do or dont accumulate the dye. (A)
Micrographs depict 4 platelets aged in vitro for 24 hours; only one platelet
has accumulated NAO (arrowhead), three platelets displaying features of
cell death (loss of resting shape, condensed cytoplasm and
vacuolisation) failed to accumulate the dye (arrows). (B.i) Cytometric
analysis of NAO-stained fresh (green) or in vitro aged (red) platelets is
shown.(B.ii) Back-gating on NAO-negative platelets reveals they have
decreased forward scatter relative to NAO positive platelets. Micrographs
and cytomery data are representative of stored platelets from many
different donors (>30).
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Figure 3.6. Platelets displaying signs of death are FM4-64 positive
and calcein negative.
Platelets were incubated for 24 hours at 37°C, stained with 100nM
calcein-AM and 10pM FM4-64 for 10 minutes and allowed to spread on
glass for 5 minutes at room temperature. Viable platelets were calcein
positive but FM4-64 negative whereas dead platelets showed the
opposite staining pattern (A). Confirmation that dead cells were indeed
platelets was sought with anti-CD41 staining (B). Bar = 3pm. Micrographs
are representative of platelets from many different donors.
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Figure 3.7. Subpopulations of platelets can be identified by
cytometry either with Caicein-AM or FM4-64.
Platelets were aged for 72 hours and stained with both 100nM Calcein-
AM and 5pM FM4-64. Bivariate analysis establishes that calcein-AM
negative platelets are FM4-64 positive (A), thus the dyes can be used
interchangeably. Histograms of fresh and stored platelets (blue and red
lines, respectively) illustrate the fluorescence shift associated with platelet
storage for FM4-64 (B), a positive shift to the right; for calcein-AM (C) a
negative shift to the left.
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Figure 3.8. Activation does not affect platelets ability to accumulate
Calcein-AM.
Platelets were activated in the presence of 2mM CaCI for 10 minutes with
no agonist (A); 20|iM ADP (B) or 50ng/ml convulxin (C) and stained for a
further 10 minutes with 10nM calcein-AM. Autofluorescence was set
within the first log order of brightness with non-activated, unstained
platelets. Activation can be confirmed as a change in forward and side
scatter from a resting-state dot plot (A) to an activated 'comet-tailed' dot
plot scatter (B and C). Data are representative of data from two different
donors.
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Activation of platelets with convulxin after being incubated for 24 hours indicated that
FM4-64+ve platelets failed to activate anbP3 integrin complex (fig. 3.9) and failed also
to produce a calcium signal (fig. 3.10) as evidenced by their lack of ability to bind
labelled fibrinogen and exhibit increased Fluo-3 fluorescence signal, respectively.
Similar data were obtained with thrombin and ADP indicating that the inability to
respond to agonists was not unique to a single receptor or signalling pathway (data not
shown).
3.2.7 Platelets die less quickly at ambient temperature than when at 37°C.
Platelets stored for subsequent transfusion are kept at 20°C. This temperature is a
compromise due to the fact that platelets stored at lower temperatures are cleared
rapidly from circulation upon transfusion, a process thought to be mediated by CR3 on
hepatic macrophages (Hoffmeister et al., 2003). Although there is much interest in
improving platelet storage conditions few reports exist as to the retention of viability of
platelets at various storage temperatures.
Therefore it was of fundamental interest to establish the rate of death for platelets stored
as PRP at both 37°C and ambient temperature (estimated to range from 18 to 22°C).
Bivariate analysis of platelets stained with calcein-AM and FM4-64 indicated that
platelets died at the significantly different rates of 13.5 +/-0.9% platelets.day"1 and 6.0
+/-1.5% platelets.day"1 at 37°C and ambient temperature, respectively (n=3 different
donors; P«0.01) (fig. 3.11).
Page 85 of 239
3.2.8 Dead platelets are phagocytosed by mouse peritoneal cells.
The ultimate fate for many dead cells lies within the phagolysosome of professional
macrophages and semi-professional phagocytes. This process of effete platelet
destruction has been demonstrated in vitro for platelets and is confirmed in this work.
Platelets stained with Cell tracker green (CTG) and aged for 6 days (a time-point that is
associated with >90% platelet death) were introduced to mouse peritoneal lavage cells
that are routinely used in this lab for the isolation of macrophages. Although the crude
cell population contains monocytes, neutrophils and epithelial cells it is found that only
peritoneal resident macrophages are capable of ingesting apoptotic neutrophils.
Therefore it was assumed that observation of any phagocytic events was evidence of an
interaction between macrophages and dead platelets. Confirmation of internalisation
was achieved using lysotracker red that accumulated within macrophage lysosomes but
did not associate with platelets. Examination of lysotracker red-stained cells after 30
minutes indicated the presence of green platelets within red lysosomes compartment
(fig. 3.12), confirming the observations made by others (Brown et al., 2000; Clarke et
al., 2003) that dead platelets produced in vitro are a target for phagocytosis.
3.2.9 Microvesiculating platelets are calcein-VE and FM4-64+VE.
It is likely that microvesicles shed from platelets are not viable cellular entities. It was
therefore reasoned that microvesiculation could be identified using calcein-AM and
FM4-64. To confirm this hypothesis platelets that were allowed to spread on glass were
then treated with either DMSO or 10pM A23187 to induce vesiclulation and
subsequently stained with calcein and FM4-64 (fig. 3.13). Control platelets (DMSO
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treated) accumulated calcein but very little FM4-64, which appeared to accumulate
within the central, granular region of the platelet. Platelets treated with A23187 to
induce microvesiculation were unable to subsequently accumulate calcein but did allow
the insertion ofFM4-64 into their plasma membranes and developing microvesicles.
3.2.10 Calcein and FM4-64 differentiate "medulla" and "cortex" regions of
large platelet aggregates.
Although the activation of fresh platelets in the absence of agitation did not lead to
changes in their ability to accumulate calcein or FM4-64, the results obtained with
vesiclulating platelets led to the hypothesis that platelets within aggregates (and thus
within an environment of high agonist concentration) would be vesiculating and that the
core of an aggregate is essentially dying. To explore this hypothesis platelets were
aggregated in response to collagen or TRAP within an aggregometer in the presence of
2mM CaCh- Platelet aggregates were then incubated with calcein-AM and FM4-64 for
20 minutes and examined by fluorescence microscopy.
It was clear that larger aggregates of platelets contained a "medulla" region of FM4-64
positive that was devoid of calcein accumulation, whereas the "cortex" was populated
by platelets that retained the ability to accumulate calcein but did not bind FM4-64 (fig.
3.14). Phase microscopy revealed also that the region of FM4-64+VE platelets coincided
with the deposition of fibrillar material presumed to be fibrin.
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3.2.11 Platelet aggregation is associated with platelet degeneration.
Freshly isolated platelets were aggregated in response to fibrillar collagen and allowed
to settle for 1 hour at 37°C. The aggregates were then fixed and prepared for electron
microscopy. Examination of sections revealed the presence of a complex array of
platelet and 'post-platelet' morphologies (fig. 3.15). Although many intact platelets in
various stages of activation could be seen there were also many that were devoid of
granules, containing dilute cytoplasm with misshapen peripheral membranes that often
contained gaps. Large areas of the sections were populated by microvesicles of varying
electron density, size and granularity. Furthermore, there were extensive areas of gel¬
like material of intermediate electron density that was unlike grouped platelets or
vesicles. The material existed outside other structures that had limiting membranes and
appeared to be confluent, with no recognisable cellular organisation of its own.
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Figure 3.9. Dead platelets are unable to bind fibrinogen in response
to convulxin.
Washed platelets were activated with 100ng/ml convulxin in the presence
of 20pg/ml Alexa488-conjugated fibrinogen whilst fresh or after incubation
overnight in calcium-free HBSS. Platelets were then stained with FM4-64
to differentiate live from dead and analysed by flow cytometry for
fibrinogen binding. Fresh platelets (Ai and ii); aged platelets (Aiii and iv).
Non activated platelets (Ai and iii); activated platelets (Aii and iv).
Fibrinogen positive platelets are gated in the right quadrants and dead
platelets are gated in the upper quadrants. Cytometry plots are
representative of data from 4 different donors (A). Quantified data from 4
donors (B); +/-SEM; *P<0.01.
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Figure 3.10. FM4-64+VE platelets do not give a calcium signal in
response to convulxin.
Platelets were incubated for 24 hours, stained with 5pM FM4-64 for 10
minutes and loaded with 1 nM Fluo-3 for 30 minutes. Platelets were then
stimulated with 100ng/ml convulxin in the presence of 2mM CaCI2 or left
in their resting state. Activation was allowed to proceed for 1 minute prior
to flow cytometric analysis of green fluorescence. Cytometry plots are
representative of results from 2 different donors.
Page 90 of 239
0 24 48 72 96 120 144
Hours
Figure 3.11. Platelet death is slower at ambient temperature.
Platelets were stored as PRP supplemented with 2mM MgS04 at either
37°C or ambient temperature for six days. Staining platelets with FM4-64
assessed death. Only CD41 positive events were collected and FM-4-64
positive events were deemed to represent dead platelets, n = 6; +/-SEM.
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Figure 3.12. Macrophages phagocytose dead platelets.
Cell tracker green (CTG)-labelled platelets were incubated at 37°C as
cPRP for 6 days (a timepoint where >90% have lost viability as assessed
by their inability to accumulate calcein-AM). Platelets were washed from
their incubation fluid and resuspended in DMEM containing 10 % foetal
calf serum and incubated in suspension with murine peritoneal cells for
30 minutes at ambient temperature on a Rollimixer. Nuclei and
lysosomes were then stained with Hoechst 33342 and lysotracker red,
respectively. Phagolysosomes (arrowhead) and phagolysosomes
containing CTG+VE platelets (asterisks) were readily observed. Platelets
outwith phagolysosomes do not colocalise with LTR (arrowhead). Bar =
10pm. Micrographs are representative of data collected from two different
donors.
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Fig 3.13. Microvesiculating platelets are calcein"Vfc and FM4-64+vt.
Platelets were allowed to spread for 20 minutes on glass and then treated
for 5 minutes with either 0.01% DMSO (control) or 10pM A23187. Platelets
were then stained with 100nM Calcein-AM and 5pM FM4-64. Control
platelets accumulated calcein and failed to allow FM4-64 insertion into their
plasma membrane, whereas A23187-treated platelets were unable to
accumulate calcein but did allow FM4-64 insertion into both developing
vesicles and the plasma membrane. Bar = 5pm. Images are representative
of data collected from serval donors.
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Fig 3.14. Calcein and FM4-64 differentiate a cortex and medulla within
larger platelet aggregates.
Platelets were aggregated with 1 jag/ml collagen for 5 minutes and stained
with 100nM calcein-AM (green) and 5pM FM4-64 (red) for a further 10
minutes and viewed by epifluorescence microscopy. Aggregates of various
sizes consistently showed strict organisation of FM4-64" E / Calcein-AM+VE
platelets to their external surface and FM4-64+VE / Calcein'°w within their
medulla. The apparent death of platelets appears to involve the production
of small vesicles that bind FM4-64 but fail to accumulate calcein-AM
(arrowheads, B.iv). A fibrillar material (presumed to be fibrin) can be seen
associated with areas of apparent platelet death (arrowhead B.i). Bar =
50pm (A); 10pm (B). Images are representative of data collected from serval
donors.
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Fig 3.15. TEMs of platelets within collagen induced aggregates 1 hour
after formation.
Platelets were aggregated with 1pg/ml collagen for 5 minutes and fixed with
1.5% gluteraldehyde and prepared for transmission electron microscopy. A
variety of changes appear to have taken place such as the formation of a
'gel' (i and iv), degranulation (ii), necrosis (ii) and microvesiculation (iii and
iv). Images are representative of many platelet aggregagates from a single
donor.
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3.3 DISCUSSION.
Despite the clinical and academic importance of platelets there have been very few
attempts to phenotype dead or dying platelets, define their program of cell death or
relate these changes to alterations in haemostasis. There are clear technical difficulties
associated with working on highly refractory cells such as platelets. It is widely
understood that without exogenous manipulation of their ex vivo environment platelets
become activated. The most widely used method achieving this is the chelation of
calcium(ex). However, even when this has been done it is possible still to stimulate
platelets to the point of activation using sub-physiological temperatures or agonists
such as thrombin and collagen; therefore chelation of calcium does not guarantee the
inhibition of platelet activation. A major concern in the current work was whether or not
platelet death was the result of activation. Previous work demonstrated that
degranulation occurred prior to death but the authors were unable to conclude that
degranulation was necessary for the death process (Brown et al., 2000). Due to the
similarities between certain types of platelet activation and programmed cell death it
was very important to avoid manipulating platelets in order to answer the question of
whether or not their death occurs independently of activation. Furthermore, it is unclear
what net result platelet activation has upon platelet lifepsan in vitro or for that matter, in
vivo.
Loss of functionality is a common feature of platelet storage and was confirmed in this
work by examination of aggregation in response to calcium ionophore and integrin
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activation and degranulation in response to TRAP. Confirmed also was the development
of a sub-population of platelets that could bind annexin-V. It is not clear if annexin-V
binding to platelets is a result of lost membrane asymmetry or lost membrane integrity
as no dyes were used that could discriminate between the two, however TEM data
indicated the presence of platelets that had lost membrane integrity. Deliberate
manipulation of membrane integrity with detergents such as saponin followed by
assessment of annexin-V binding may help to resolve this question.
The current data are in disagreement with a previous report that incubation of platelets
in the absence of plasma leads to accelerated cell death (Brown et al., 2000). The
reasons for this are unclear but may reflect a lack of magnesium (a crucial cofactor for
ATP) in the plasma-free incubation medium and / or the 5-fold greater amount of CaCb
in the annexin-V binding buffer (lOmM versus 2mM used in the present work) or a
combination of factors that promoted platelet PS exposure in response to annexin-V
binding buffer.
Previous examination of platelets aged in vitro led to the hypothesis that a program of
cell death occurs that is independent of caspase activity (Brown et al., 2000).
Ultrastructural examination of the platelets aged as platelet rich plasma or as diluted
PRP revealed the presence of two conspicuous platelet populations, a resting population
and one where resting shape was lost to a spherical morphology with dilute internal
cytoplasm that was condensed in some areas. This population showed signs of granule
fusion, organelle loss, loss of glycogen and loss of plasma membrane integrity. Apart
from the formation of large vacuoles that appeared to be independent of platelet death
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(discussed in a later chapter) there was no evidence of a progressive death phenotype
over and above a sudden and catastrophic loss of cellular integrity. Interestingly the
caspase-independent cell death program described previously was not associated with
signs of necrosis, despite TEMs showing gaps within the plasma membranes of in vitro
aged platelets (Brown et ah, 2000; Clarke, 2002). The progression of platelets in that
model also appeared to involve P-selectin expression, something that was not seen in
the current work, thus platelet death can occur independently of P-selectin expression.
This raises the possibility that P-selectin expression in the previous model was due to
activation and that the phenotype of dying platelets was affected by this event.
The phenotype described in this thesis is not uncommon in the literature, being similar
to platelets treated with a combination of thapsigargin and thrombin (Stuart et al., 1995)
or the calcium ionophore, A23187 (Gerrard et al., 1974) but it is similar also to the
phenotype of platelets that develop platelet storage lesion during ex vivo storage.
Platelets activated with ionophore or with physiological agonists in the presence of
thapsigargin display within seconds sphering, dilution of their cytoplasm and
microvesiculation. Thapsigargin is known to increase intracellular calcium
concentration due to inhibition of calcium uptake into the dense tubular system
(Engelender et al., 1995). In synergy with agonist it has a potent effect on the platelets'
plasma membrane lipid asymmetry and allows for the study of annexin-V binding to
exposed PS (Stuart et al., 1995; Dachary-Prigent et al., 1995). Also the phenotype is
similar to that induced by the calcium ionophore A23187. This platelet agonist is non-
physiological but is used widely for the study of platelet biology. The ionophore
abolishes divalent cation gradients within cells by binding and transporting cations
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across membranes; thus it causes dramatic emptying of calcium stores and a rapid rise
in cytoplasmic calcium concentration in platelets leading to activation and, in particular,
microvesicle formation with PS exposure (Chang et ah, 1993; Dachary-Prigent et ah,
1993). Other agonists such as ADP or thrombin produce less dramatic events such as
integrin activation and degranulation and are not associated with PS exposure or
vesiculation unless in conjunction with collagen (or thrombin). Both the calcium
ionophore and thapsigargin based platelet activation strategies are known to induce the
formation ofmicrovesicles by platelets, a process that appears to depend upon the influx
of extracellular calcium through store-operated calcium channels (SOCCs) (Pasquet et
ah, 1996) and the activation of calpains (Wolf et al., 1999).
Microvesicle formation during storage of platelets was not observed either at the
electron or light microscopic level in this thesis. This may be a reflection of the low
calcium environment of platelet storage, which could conceivably prejudice any
contribution that an influx of calcium into platelets has on the vesiclulation process;
however this pre-supposes that calcium stores are depleted during storage and that
SOCC has become activated, a possibility examined in Chapter 6.
The phenotype of dead platelets is most similar to descriptions of the platelet storage
lesion (Murphy and Gardner, 1969; Solberg et al., 1986) a common but poorly
understood consequence of platelet storage ex vivo for transfusion purposes. It is likely
that PSL and the platelet death observed in this work and by others (Brown et al., 2000;
Clarke et al., 2003) are the same. PSL is known to be associated with a toxic increase in
intraplatelet lactate (Bode and Miller, 1989; Bertolini et al., 1993) and raises the
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possibility that if a catastrophic loss of integrity was witnessed in this thesis it was due
to a metabolic dysfunction which led to necrosis, a process that can have many
similarities to programmed cell death (Kroemer et ah, 1998; Vande Velde et ah, 2000).
To avoid the labour intensity associated with electron microscopy a reliable high-
throughput methodology for the analysis of dead platelets was sought. During the
course of the thesis it was of interest to establish the whereabouts of mitochondria using
a dye that accumulated in the organelles independently of their ATm. It was found that
10-M-nonyl acridine orange was able to accumulate to small structures within platelets
consistent with its ability to associate with cardiolipin, a charged phospholipid found
exclusively in mitochondria. NAO accumulated in >95% of freshly isolated platelets but
failed to accumulate within a sub-population of in vitro aged platelets displaying signs
of lesion, suggesting a qualitative change to mitochondria / cardiolipin that occurred at
this point which prevented the accumulation of NAO within platelets. Microscopic
examination of stored platelets consistently revealed that only those platelets exhibiting
lesion failed to accumulate the dye.
This prompted two questions; if NAO was accumulating independently of ATm what
second event caused loss of NAO accumulation and is this second event the cause or
consequence of lesion? To examine these questions in detail the mitochondria and
changes to them caused by experimental manipulation were examined and form the
body of work presented in another chapter.
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It was found that the liberation of fluorescent calcein from calcein-AM could be used as
an indicator of platelet viability. Freshly isolated platelets readily accumulated the dye
in their cytoplasm and more so to discrete granules. Calcein+VE platelets could spread on
glass, indicative of viability and responded to agonists such as TRAP and ADP.
Platelets accumulated calcein comparably well after 10 minutes under unstirred
conditions in the presence of maximal doses of ADP, CVX or TRAP; therefore calcein
accumulation occurred independently of single platelets' activation status.
Microscopic and cytometric examination of platelets incubated for 24 hours at 37°C and
then 10 minutes in calcein-AM at 37°C revealed that a subpopulation of platelets could
no longer accumulate the dye; by microscopy these platelets were morphologically
distinct from calcein+VE platelets. Calcein"VE platelets showed signs of PSL such as
cytoplasmic condensation and did not spread on glass nor respond to agonists. The
calcein"VE platelets had also reduced forward and side scatter characteristics by flow
cytometry, another identifier of cell death. It is not clear if calcein-AM fails to
accumulate in lesioned platelets due to loss of esterase activity or due to loss of
membrane integrity. However, it is likely that these platelets are the same ones that
cannot accumulate NAO. This hypothesis was not tested because the molecules have
similar fluorescence emission spectra that cannot be differentiated by cytometry.
Nonetheless, the rate of platelet lesion over several days in vitro was similar whether
examined with NAO or calcein. Thus the abilities to accumulate NAO and liberate
calcein are lost simultaneously. The observation at the TEM level that plasma
membrane integrity is lost in platelets exhibiting other signs of PSL is suggestive that
the ability of platelets to accumulate calcein is dependent on them having an intact
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plasma membrane. Loss of plasma membrane integrity would allow annexin-V to bind
PS on both the endo- and exofacial sides of the plasma membrane (which is why plasma
membrane-sensitive dyes are used in conjunction with annexin-V to discriminate
between apoptosis and necrosis). Thus it is possible that the lesion / death of platelets
detected by annexin-V, NAO and calcein-AM is the result of a loss of plasma
membrane integrity leading to swelling of platelets due to influx of solutes.
It was demonstrated that the platelets displaying signs of cell death by morphology
could associate with substantially more of the yeast vacuole marker FM4-64 than viable
platelets. The reason for the association of this dye with dead platelets is not
understood, however similar results are obtained with dead neutrophils (the dye binds
only the apoptotic and necrotic cells). When used with viable yeast the dye inserts into
the plasma membrane at low temperatures and within 20 minutes of transfer from 4°C
to 25 °C endocytosis of the dye and its accumulation at the vacuole can be observed
(Vida and Emr, 1995), however this does not appear to occur with fresh platelets. Even
with extended periods of time at 37°C, the dye did not associate with the plasma
membrane or accumulate within discrete organelles of fresh platelets. This may reflect
the dye's usage at a lower concentration in this study than with yeast (5pM compared to
40pM with yeast) but may also suggest fundamental differences between the plasma
membranes of yeast and that of platelets / animal cells. Dye insertion into the plasma
membrane of dead platelets may reflect the known changes in membrane asymmetry
and charge that accompany cell death (Morris et ah, 1984; Savill et ah, 1989). Dual
labelling of platelets indicated that association of FM4-64 with dead platelets' plasma
membrane occurs concomitantly with the platelets' inability to accumulate calcein and
Page 102 of 239
that no other platelet populations were defined. Using FM4-64 it was confirmed that
FM4-64+ve platelets were unable to respond either by initiating a calcium signal or
binding fibrinogen in response to strong agonist such as convulxin. It was demonstrated
also that dead but not viable platelets could be internalised by phagocytes. These data
are strong arguments in favour of the conclusion that NAO; calcein and FM4-64 are
capable of detecting dead platelets. Although there is strong evidence for a necrotic
endpoint for platelets in vitro it is not possible to determine if the dyes utilised in this
study are capable of detecting only necrotic or a mix of both pre and post-necrotic
platelets.
It was found that platelets aged for several days at 37°C died more rapidly than those
kept at ambient temperatures. The use of vital stains in conjunction with cytometry is a
worthwhile means of exploring platelet storage conditions.
Platelet micro-vesicle formation has long been regarded as a process similar to that of
apoptotic 'blebbed' body formation, however microvesiculation is effected by calpain
rather than caspase activity (Wolf et al., 1999) and there is indirect evidence suggesting
that PS exposure associated with platelet vesiclulation is distinct from that observed
during apoptosis (Williamson et al., 2001). Despite these differences it was probable
that platelet microvesicle formation was detectable with FM4-64 and calcein-AM. It is
unlikely that these activation-dependent events are similar to what causes lesion, but it
was demonstrated that the end point is similar; the insertion of FM4-64 into platelet
plasma membrane and an inability to accumulate calcein-AM. Furthermore, phase
microscopy of large aggregates indicated that the region of most FM4-64 and least
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calcein accumulation coincided with a zone where fibrillar material, presumed to be
fibrin was deposited. Examination of aggregates at the electron microscopic level
revealed the presence of microvesicles but also platelets that had diluted cytoplasm and
gaps in their plasma membrane. It was also noted in some areas that platelets had
degenerated to a slurry-like or gel-like material that surrounded activated platelets and
membrane-limited structures of unclear identity. This degeneration of platelets has been
mentioned before but is poorly described as 'cellular debris'(Jorgensen et al., 1967),
suggesting a stochastic rather than an elegant process of degeneration for the apparent
purpose of haemostasis. It is submitted that platelet activation beyond a point of no
return (i.e. trapped within the core of an aggregate or plug) leads to platelet
degeneration and, as such, must be viewed as a form of 'programmed cell necrosis' that
has evolved for the deliberate plugging of damaged vessels.
It appears that these dyes are useful for detecting and quantifying loss of platelet
viability during storage but also for the detection of microvesiculation / changes to
platelets within the medulla of aggregates. Whether the use of FM4-64 for the detection
of circulating microvesicles in individuals thought to have high circulating numbers of
these entities is feasible remains to be seen. It is worth speculating that the dye when
used in conjunction with intravital microscopy would be a useful discriminator of
vesiculation events associated with thrombus formation in vivo.
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4 DEAD PLATELETS FORM AGGREGATES.
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4.1 Abstract.
Using calcein-AM and FM4-64 as vital stains it was observed that during in vitro
storage dead but not live platelets formed loose aggregates. Dead platelets
were also CD42b"VE, due to shedding of a 130kDa extracellular fragment into
the supernatant. Incubation of platelets with the metalloproteinase inhibitor
GM6001 had no effect upon platelet viability but inhibited both the shedding of
CD42b and platelet aggregation. The pattern of MMP-2 surface expression
changed during platelet incubation and a novel 110kDa gelatinase activity was
associated with stored platelets. It was not possible to implicate MMP-2 in either
the loss of CD42b or the adhesion event between dead platelets. It is not clear
what, if any, physiological relevance this metalloproteinase-dependent adhesion
event has but it may be important for clot architecture during haemostatic plug
formation.
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4.2 Results.
4.2.1 Dead platelets form micro-aggregates during in vitro incubation.
Platelets incubated at 37°C as cPRP for several days in vitro were observed both by
light and electron microscopy to form micro-aggregates. Although many single dead
platelets existed, the aggregates that had formed appeared to be populated exclusively
by dead platelets according to calcein accumulation / FM4-64 binding. It was rare (<1%
of all aggregates examined) to find calcein+VE / FM4-64"VE platelets within the
aggregates. By 24 hours of incubation these aggregates commonly comprised of only a
small number of platelets, typically between 2 and 30 (fig. 4.1). Further incubation led
to the accumulation of greater numbers of dead platelets within the aggregates. During
this thesis it was useful to incubate platelets overnight as a 50-fold dilution of PRP; at
no time was there any indication that this reduced the amount of death seen by 24 hours
relative to incubations done in full PRP. This indicates that platelet death occurred
independently of aggregate formation and argues for the formation of aggregates as a
result of death rather than vice versa.
4.2.2 Shedding of CD42b is tightly associated with platelet death.
Changes in CD42b are a common feature of storage and activation (Bergmeier et al.,
2003; Hoffmeister et al., 2003; Hoffmeister et al., 2003), therefore the surface
expression of CD42b was examined during in vitro incubation. It was noted that
although calcein+VE platelets showed surface expression of CD42b, the epitope
recognised by the antibody was completely lost from calcein"VE platelets displaying
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morphological signs of death (fig. 4.2.A). To explore the relationship between platelet
death and the loss of CD42b platelets were incubated with GM6001, a hydroxamic acid-
based inhibitor of various metalloproteinases known to block the loss of CD42b from
platelets during storage or due to experimentally induced mitochondrial injury
(Bergmeier et ah, 2003). It was clear that GM6001 at lOOpM maintained CD42b
expression upon platelets that appeared dead (compare fig.4.2.A.v-viii with fig.
4.2.A.ix-xii).
Bivariate analysis of platelet CD42b expression and calcein accumulation confirmed
that only the calcein"VE platelets lost CD42b and that GM6001 was inhibiting this loss
without affecting platelet viability (fig 4.2.B). Quantification of the loss of CD42b was
performed with platelets over a 5-day period in vitro (fig. 4.3.A). The close temporal
association of CD42b loss and platelet death did not change during 5 days of incubation,
indicating that platelet death did not promote the loss of CD42b from viable bystander
platelets.
4.2.3 Surface biotinylation confirms the shedding of a 130kDa protein
Biotinylated proteins shed from the surface of platelets were affinity purified from
plasma using streptavidin-coated latex beads and examined by Western blotting. Results
indicated that a protein of ~130kDa corresponding to the known size of glycocalicin
(Bergmeier et al., 2000), accumulated within plasma during storage. The accumulation
of this protein was greatly reduced in supernatants from platelets that had been
incubated in the presence of the metalloproteinase inhibitor GM6001 (fig. 4.3.B). These
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Figure 4.1. Dead platelets associate during in vitro storage.
Micrographs show platelets that were aged in vitro at 37°C for 72 hours,
stained with 5pM FM4-64 for 10 minutes and examined by
epifluorescence microscopy. Aggregates of various sizes are common by
72 hours but can be seen also at 24 hours. Aggregates appear to be
populated exclusively by platelets exhibiting morphological features of
death, this is supported by their accumulation of FM4-64. Bar = 10pm.
Micrographs are representative of images obtained from many different
donors.
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Figure 4.2. Dead platelets lose CD42b.
A freshly isolated platelet incubated stained with calcein-AM and incubated with anti-
CD42b antibodies for 20 minutes and then examined by epifluorescence microscopy
is shown spread upon glass (A.i-iv). Platelets showing morphological signs of death at
24 hours were unable to accumulate calcein-AM and were noted to be immuno-
negative for CD42b (A.v-viii). Incubation of platelets with the broad-spectrum
metalloproteinase inhibitor GM6001 (100pM) inhibited the loss of CD42b from dead
platelets (A.ix-xii). Bar=3pm. Bivariate analysis of platelets' viability and CD42b
expression after in vitro incubation for 24 hours (B) confirms that only those platelets
unable to accumulate calcein are devoid of CD42b (red plots) and that GM6001 blocks
this loss (blue plots) without affecting viability. Micrographs and cytometry plots are
representative of data collected from many (>10) donors.







Figure 4.3. Loss of CD42b is closely associated with the timing of
platelet death and is inhibited by GM6001.
Platelets were aged as PRP supplemented with magnesium for 5 days
and stained with 100nM calcein-AM (open squares) and anti-human
CD42bRPE antibodies for 20 minutes (closed squares) and analysed by
flow cytometry (A); n =4; +/-SEM.
Surface biotinylation allows for the subsequent panning of released
biotinylated proteins from platelets with magnetic avidin beads. Platelet
proteins captured by the beads were electrophoresed, blotted and probed
with streptavidin-HRP. A biotinylated protein of approximately 130kDa
corresponding to the expected size of glycocalicin is shed into platelet
supernatants over a three-day period but to a lesser extent when
GM6001 is present (B).
Page 111 of239
data indicate that CD42b is shed from dead platelets into the incubation media during
storage.
4.2.4 GM6001 has an ED50 of ~20pM.
The inhibitory activity of GM6001 towards the shedding of CD42b has been described
at only one concentration, lOOpM (Bergmeier et ah, 2003), therefore it was of interest
to know the effective dose range for the agent. Dose-response data for the ability of
GM6001 to inhibit the loss of CD42b from dead platelets was collected from three
donors and indicated an ED5o ofGM6001 in platelet rich plasma of~20pM (fig. 4.4).
Examination of platelets stored for 24 hours in the presence or absence of GM6001
showed no difference in the frequency of either calcein"VE or FM4-64+VE platelets
between control and GM6001-treated platelets (fig. 4.4.B). Thus GM6001's effect was
not due to an indirect ability to affect platelet viability.
4.2.5 GM6001 inhibits the interaction between dead platelets.
The previous data confirm that dead platelets shed CD42b from their surface and that
this event appears to be mediated by metalloproteinase activity as evidenced by its
sensitivity to GM6001. It was serendipitous then to find that the effect of GM6001
extended also to the aggregate formation between dead platelets. Platelet samples
incubated for 72 hours in the presence of GM6001 contained far fewer aggregates than
controls (fig. 4.5.A).
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As platelet aggregation is observed by an increase in side scatter by cytometry it was
reasonable to assume that cytometric analysis of the stored platelets' scatter
characteristics would yield an objective measure of aggregate formation and an assay to
determine the efficacy of GM6001's ability to block platelet-platelet interactions.
Analysis of stored platelets stained with FM4-64 dead confirmed that aggregates (as
seen by increased side scatter) were populated by dead and not live platelets. When
platelets were stored in the presence of GM6001 the side scatter of dead platelets was
qualitatively reduced to that seen with viable platelets (arrows fig. 4.5.B).
4.2.6 The metalloproteinase-dependent adhesion event is independent of
plasma factors.
It has been established already that washing platelets from plasma and storing them in
calcium-free HBSS for 24 hours at 37°C did not promote death relative to platelets
maintained as cPRP (Chapter 3, fig. 3.2). In order to understand the interaction between
dead platelets further it was important to establish whether or not soluble plasma factors
played a role. It was clear by both microscopy and cytometry that platelets washed from
plasma and aged in calcium-free HBSS for 24 hours still formed aggregates, indicating
that the adhesion event did not require a soluble plasma factor (fig 4.6.B). Furthermore,
aggregate formation was inhibited in washed platelet suspensions by the presence of
GM6001, confirming that the metalloproteinase activity responsible for the aggregation
was intrinsic to the platelets and not plasma derived. Inhibition of aggregate formation
with GM6001 led to maintenance of platelet numbers over a period of 72 hours relative
to controls (fig. 4.7).
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Figure 4.4. GM60O1 blocks CD42b loss from platelets with an ED60 of
~20nM.
Platelets were incubated for 24 hours at 37°C in either the presence of a
broad dose range of GM6001 and examined by cytometry for CD42b
expression (A). GM6001 is able to block the loss of CD42b but this is not
due to an ability to inhibit platelet death (B). n=3; +/- SEM for both
graphs.
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Figure 4.5. GM6001 inhibits aggregate formation between dead
platelets.
Micrographs of platelets incubated for 72 hours at 37°C in either the
presence (a.i) or absence (a.ii) of 100pM GM6001 illustrating the agent's
effect on the formation of microaggregates; n =3; +/- SE. Cytometric
analysis of side scatter properties confirms that incubation of platelets for
72 hours with the metalloproteinase inhibitor GM6001 abolishes
microaggregate formation by dead (FM4-64+ ) platelets (arrows in B.i
and B. ii). Micrographs and cytometry plots are representative of data
collected from >3 different donors.



































Figure 4.6. GM6001 inhibits aggregate formation between dead
platelets.
Platelets were incubated for 24 hours at 37°C in either the presence or
absence of 100pM GM6001 and examined by cytometry after vital
staining (FM4-64 5pM for 10 minutes). Data is presented as the forward
scatter multiplied by side scatter. GM6001 blocks aggregate formation
and reveals that dead platelets have reduced scatter properties
compared to live platelets (A), n =3; +/- SE. A similar experiment was
performed with washed platelets incubated in HBSS to illustrate that no
soluble plasma factors are required for aggregate formation (B). n =3; +/-
SEM; *P<0.05 from live; #P<0.05 from DMSO.


























Figure 4.7. Inhibition of platelet aggregate formation maintains
platelet numbers and allows more accurate estimate of platelet
death rate.
Platelets were incubated as cPRP at 37°C with or without 100pM
GM6001 for the length of time as specified in the figures. Platelet
numbers were estimated by Coulter Counter and expressed as a
percentage of the numbers within freshly isolated PRP. Viability was
assessed by cytometry after dual staining platelets with calcein-AM and
FM4-64. n = 4 different donors; +/-SEM; *P<0.01 relative to control.
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4.2.7 GM6001 fails to affect the aggregation of fresh platelets.
In order to explore the possibility that the adhesion event occurring between dead
platelets was a modified version of one that is known to occur between fresh platelets
the effect of GM6001 was examined during the aggregation of freshly isolated platelets.
GM6001 at concentrations able to inhibit interactions between dead platelets did not
affect aggregation of fresh platelets in response to either low or maximal doses of
convulxin or TRAP (fig. 4.8), suggesting that its inhibitory target was specific to a
death-dependent interaction.
4.2.8 Zymography reveals a novel metalloproteinase activity that is
unique to in vitro aged platelets.
Proteins from platelets aged in vitro for 48 hours were separated by size under non-
reducing conditions within acrylamide gel containing 1% gelatin and examined for
gelatinase activity. Although enzymatic activity was associated predominantly with
proteins of 72kDa corresponding to MMP-2, a minor enzymatic activity was seen also
at 92kDa, which corresponds to MMP-9. Of particular interest was the presence of a
higher molecular weight gelatinase activity detected at approximately llOkDa in aged
but not fresh platelet pellets (fig. 4.9).
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4.2.9 Western blotting does not confirm the existence of a 110kDa MMP-2
complex.
To establish whether or not the llOkDa gelatinase activity associated with stored
platelets was that of MMP-2, platelet pellets electrophoresed under non-reducing
conditions were probed by Western blot with anti-MMP-2 antibodies. Although reactive
polypeptides of >200kDa, ~120kDa and ~80kDa could be seen in samples from
platelets stored for 48 hours in the presence of GM6001, no other polypeptides were
observed in stored or fresh platelet samples (fig. 4.10). The significance of this result is
not clear as the antibody (from the same stock) readily detects a 72kDa poylpeptide
presumed to be MMP-2 under reducing conditions (Simon Riley, pers. comm.), thus the
antibody may be ineffective for the detection of MMP-2 electrophoresed under non-
reducing conditions.
4.2.10 The surface expression of MMP-2 changes during in vitro storage.
To further investigate this possibility the surface expression of MMP-2 was examined
on stored platelets. After immuno-cytochemical staining stored and fixed platelets it
was clear that a broad range of intensity of MMP-2 surface expression was detected.
Dual labelling with CD42b enabled the evaluation of platelet viability in the absence of
vital stains because CD42b in this work has been shown to be only lost from dead
platelets. Four distinct platelet populations could be observed by epifluorescence
microscopy. Two viable platelet populations could be seen, one with and one without
MMP-2 immuno-reactivity and the same was observed for the non-viable (CD42b"VE)
platelets (fig. 4.11). The least complex scenario envisaged by such an expression pattern
is that MMP-2 expression is low on freshly isolated platelets but increases several-fold








Figure 4.8. GM6001 neither inhibits nor promotes aggregation of
platelets in response to CVX or TRAP.
Low and high doses of agonist (green and red plots, respectively) were
10ng/ml or 50ng/ml for Convulxin and 4pM or 20^M for TRAP. Incubation
of fresh platelets for 10 minutes with GM6001 prior to activation (the
second group of plots for each agonist) had no effect upon the
aggregation of platelets relative to the DMSO control. Plots are
representative of experiments carried out with three different donors.
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Figure 4.9. Zymography reveals MMP-2 and MMP-9 activity
associated with fresh and aged platelets and also a novel activity
associated only with platelets stored at 37°C.
Platelets pellets were lysed, electrophoresed through acrylamide gel
containing 1% gelatin. The gel was Incubated for 48 hours and stained
with coomassie to reveal areas where gelatin had been degraded. Fresh
platelets from 2 donors (lanes 1 and 3), platelets aged for 48 hours from
the same donors (Lanes 2 and 4). A positive control of amniotic fluid was
used to determine MMP activities (AF). M - Markers.
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Figure 4.10. A 110kDa MMP-2 polypeptide is not found associated
with fresh or aged platelet pellets.
Platelets pellets were lysed, electrophoresed under non-reducing
conditions through an 8% polyacrylamide gel, blotted onto a PVDF
membrane and probed with anti-MMP-2 antibodies. Lanes 1 and 4
represent samples from 2 different donors' fresh platelets, lanes 2 and 5
are samples from platelets aged in vitro for 48-hours and lanes 3 and 6
are from platelets aged for 48 hours in the presence of 100mM GM6001.
Immuno-reactive polypeptides corresponding to the expected
electrophoretic mobility of MMP-2 activity are not detected, however a
large molecular weight polypeptide >200kDa is detected in the samples
aged in the presence of GM6001.
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Figure 4.11. MMP-2 appears to be up-regulated on platelets prior to
their death and may be lost as a late event.
Platelets were aged for 24 hours at 37°C then fixed with 1 volume of 4%
formaldehyde for 20 minutes. Stained with anti-MMP-2 antibodies for 30
minutes at 37°C, washed and incubated with anti-Mouse lgG-Alexa488
for 30 minutes. Platelets were then washed twice and incubated with
Mouse anti-CD42bRPE for 20 minutes. An irrelevant primary control IgG
(Mouse anti-CD16) gave no staining. Loss of CD42b is indicative of
platelet death; three platelets displaying loss of CD42b are shown that
also display morphological signs of cell death (arrowheads, i). Two of the
dead platelets are MMP-2 immuno-positive, whereas the other is
negative. Two live (CD42b+VE) platelets are shown, one with little MMP-
2 immuno-positivity the other with considerably more. Bar = 3pm
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prior to death and that expression is maintained upon dead platelets until a later event
leads to its loss.
4.2.11 The surface expression of CD42b is unaffected by activation with
TRAP or incubation of platelets with active MMP-2.
Due to the apparent links between the loss of CD42b, metalloproteinase activity and the
interaction between dead platelets it was hypothesised that if a metalloproteinase could
be implicated in the modification of CD42b that this would represent a good candidate
for the mechanism behind dead platelet-platelet interactions. CD42b expression was
examined on fresh platelets and platelets activated with 20pM TRAP either in the
absence or the presence of serial dilution of active MMP-2. Although MMP-2
bioactivity was confirmed by an ability at lpg/ml to inhibit platelet aggregation in
response to either collagen or TRAP (fig. 4.12), it had no effect upon the surface
expression of CD42b (fig. 4.13). Nor was there any indication that incubation of fresh
platelets with MMP-2 caused spontaneous interactions.
4.2.12/n vivo biotinylation of mice enables an estimate of the circulating
lifespan of labelled platelets.
Mice were injected with NHS-biotin in order to label circulating blood cells.
Examination of whole blood isolated from mice 1 hour after injection of biotin and on
several consecutive days revealed that a surface biotinylated population of platelets
existed that became reduced in number over the period of analysis (fig. 4.14). The
reduction in number of biotinylated platelets was not due to spontaneous loss of surface
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biotin because erythrocytes, which are known to circulate for several weeks, displayed
no such losses (fig. 4.15).
4.2.13 Injection of mice with GM6001 has no effect upon the circulating
lifespan of platelets
The possibility that the adhesion event between dead platelets was a surrogate
interaction that would otherwise occur between a dead platelet and a phagocyte was
examined in vivo. Manipulation of mice by injection either via the intraperitoneal or
intravenous route with 15pi of lOOmM GM6001 was attempted in order to explore the
hypothesis that metalloproteinase activity modifies platelets for subsequent recognition
and phagocytosis by macrophages. Assuming an average weight of 20-25g per mouse
and that this weight correlates with volume, the injection of this much GM6001 was
expected to yield a final concentration of approximately 75pM; well above the ED50 of
20pM estimated for the agent in vitro. The curves produced by control and GM6001
treated animals did not differ significantly from each other, regardless of the route of
delivery (P=0.876); n=3 mice in each group (fig. 4.16).
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Figure 4.12. MMP-2 inhibits platelet aggregation in response to
collagen and also to TRAP.
Platelets were incubated with or without 10ng/ml MMP-2 for 5 minutes
prior to the addition of agonist (either fibrillar collagen at 1ug/ml or TRAP
at 20|iM) and calcium chloride to 2mM. Aggregation proceeded for 5
minutes.
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Figure 4.13. MMP-2 has no effect on the surface expression of
CD42b on resting or activated platelets.
Freshly isolated platelets were incubated in the presence or absence of
10ng/ml MMP-2, activated with 20pM TRAP for 10 minutes and stained
with anti-CD42b antibodies and examined by flow cytometry, n =1.























Figure 4.14. Murine platelets can be labelled with biotin by
intravenous injection of NHS-biotin.
Nine mice were injected twice (at time -4 hours and 1 hour later) with
6pg of NHS-Biotin in a volume of 200pl of 10% DMSO / PBS. Blood
samples were taken at 4 hours after the initial injection (Time 0) from tail
nicks into 10 volumes of 3.8% sodium citrate, stained with streptavidin
and analysed by flow cytometry for surface biotin against stained blood
from non-biotinylated mice. Each line represents the loss of biotinylated
platelets from circulation over a 5-day period. The method is highly
repeatable with little intra-group variation.
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Hours
Figure 4.15. Biotin signal is maintained on erythrocytes indicating
that it is not spontaneously lost from platelets.
Mice were injected i.v with NHS biotin. Erythrocytes and platelets were
labelled using streptavidin and examined by flow cytometry. The loss of
biotinylated platelets from circulation does not appear to be due to
spontaneous shedding of surface biotin because erythrocytes do not lose
the biotin signal despite being within the same environment as the
platelets. n=5] +/-SE.
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Figure 4.16. Injection of GM6001 into mice does not affect
circulating platelet lifespan.
Mice were injected with 15pl of 100mM GM6001 dissolved in DMSO (as
a bolus of the agent dissolved in PBS) via either an intraperitoneal (i.p) or
intravenous (i.v) route on day 0 and day 1. Controls were injected with
DMSO: PBS Platelets were labelled on day 0 by in vivo biotinylation and
blood samples taken on consecutive days to establish the rate of platelet
exit from circulation; n=3 mice in each group; +/-SE; P>0.05 for both
treatment routes.
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4.3 DISCUSSION.
One of the most obvious consequences of incubating platelets for prolonged periods at
37°C was the formation of micro-aggregates. By both light and electron microscopy it
was observed that small numbers of platelets associated with each other within 24 hours
of incubation at 37°C and that further incubation led to increased aggregate size.
By electron microscopy it was clear that although single platelets exist with features of
cell death the micro-aggregates were comprised of only those platelets that were
apparently dead according to their morphology. Use of the vital dyes calcein-AM and
FM4-64 in conjunction with antibodies able to identify the am, integrin support this
conclusion. That platelet death was intimately associated with aggregate formation led
to the question as to whether death was dependent upon aggregation or vice versa. It
was a consistent finding throughout this thesis that the amount of platelet death after 24
hours in vitro was similar if platelets had been maintained in cPRP or if platelets had
been diluted 50-fold. It is assumed that a 50-fold dilution of platelets is sufficient to
reduce the possibility of platelet-platelet interactions and that this result indicates
platelet death was not the result of aggregate formation.
A second consequence of platelet death was the shedding of CD42b. Programmed cell
death of nucleated cells is associated with loss of surface proteins such as CD31 from
apoptotic endothelial cells (Ilan et al., 2001), E-cadherin from apoptotic epithelial cells
(Steinhusen et al., 2001) and both CD 13 and CD33 from apoptotic THP-1 cells (Brown
et al., 1996). Of the small handful of reports regarding this phenomenon the role for
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metalloproteinases has been described in the shedding of CD31 and E-Cadherin (Ilan et
ah, 2001; Steinhusen et ah, 2001). Interestingly both cleavage events are mediated by
caspase activity upon the cytoplasmic tail of the respective proteins and
metalloproteinase activity on the extracellular domain. The significance of these
shedding events is not understood but may be something to do with disruption of cell-
cell contacts and the exit of the dead cell from its surroundings (Steinhusen et al., 2001)
or altered signalling capacity during cell death (Ilan et al., 2001).
Reduced surface expression of vWF receptor proteins (in particular, the CD42b /
GPIba subunit) from platelets has been observed in response to agonists such as
thrombin or collagen. The nature of its disappearance has been explained by two
models; shedding (Fox, 1994) and translocation to the OCS (Michelson et al., 1991;
Michelson et ah, 1996), however the authors note that these mechanisms are not
necessarily mutually exclusive of each other. It has been observed that CD42b was lost
from a subset of platelets during in vitro storage and, although the authors do not
discuss these platelets explicitly and no mention of aggregate formation was made, it is
likely that these platelets represent the same endpoint of the platelets generated in this
work (Michelson et al., 1988).
More recently the metalloproteinase-dependent loss of CD42b from both human and
murine platelets was demonstrated during in vitro storage and in response to
experimentally induced mitochondrial damage. Although the authors report almost
complete loss of CD42b from both stored and 'damaged' platelets there was no mention
of aggregate formation, despite platelets being stored with agitation. Mitochondrial
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damage elicited by fCCCP was used as a model of platelet storage lesion, however the
work presented in this thesis suggests that platelets without ATm are not necessarily
those that have lost CD42b. However it remains to be seen whether changes to the
mitochondria are a better indicator of platelet suitability for subsequent transfusion than
loss of viability as assessed by either the calcein or FM4-64 assays. It is not clear why
in the current work the loss of CD42b did not correlate with loss of ATTn according to
JC-1. The deliberate collapse of ATm in human and murine platelets with high
concentrations of fCCCP (lOOpM), may have been somewhat aggressive and
unnecessary method of inducing storage lesion (considering that PSL occurs
spontaneously). The data presented by the authors and by the same group in a more
recent paper indicates that platelets were activated by the fCCCP treatment (Bergmeier
et ah, 2004), thus the loss of CD42b from the majority of platelets may have reflected
indirect effects of rapidly and massively damaging mitochondria, which are a large
source of calcium (Rizzuto et al., 2000). Nevertheless, the work presented in this thesis
agrees with previous findings indicating that stored platelets lose CD42b due to
metalloproteinase activity.
Despite a number of groups documenting the accumulation of spontaneous aggregates
during platelet storage and reduction of platelet numbers during storage (Murphy and
Gardner, 1971; Holme et al., 1987; Martin-Valmaseda et al., 1999) an interaction
between dead platelets has not been described before. This is possibly due to the
entirely reasonable assumption that the aggregates had formed due to platelet activation.
The mechanism of adhesion between dead platelets appears not to be common to those
induced by activation of fresh platelets because a) GM6001 had no effect upon the
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aggregation of fresh platelets. This may indicate that the adhesion event is dependent
upon platelet death and thus represents a novel platelet-platelet interaction of unknown
physiological relevance.
Due to the apparent metalloproteinase-dependent nature of both CD42b shedding and
the adhesion event between dead platelets it was important to examine
metalloproteinase activity associated with stored platelets. Gelatin zymography is
known only to identify MMP-2 and MMP-9 activities (Simon Riley, pers. comm.).
Typically, latent MMP-2 and 9 activities are observed at 72 and 92kDa, respectively
with pro form activity being seen at approximately lOkDa less due to loss of the
inhibitory N-terminal pre domain. Zymograms consistently show other activities at
>200kDa and 125kDa which are thought to be due to MMP-9 dimerisation and MMP-9
complexed with a member of the lipocalin family. In the present work gelatinase
activity associated with platelet pellets complied with this expected pattern of activities
and, for resting platelets, was the same as that published by others (Fernandez-Patron et
al., 1999). However, a gelatinase activity of approximately 1 lOkDa was associated with
the pellets of stored platelets and, to the author's knowledge, has not been described for
platelets. An extensive literature search and conversation with researchers in the field of
metalloproteinase biology indicates that only a single report exists regarding a llOkDa
gelatinolytic activity (Kim et al., 2001). This activity was seen in bovine follicular fluid
and was described as being a novel form ofMMP-2 due on the basis ofwestern blotting
evidence. Although the llOkDa gelatinase activity was not identified in the present
work as MMP-2 further attempts should be made to confirm its identity because it is the
only activity unique to stored platelets and may represent an MMP or MMP-containing
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protein complex responsible for CD42b shedding and the interaction between dead
platelets.
Immunocytochemical analysis of platelets with anti-MMP-2 antibodies revealed that the
surface antigenicity of this metalloproteinase changed dramatically during in vitro
storage. Dual staining with anti-CD42b antibodies confirmed previous results that loss
of CD42b coincided with dramatic changes to platelet morphology associated with
death and that the surface expression of MMP-2 appeared to increase upon viable
platelets during storage. Dead (CD42b negative) platelets showed low or high-level
surface expression ofMMP-2; the simplest scenario to explain this temporal pattern of
expression is that MMP-2 surface expression is greatly up regulated prior to platelet
death but at some point after death its antigenicity is lost from the platelet surface. Due
to the complexity of MMP regulation and activity it is very difficult to speculate as to
the relevance of this change in MMP-2 expression to the changes associated with dead
platelets thus further examination of the effects ofMMP-2 on platelets was sought.
In an attempt to implicate or exclude MMP-2 in the loss of CD42b and the interaction
between dead platelets freshly isolated platelets were incubated with active MMP-2.
Addition of exogenously activated MMP-2 to PRP failed to effect spontaneous platelet-
platelet interactions nor changed the surface expression of CD42b; the latter of these
results contradicts results gained by others indicating that MMP-2 can positively affect
CD42b expression on platelets (Radomski et al., 2001). The reasons for this discrepancy
are unclear, especially as MMP-2 bioactivity was confirmed by its ability to inhibit
platelet aggregation in response to collagen or TRAP.
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The incubation of single purified metalloproteinases with platelets as a means of
implicating a particular species is flawed inasmuch that it is entirely plausible that the
MMP activity responsible for the observations made in this thesis relies upon, and is
subsequent to, other signals / events within dying platelets. For example, the temporal
pattern of MMP-2 surface expression does not correlate with CD42b shedding -
suggesting that either the metalloproteinase is not involved with loss of CD42b / the
adhesion event or that its activity is not sufficient to bring about these changes. This is
certainly true for the shedding of CD31 from endothelial undergoing apoptosis; the
cytoplasmic tail of CD31 appears to require proteolysis by a caspase before
metalloproteinase activity could liberate a soluble form of the protein from the
extracellular domain (Ilan et al., 2001). Thus, the incubation of active MMPs with fresh
platelets may be an inadequate way of establishing which MMP effects the interaction
between, and the shedding of CD42b from, dead platelets.
An unanswered but key question raised by this thesis is what, if any, physiological role
is there for either platelet death or the metalloproteinase activity mediating an
interaction between dead platelets? MMP-2, like many other MMPs, has a vitronectin-
like domain recognised by the vitronectin receptor (avP3 integrin complex) (Silletti et
al., 2001) and it is known that the recognition of apoptotic cells by macrophages can be
mediated by the macrophage vitronectin receptor (Savill et al., 1990) thus it is worth
speculating that the change in MMP-2 expression upon the platelets' surface may aid
recognition of effete platelets by macrophages via their vitronectin receptors prior to
their death (as assessed by calcein or FM4-64). To address this possibility mice were
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injected with GM6001 and the agent's effect upon the circulating lifespan of platelets
was assessed by in vivo biotinylation. No effect on the platelets' lifespan was recorded,
however it is difficult to interpret this data without knowing if the GM6001, once
injected, had retained biological activity in circulation. Injection of mice with the agent
and subsequent analysis of their blood plasma for its ability to inhibit loss of CD42b
from human platelets during storage would resolve this question. Furthermore, it may
be expected that analysis of the circulating lifespan of platelets as assessed by
biotinylation would not report on changes to the mechanism of removal of effete
platelets from circulation because no information is obtained about retention time of
such platelets within the spleen prior to phagocytosis by splenic phagocytes (if indeed
this is the means by which platelets are removed from circulation). Thus if bioactivity
was confirmed without an effect upon lifespan this could be a false positive result. In
the event of a positive result (an extension of platelet lifespan due to failed clearance of
effete platelets) an extensive examination of splenic architecture would have to be
performed to establish if results were due to indirect effects of the agent on numbers,
viability and function of phagocytes within the spleen.
At the time of writing this thesis a paper was published that implicated strongly the
metalloproteinase activity of TNF-alpha converting enzyme (TACE) in the shedding of
CD42b from platelets (Bergmeier et al., 2004). The authors demonstrated that plasma
glycocalicin levels in TACE-deficient mouse are reduced by 90% compared to controls
and appear to have solved the decades-old mystery of which enzyme controls
glycocalicin levels within blood. Interestingly there does not appear to be any
differences between TACE-deficient platelets and controls in terms of size, number,
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aggregation, degranulation or tail bleeding times. In agreement with the group's earlier
publications the post-transfusion recovery of TACE-deficient platelets was improved
relative to controls. It still remains unclear what the physiological significance the
shedding of glycocalicin has. Storage of platelets from the TACE-deficient mouse
would help resolve whether the interaction between dead platelets is due to TACE
activity.
Interestingly dead platelets like those generated in vitro could not be found within
murine spleens, despite extensive searching (see appendix, fig. 8.4). This result reflects
a general frustration that platelet-phagocyte interactions were rarely explicitly presented
by any groups within the literature. Obviously the absence of a result in no way
indicates a negative, however it highlights a difficulty in the establishment of a
clearance mechanism in vivo. If phagocytosis is the means by which platelets are
removed from circulation the treatment of spleens with lysosomal inhibitors to cause an
accumulation of material within phagolysosomes and outwith the phagocytes could be
employed to study the phenomenon; a strategy analogous to the methodology used in
the study of autophagosome formation (Yamamoto et al., 1998).
In summary, platelet death in vitro involves a metalloproteinase dependent process of
CD42b shedding and an interaction between dead platelets. An individual
metalloproteinase activity could not be implicated but changes to MMP-2 surface
expression occurred during in vitro storage. Furthermore a novel gelatinase activity was
associated with stored but not fresh platelets. It is not clear what the interaction or the
shedding events represent nor what physiological relevance they have. It is difficult to
Page 138 of 239
find platelets exhibiting signs of death in spleens but they are readily found within
aggregates generated in vitro (this study) and in vivo (Jorgensen et al., 1967; Davies et
ah, 1975). In view of the data regarding the differential accumulation of calcein and
FM4-64 in collagen-induced aggregates, the possibility arises that changes to platelets
occurring within aggregates and haemostatic plugs may be synonymous with death and
that metalloproteinase activity stabilises the architecture of these developing structures.
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5 AUTOPHAGY DURING PLATELET DEATH
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5.1 Abstract.
Platelets die in vitro in a caspase independent manner with features of necrosis.
Therefore the role of an alternative cell death path for human platelets was
examined. By electron microscopy it was observed that large vacuoles formed
within platelets during 24 hours of storage at 37°C. Vacuoles contained
amorphous material of uncertain origin and were sometimes lined with electron
dense granular material presumed to be glycogen. By epifluorescence
microscopy platelets could be seen to have accumulated both lysotracker red
and the autophagic vacuole marker monodansylcadaverine to discrete small
structures within freshly isolated platelets but to large vacuoles within stored
platelets. The large vacuoles that formed within stored platelets showed positive
immune staining for Lamp-2, confirming their lysosomal origin. Storing platelets
in the presence of amino acids or the autophagy inhibitor 3-methyladenine
incompletely inhibited vacuole formation. 3-MA was toxic to platelets. Amino
acids did not promote survival but did promote the retention of platelet function.
Concomitant with the increase in large vacuoles was the reduction of anb
surface expression. The loss of anb and the formation of vacuoles were inhibited
by the supplementation of 2mM magnesium sulphate. 3-MA was not toxic to
platelets in the presence of MgS04. Platelet death in vitro does not appear to be
due to a classical autophagic process although it may represent an adaptation
to low-cation conditions for the preservation of function.
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5.2 Results.
5.2.1 Vacuoles appear in stored platelets.
Electron micrographs of platelets indicated the presence of large vacuoles within stored
but not fresh platelets that had retained discoid shape and were not showing signs of cell
death such as cytoplasmic condensation and loss of membrane integrity (see Chapter 3).
It has been established in the previous chapter that in vitro platelet storage does not lead
to classical signs of activation (i.e. integrin activation and CD62P expression due to
degranulation) thus the vacuoles appear independently of the platelets' activation status.
By transmission electron microscopy, vacuolisation appeared to be restricted to the
formation of one to two large vacuoles per platelet. Vacuoles showed heterogeneous
morphology, some were lined with glycogen (fig 5.1, arrow in A and B), some
contained amorphous material of unclear origin (fig 5.1, arrows in C and D). To the
periphery of many vacuoles were small double membrane limited vesicles dissimilar
from alpha and dense granules, which are relatively larger and more electron dense (fig
5.1, arrow D). However, at no point were multi-lamellar macro-autophagic vacuoles
observed. Apposed membrane regions existed in some platelets but were not seen
connected to vacuoles (fig 5.1, arrowhead in A, B and E).
5.2.2 Vacuoles accumulate Lysotracker red and are immuno-positive for
Lamp-2.
It was reasonable to assume that, because the vacuoles contained what appeared to be
degraded material, they were lysosomal in origin. It was pertinent also to examine by a
less labour intensive method than electron microscopy the formation of these vacuoles
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during in vitro storage of platelets. To confirm the identity of these vacuoles as
lysosomes the acidotropic dye Lysotracker red (LTR), was incubated with platelets. The
dye accumulated rapidly (within 10 minutes at 37°C) in both fresh and aged platelets to
discrete structures (fig 5.2.A and B), and there was accumulation also of the dye to the
periphery of large structures in aged platelets (fig 5.2, arrow in B). Incubation of fixed
and permeabilised platelets with antibodies to Lamp-2, (an integral lysosomal
membrane protein important for lysosomal development and the docking of autophagic
vesicles (Eskelinen et al., 2003)) confirmed that the vacuoles were lysosomal in origin
(fig 5.2.C).
5.2.3 Lysosomes and large lysosomal vacuoles accumulate monodansyl-
cadaverine (MDC).
MDC is an autofluorescent lipophilic molecule that has been shown to specifically
accumulate within autophagic vacuoles at various stages of their development. It has
been demonstrated in various mammalian cell lines that MDC accumulates to small
spherical structures that, when fractionated through sucrose gradients and examined by
TEM, have morphology consistent with them being autophagic vacuoles (Biederbick et
al., 1995). The dye has been used also to identify autophagic vacuoles that formed in
Chinese hamster ovary (CHO) cells in response to amino acid starvation (Munafo and
Colombo, 2001). When incubated with fresh or aged platelets MDC co-localised to the
same structures as LTR (fig 5.2). Although there was reason to believe that MDC
accumulated with varying efficiency to different LTR+VE structures this was not
quantified. These data indicated that MDC was capable of labeling lysosomes in
Page 143 of 239
Figure 5.1. Vacuoles appear in platelets aged in vitro at
37°C.
Electron micrographs showing platelets aged for 24 hours
containing large vacuoles lined with electron dense material
consistent with the appearance of glycogen (arrow, B).
Various vesicle structures (arrow, D) are associated with
vacuoles with internal amorphous contents (arrowhead, D).
Open canalicular system zippering can be seen (arrowheads
A, B and E).
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Figure 5.2. Platelets accumulate Lysotracker red, mito-tracker green
monodansylcadaverine and are immunopositive for Lamp-2.
Platelets both fresh and incubated for 24 hours accumulated LTR, MTG
and MDC to discrete structures within the cytoplasm. MDC and LTR
appear to colocalise without exception. MTG accumulates within discrete
structures distinct from those labelled by LTR or MDC. Large vacuoles
that form during incubation accumulate LTR and MDC but do not
accumulate MTG. Immuno-positive staining for the lysosomal protein
Lamp-2 can be seen in small structures within fresh piatelets and within
large vacuoles of in vitro aged platelets (C).
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platelets and that it is not a specific marker of autophagic vacuoles in these cells,
however this does not exclude the possibility that the large LTR+VE / MDC+VE vacuoles
were autophagosomes.
5.2.4 Lysosomal vacuoles are rare in fresh platelets but relatively
common in aged platelets.
It was clear by both electron and light microscopy that vacuolisation of platelets was
occurring in viable platelets prior to death; therefore quantification of the frequency of
platelets containing these vacuoles was performed only on the platelets able to spread
on glass and did not include dead platelets. Dead platelets could not be assessed for
vacuoles due to the state of their cytoplasm and loss of organelle structure.
No evidence of a loss of vacuoles during spreading was observed. Of the freshly
isolated platelets able to spread on glass only 1.4 +/- 0.2% contained large vacuoles
whereas 38.4 +/- 2.2% of the platelets that had been aged overnight had vacuoles (fig
5.3.A).
5.2.5 The autophagy inhibitor 3-Methyadenine (3-MA) partially blocks the
formation or enlargement of vacuoles.
3-MA was identified as an inhibitor of autophagy in 1982 during a screen for
compounds able to inhibit lysosomal proteolysis but not protein synthesis (Seglen and
Gordon, 1982). It is used widely in the autophagy field and is one of the few tools able
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to interfere with the autophagic process. It would be expected therefore that if
vacuolisation was autophagic in nature 3-MA could inhibit the process.
Incubation of platelets in the presence of lOmM 3-MA led to a 53% reduction in the
frequency of platelets containing large vacuoles (overnight control, 38.4 +/- 2.2%;
overnight in the presence of lOmM 3-MA, 17.0 +/-1.4%; n=4, P<0.01) (Fig 5.3.A),
consistent with the notion that vacuolisation represented an autophagic process.
However, concomitant with the partial inhibition of vacuole formation during storage
was an increased frequency of dead platelets indicating that 3-MA was also toxic,
suggesting that vacuolisation might be less to do with an active death program in
platelets and more to do with a survival process, that if inhibited, contributed to cell
death (fig 5.3.B).
5.2.6 Amino acid supplementation reduces vacuole formation.
To study the possibility that platelets were adapting to a nutrient-limiting environment
by up-regulating autophagy platelets were supplemented with lx amino acids and aged
for 24 hours at 37°C. Amino acid supplementation of platelets significantly reduced
vacuole formation by 57% from control levels (control platelets, 38.4 +/-2.2%; amino
acid supplemented platelets 16.3 +/-2.4%; n=4, P<0.01) (fig 5.3.A). Although amino
acids were able to reduce vacuole formation there was no concomitant pro-survival
effect elicited by the supplementation, contrasting the data obtained with 3-MA that
suggested vacuolisation was a survival process (fig 5.3.B). This indicates that amino
acids, although able to block vacuolisation, do not affect platelet viability and that
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Figure 5.3. Vacuoles are rare in freshly isolated platelets but
commonly seen in platelets aged overnight.
Platelets were aged overnight in the presence or absence 10mM 3-MA,
amino acids or without supplementation. Platelets were assessed for the
presence of vacuoles (A) and results w=are expressed as the ratio of
platelets with vacuoles versus those without. Viability (B) was assessed
with 100nM calcein-AM and it was found that by 3-MA negatively affected
viability and correlated with incomplete inhibition of vacuole formation.
Amino acids although inhibiting vacuolisation had no effect on viability, n
>4; +/-SEM; *P<0.01 from Time 0; *#P<0.01 from control at 24 hours.
Page 148 of 239
vacuolisation is thus uncoupled from survival. This apparent uncoupling argues also
that the effects of 3-MA on vacuolisation are due to toxic effects upon platelets rather
than any direct ability of the drug to interfere with autophagy.
5.2.7 Fresh and in vitro-aged platelets accumulate similar amounts of
MDC.
To examine the possibility that the large vacuoles were forming de novo (as might be
expected if macro-autophagy was the driving force for their production) the amount of
MDC-associated fluorescence in platelets that had been incubated with the dye for 20
minutes at 37°C was quantified by flow cytometry (fig. 5.4). Fresh platelets and in
vzYro-aged platelets exhibited similar levels of MDC fluorescence (40.9 +/-3.8mfu and
36.5 +/-3.4mfu, respectively; n-4; P=0.11) and incubation of platelets with amino acids
gave similar results (45.4 +/-6.1 and 44.8 +/-5.6; n=4; P=0.90). The presence of 3-MA
reduced MDC accumulation within platelets by ~45% from 40.1 +/-4.0 when fresh to
21.9 +/-2.0mfu after 24 hours (n=4; P<0.01). This effect was not due to 3-MA
interfering with MDC fluorescence because 3-MA was present within the fresh platelet
samples. It was unlikely that this reduction in the ability of platelets to accumulate
MDC was the result of increased platelet mortality because MDC fluorescence was
reduced within the whole population of platelets. This data indicated that in control and
amino-acid supplemented platelet samples neither a loss nor gain in MDC accumulation
occurred as a result of platelets being aged in vitro for 24 hours, whereas ageing
platelets in the presence of 3-MA had a profound negative effect upon the platelets'
ability to accumulate the dye.
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5.2.8 Amino acids maintain platelet function after storage and 3-MA
completely inhibits platelet activation in response to convulxin.
Due to amino acid supplementation having no effect upon platelet survival it was
postulated that the apparent autophagy was capable of 'eating into' non-vital
components of the platelets, such as storage granules. To this end it was worth
exploring the platelet's functional response to the strong agonist, convulxin (fig 5.5).
Freshly isolated platelets supplemented with amino acids had improved degranulation in
response to CVX when compared to controls (61.1 +/-8.2% control; 76.2 +/-4.3%
amino acid supplemented; n=4; P<0.05). Interestingly, 3-MA within the same
experiment completely inhibited degranulation (1.9 +/-0.4%) (and also shape change as
assessed by cytometry). The same experiment performed 24 hours later after in vitro
storage revealed that amino acids supplemented platelets retained a greater ability to
degranulate (relative to the amount they degranulate when fresh). Control platelets'
response to CVX was reduced by 61% (to 26.8 +/-8.44 % of platelets expressing
CD62P), whereas platelets maintained overnight with amino acid supplementation
showed only a 30% reduction in their ability to degranulate (52.0 +/-5.8% expressing
CD62P) (n=6; P<0.01). In all non-activated controls at 24 hours no CD62P expression
was observed confirming that platelets do not spontaneously degranulate alpha granules
during in vitro storage. This result is consistent with the idea that vacuolisation may
involve a degradation of granule contents in the lysosome and that amino acids are
capable of blocking this process without affecting platelet viability.





























Figure 5.4. Changes to platelet-associated monodansylcadaverine
fluorescence (MDC).
Fresh patelets incubated supplemented with 1x amino acids or 10mM
3MA were incubated with 25pM MDC for 10minutes and analysed for
fluorescence by cytometry. MDC staining was performed again after
platelets ahd been incubated at 37°C for 24 hours. Fresh and in vitro
aged platelets incubated in the presence of amino acids accumulated
MDC similarly, however, platelets aged in the presence of 10mM 3-MA,
failed to accumulate MDC to similar levels relative to freshly isolated.
n=4; +/-SEM; *P<0.01.
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HBSS HBSS & Amino Acids
Figure 5.5. The effects of amino acids and 3-MA on platelet function
before and after in vitro storage.
Platelets were activated with 50ng/ml convulxin (CVX) in the presence of
2mM CaCI2 when fresh (A) and 24 hours later (B). Activation was
determined by the level of degranulation as assessed by the percentage
of platelets expressing CD62-P and are depicted as percentage platelets
expressing CD62P (A) or the percentage of platelets expressing CD62P
relative to the results obtained when fresh, n = 6; +/-SEM; *P<0.01
compared to non-activated controls; # P<0.05 vs HBSS.
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5.2.9 Mitochondria are readily identified in platelets using Mitotracker
Green.
The observation of lysosomal autophagic-like vacuoles led to the question ofwhat intra-
platelet components were being trafficked to the vacuole for destruction. Although no
discernible intraplatelet organelles could be identified at the TEM level it was
hypothesised that, because of the lack of effect that Antimycin had on platelet viability
and the uncoupling of a loss of AThn from viability, damaged mitochondria were being
destroyed in the lysosomes. This phenomenon is known to occur in neurons starved of
growth factors (Xue et al., 1999) and is thought to result in the specific destruction of
damaged mitochondria by autophagy (Elmore et al., 2001).
Mitotracker green is able to accumulate with very little cytosolic background
fluorescence in mitochondria and the dye accumulated to discrete structures in platelets
that were distinct from lysosomes and dense granules as assessed with LTR and
quinacrine (not shown), respectively (fig. 5.6). To the authors knowledge this is the first
usage of the dye with platelets and revealed that mitochondria exist as apparent single
entities within platelets in contrast to their 'string of beads' appearance in other cells.
This singleton morphology may represent their low level of activity within resting
platelets.
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The number ofmitochondria in fresh platelets that were allowed to spread was 9.27 +/-
0.51 per platelet; this number decreased to 7.1 +/-0.3 mitochondria per platelet after 24
hours incubation (n=5; P<0.01) (fig 5.5, A).
5.2.10 Viable platelets have a decreased ability to accumulate NAO.
Because MTG is thought to be sensitive to mitochondrial membrane potential (Keij et
al., 2000) it was possible that the reduction in mitochondrial numbers per platelet was
due not to their degradation within the lysosome but to an inability of the dye to stain
depolarised mitochondria that remained within the platelet. To address this possibility
the amount of cardiolipin (a mitochondria-specific phospholipid) left within viable
platelets was assessed indirectly by incubating platelets with 10-A-nonyl acridine
orange (NAO), a fluorescent dye that is used widely for the measurement of
mitochondrial mass (Leprat et al., 1990; Dumas et al., 1995) and has also been used for
the demonstration of mitochondrial loss by autophagy (Kirkland et al., 2002) (fig. 5.7).
Ageing platelets in vitro led to a decreased ability to accumulate NAO as assessed by
cytometry (21.0 +/-1.2mfu when fresh to 17.1 +/-0.8mfu at 24 hours and 14.9 +/-1.6mfu
after 48 hours; n=11 donors, p<0.01) (fig 5.7.A). The decreased ability to accumulate
NAO from day 0 to day 1 was 18.4% and tallies with the decrease in the number of
mitochondria per platelet from approximately 9 to 7 (a 22% decrease) during the same
period of incubation (fig 5.7.B). Thus it appeared that the changes in mitochondrial
numbers observed with MTG are due to a real decrease in the average number of
mitochondria per platelet and not due to changes in their membrane potential.
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5.2.11 Vacuole formation is completely inhibited by MgS04.
One of the caveats of maintaining platelets in a resting state during storage is the
removal or reduction of the extracellular calcium concentration. It is known that under
low calcium conditions the fibrinogen receptor / am,P3 integrin complex can dissociate
(Fujimura and Phillips, 1983; Zucker et ah, 1983) and that the am, subunit can homo-
dimerise in trans leading to the zippering-up of the open canalicular system (Hanau et
ah, 1991; Gachet et ah, 1992; Gachet et ah, 1993). Although these reports relied on the
ability of EDTA to chelate calcium and dissociate the integrin complex within a short
time frame (generally less than 5 minutes) it was reasoned that, under the chronically
low calcium conditions of incubation used in this thesis, there would also be a
dissociation of the integrin complex. Furthermore, due to the zippering of the OCS,
membrane fluidity and endocytosis would be affected, thus leading to an artefactual
nutrient shortage that might provide the driving force of the lysosomal vacuole
formation. To address this possibility the expression of the am, subunit was examined
and lysosomal vacuole formation was reassessed in platelets aged in the presence of
2mM magnesium, which can maintain the integrin complex.
During overnight storage of platelets as citrated PRP there was complete loss of am,
epitope recognised by the antibody as determined by microscopy and flow cytometry
(fig. 5.8). Supplementation of the incubation medium with 2mM magnesium sulphate
resulted, as expected, in complete retention of the anb epitope. Further to this, there was
complete inhibition of vacuole formation in the presence of MgS04 (fig. 5.9). It has
already been noted that, in the absence of magnesium, vacuole formation was inhibited
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by 3-MA but that this was also toxic to platelets; surprisingly when platelets were
incubated in the presence of MgSC>4 the toxic effect of 3-MA was lost (fig. 5.9.B). The
correlation between of changes to anb expression and vacuole formation prompted the
examination of 3-MA's ability to alter am, expression as a possible mechanism of its
ability to inhibit vacuole formation. 3-MA had no effect upon anb expression indicating
that its ability to inhibit vacuole formation was independent of changes to the
expression of (fig. 5.9.C).
5.2.12 Total protein does not decrease during in vitro storage.
A cursory examination of total protein levels in platelets stored either in the presence or
absence of exogenous amino acids did not reveal any differences in total protein as
assayed by the Bradford method, nor were there any noticeable changes to the
coomassie blue-stained protein profiles of stored platelets (fig 5.10).
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Figure 5.6. Mitochondria are discrete organelles within platelets and
can be found in close association with vacuoles.
Fresh (A) or 24 hour-aged (B) platelets were incubated with mitotracker
green and lysotracker red. Mitochondria are easily identified in spread
platelets and are not associated with lysosomes. Incubation for 24 hours
leads to the formation of vacuoles that can be seen to have associated
with mitochondria. Bar = 2pM. Micrographs are representative of many
platelets from several donors.



























Day 0 Day 1
Figure 5.7. Mitochondrial signals are depleted during in vitro
storage.
Mitochondria were quantified in spread platelets at time 0 and after 24
hours storage in vitro. Mitochondria were visualised with 100nM
mitotracker green and at least 50 platelets per donor were examined (A);
N=5; +/-SEM. Cardiolipin levels were determined using 500pM nonyl-
acridine orange. NAO accumulates within viable platelets and fluoresces
green. NAO shows reduced accumulation within platelets aged for 48






Figure 5.8. Loss of anb during in vitro storage.
Platelets were examined for the surface expression of allb during in vitro
storage. Loss was confirmed by microscopy (A) and flow cytometry; blue
line was autofluorescence set with irrelevant IgG and red was anti- cxl!b
(B) and could be blocked by supplementation of platelet incubates with
2mM MgS04. Changes to the surface expression were examined at 6
and 24 hours (C); n = 3; +/-SE.





























































Figure 5.9. Vacuolisation is inhibited by magnesium sulphate and
the toxicity of 3-MA is only realised when vacuolisation occurs.
Platelets were examined for the presence of Lysotracker red positive
vacuoles when fresh and when aged over night in the absence or
presence of MgS04 (A). Viability of platelets aged overnight in the
presence or absence of 2mM MgS04 with and without 10mM 3-
Methyadenine was examined by cytometry using FM4-64 as a vital stain
(B). The effect of 3-MA on the surface expression of allb was examined
after 24 hours of in vitro storage, (n > 3; * P<0.05; +/-SEM)
Page 160 of 239
Day 0 Day 1 Day 2
Donor A DonorB
Figure 5.10. Total protein is not lost from platelet incubates
nor is there gross signs of proteolysis associated with
platelet pellets.
Platelet protein concentrations were estimated by the Bradford
method from pellets collected by centrifugation (n =4; +/-SEM)
(A). Protein profiles were obtained from platelets samples
obtained after immediate isolation (dO) or after 24, 48 or 72
hours (d1, d2 and d3, respectively) incubation at 37°C. Platelet
protein samples were electrophoresed through 6%
polyacrylamide under reducing conditions profiles and
polypeptides detected using coomassie brilliant blue (B).
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5.3 Discussion.
The caspase-independent cell death of platelets described by some (Brown et al., 2000)
and eluded to by others (Bertino et al., 2003; Wadhawan et al., 2004) and the
observation in this thesis of a necrotic-like end point for stored platelets led to the
hypothesis that their death was autophagic in nature. Autophagic cell death is
persistently associated with vacuolisation and destruction of cytoplasmic contents
including organelles leading to near complete catabolism and a necrotic-like end point
(Thummel, 2001; Lee and Baehrecke, 2001; Bera et al., 2003). This contrasts the
phenotype associated with apoptosis; preservation of organelles and maintenance of
plasma membrane integrity (Kerr et al., 1972). However, it is important to note that
there appears to be overlap between the mechanisms of autophagic and apoptotic cell
death (Bursch et al., 2000; Uchiyama, 2001; Lee et al., 2003).
The first step in the establishment of autophagy in platelets was an examination of
internal membrane morphology at the electron microscope level. Autophagic
sequestration of cytosol and organelles involves the formation of a pre-autophagosomal
(Suzuki et al., 2001) structure followed by the de novo synthesis of a double-membrane
limiting vesicle, termed the autophagic vacuole. This vacuole in mammalian cells has a
characteristic multi-lamellar morphology that is readily identifiable at the TEM level
(Eskelinen et al., 2002). Examination of either freshly isolated or overnight aged
platelets at the TEM level never revealed the existence of any multi-lamellar structures
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that could be identified as autophagic vacuoles. In stored but not fresh platelets the
presence of large vacuoles was observed but, except for the deposition of glycogen
around their perimeter, there were no signs of identifiable organelles within these
structures. It is likely therefore, that macro-autophagy is not the cause of the large
vacuoles.
Accumulation of the dyes lysotracker red and monodansylcadaverine to large vacuole
structures was consistent with an autophagic phenotype (see appendix fig. 8.5) however
the fact that the vacuoles and lysosomes in fresh platelets accumulated MDC indicates
that this dye is not suitable for the specific detection of autophagic vacuoles, a
conclusion reached by others (Elmore et al., 2001) and Aviva Tolkovsky (pers. comm.).
Confirmation that the vacuoles were indeed of a lysosomal origin was obtained using
the antibodies to the lysosome specific protein, Lamp2.
Changes to the amount of MDC accumulated by platelets within a 20 minute period
with the dye did not alter after in vitro incubation, indicating that the vacuoles were not
synthesised de novo but that they had formed from the original lysosomal compartment.
The observation that the average number of mitochondria in platelets decreases during
storage and that this tallied with a reduction in the amount ofNAO that associated with
viable platelets suggested that the vacuole formation may have been the result of
lysosomal fusion with, and destruction of, effete / damaged mitochondria.
Mitochondrial disappearance from cells occurs in response to nerve growth factor
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(NGF)-starvation in primary neuron cultures (Xue et al., 1999; Tolkovsky et al., 2002)
and serum starved hepatocytes (Elmore et al., 2001). This disappearance reflects an
ability of the cell to selectively destroy mitochondria in the lysosome indicating that
autophagy can be a highly selective process. Examination by fluorescence microscopy
of platelets loaded with MTG and LTR revealed on rare occasions that mitochondria
had become clustered around the large vacuoles, however co-localisation of the dyes
was never observed. It is reasonable to think that if mitochondria were fusing with
lysosomes to form large vacuoles, at some point co-localisation between MTG and LTR
should have been observed. Therefore the apparent disappearance ofmitochondria is not
likely the result of crinophagic fusion with the lysosomes. In support of this conclusion
is an observation that serum starved, glucagon treated rat hepatocytes up-regulated the
number of LTR-labelled acidic compartments and that mitochondria without a
membrane potential (measured by the sudden green fluorescence caused by the loss of
quenching that occurs when mitochondria co-loaded with MTG and
Tetramethylrhodamine methylester (TMRM) loose ATTn and leak TMRM) were
sequestered into these acidic structures, a result that could be blocked by maintaining
ATm with cyclosprin A which is able to block the permeability transition pore (Elmore
et al., 2001).
Another explanation for the reduction in the average number of mitochondria per
platelet and the reduced NAO fluorescence is the possibility that the platelets with the
largest number ofmitochondria die first.
Page 164 of 239
Vacuole formation is sensitive to 3-MA, a drug extensively used in the field of
autophagy research. However, used at 1 OmM it has non-specific effects on cells such as
an ability to increase cAMP (Caro et al., 1988) and can inhibit endosomal transport to
lysosomes (Punnonen et al., 1994) - yet many groups have based the identification of an
autophagic mechanism solely on the effects of 3-MA (Sandvig and van Deurs, 1992). In
the present study 3-MA was able to incompletely block vacuole formation during in
vitro storage. This inhibition was accompanied by toxicity. This may indicate that
vacuole formation, if autophagic, was a survival strategy invoked by in vitro conditions
whose inhibition would promote platelet death. This is supported by the observation that
3-MA was only toxic to platelets when vacuolisation was occurring; toxicity was lost in
the presence of MgSC>4, which was able to completely block vacuolisation. However, a
complicating factor in this conclusion is the observation that 3-MA was able to
completely inhibit platelet activation in response to various agonists, indicative of non¬
specific effects of the drug on platelet biology. This ability to inhibit platelet activation
appeared to not just affect degranulation and integrin activation but also very early
events linked to shape change. The fact that activation in platelets is inhibited at the
shape-change stage is suggestive of increased intracellular cAMP concentration, which
is known to occur in isolated hepatocytes treated with 3-MA (Caro et al., 1988). Thus it
is not clear if the toxicity associated with 3-MA is linked to its ability to block vacuole
formation or whether it is the result of an effect unrelated to autophagy that is only
realised in the absence of magnesium. Although untested, if levels of cAMP are
constitutively high in the platelets this may represent a drain on cellular ATP that leads
to loss of viability. Therefore the results with 3-MA may be due to indirect toxic effects
on platelets. However, the fact that 3-MA was capable of completely inhibiting platelet
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activation is further evidence that platelet death in this model can occur independently
of platelet activation.
Amino acid starvation is used to experimentally stimulate autophagy in a wide variety
of cells (Lenk et ah, 1999; Mordier et ah, 2000) therefore it was possible that vacuole
formation was a response to one or a number of amino acids becoming limiting.
Supplementation of platelet incubates with amino acids was able to partially reduce
vacuole formation in platelets but had no effect on platelet survival, contrasting the
results obtained with 3-MA; this suggests that vacuole formation and platelet survival
were independent of each other. However, this conclusion is tentative due to the known
divergence of autophagic responses to starvation (Schworer and Mortimore, 1979).
Autophagic responses elicited by glucagon involve lysosomal glycogen breakdown
whereas those elicited by amino acid starvation lead to proteolysis. However, amino
acid supplementation can reduce glycogen autophagy in glucagon treated hepatocytes
(Schworer and Mortimore, 1979). Therefore vacuolisation may be a response to
carbohydrate limitation and that amino acid supplementation, although able to down-
regulate vacuole formation, is not sufficient to provide a pro-survival signal and
compensate for the carbohydrate limitation.
Examination of platelet function in response to convulxin revealed that amino acids
could retain better platelet function than non-supplemented platelets. This suggests that
loss of platelet function is linked to increasing vacuolisation and may suggest that
amino acid uptake by platelets is key not for survival but for maintenance of functional
responsiveness to agonists. The fusion of storage granules with the lysosome is known
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as crinophagy but the process has never been described in platelets. It is tempting to
think that the collection of observations made in this work is consistent with a
crinophagic process of granule destruction. This autophagic response may have been
initiated by a stress linked to low cations, such as OCS zippering, but one that could be
obviated by magnesium. Although not having any effect on viability it has profound
effects on platelet function.
Although total protein levels did not decrease during in vitro storage further work
should examine more specifically the elements of degranulation that appear to be
protected by amino acid supplementation. An examination of the amount of alpha
granule protein retained by platelets supplemented with amino acids relative to controls
and an examination of the contents of vacuoles would be beneficial in understanding the
role of vacuolisation. Indeed, the lack of total protein changes during storage may
indicate that dense granules rather than alpha granules are fusing with lysosomes;
consistent with the amino acid data this would reduce the amount of releasable
serotonin, calcium and ADP and negatively affect CD62P expression during
degranulation.
Also, the presence of LC-3 in platelets should be confirmed and, if present, its sub¬
cellular localisation examined. Efforts to establish the presence of LC-3 were
unsuccessful due to technical difficulties in optimising western blotting conditions and
the highly limited availability of this non-commercial antibody (a very kind gift of
Takahashi Ueno).
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This work dealt with the hypothesis that autophagy was involved in the caspase
independent cell death of platelets during in vitro incubation. The large vacuoles that
formed in vitro were identified as lysosomal in origin but it is not clear why they have
become enlarged. A single factor leading to vacuolisation was not identified in this
work and it remains obscure as to why vacuolisation occurs when platelets are held in
citrated plasma. The current data support the hypothesis that the enlargement of
lysosomes in platelets is the result of crinophagy, a fusion of granules with the lysosome
that is controlled by divalent cation availability. In conclusion it is unlikely that macro-
autophagy is responsible for platelet death in vitro, however the possibility remains that
vacuolisation is an autophagic response to changes in conditions important for the
maintenance of platelet function.
The lack of a change to total platelet protein indicates that although necrosis may have
been detected at the TEM level (and possibly by the platelets' inability to accumulate
calcein-AM) that no substantial leakage of polypeptides to the extracellular milieu
occurs. This contrasts the known result of necrosis, which is typified by rapid and
irreversible loss of cellular integrity with consequent pro-inflammatory spillage of
cellular contents. Therefore, the retention of protein within dying platelets argues for a
more elaborate form of cell death than necrosis.
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6 GLYCOGEN INFLUENCES PLATELET SURVIVAL
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6.1 Abstract.
Platelets possess large fields of glycogen and express few GLUT transporters on their
surface whilst in their resting state. This led to the hypothesis that glycogen and / or an
ability to catabolise glycogen is a determinant of the platelet's lifespan in vitro. It was
confirmed at both the light and electron microscopic level that platelets contain large
deposits of glycogen. These glycogen deposits, as measured by the anthrone assay,
become depleted from platelets during incubation at 37°C. The depletion of glycogen
from platelets could be partially inhibited by the glycogen phosphorylase inhibitors,
caffeine and the novel caffeine analogue, CP-91149. Lithium was also capable of
partially inhibiting glycogen depletion from platelets, possibly by indirectly
antagonising glycogen phosphorylase activity. All three agents were also toxic to
platelets as assessed by the calcein-AM accumulation assay providing evidence of a
correlation between an ability to breakdown glycogen and maintenance of platelet
viability. Interestingly, hypoglycaemia caused changes to the platelets' ability to
accumulate NAO and calcium(i), suggesting that low exogenous glucose promotes
fundamental changes to mitochondia and calcium homeostasis but that these changes do
not translate to toxicity. Consistent with this hypothesis were the observations that
platelets maintained with antimycin did not die and that deliberate collapse of
mitochondrial membrane potential did not promote platelet death either. Hypoglycaemia
appeared to prime platelets to the cell death promoting ability of antimycin and BH3I-
2', a small molecule promoter of pro-apoptotic Bcl-2 family balance within cells.
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6.2 Results.
6.2.1 Platelets possess large fields of glycogen.
Platelets examined at the light microscope level after PAS staining contained abundant
PAS-positive material (fig. 6.1) consistent with the size of glycogen fields. By TEM
glycogen could be seen in close proximity of a membrane limiting structure presumed
to be part of the open canalicular system (fig. 6.2). Although not shown, it was clear
from examination of electron micrographs of platelets that had been incubated at 37°C
for 72 hours that platelets contained very little glycogen.
6.2.2 Glycogen content of platelets is dramatically reduced during
storage.
To explore quantitatively the glycogen content of platelets the anthrone assay was
employed. The anthrone assay estimates the amount of glucose hydrolysed from total
carbohydrate isolated from cells by alkaline precipitation, thus results describe glucose
concentrations rather than glycogen content. Glycogen content of platelets was
estimated from a pellet of platelets harvested from 1ml of autologous PRP. Results are
therefore expressed as micrograms of glucose per ml of platelets.
Freshly isolated platelets yielded 44.8 +/-6.2pg glucose/ml platelets, whereas by 24
hours the content of glycogen had fallen to 18.4 +/-1.8pg glucose/ml platelets and by 48
and 72 hours to 12.0 +/-1.3 and 5.3 +/-2.8 pg glucose/ml platelets, respectively (n>3;
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P«0.01) (fig. 6.3). This data are consistent with the observation made at the TEM level
that platelets lose glycogen during in vitro incubation.
6.2.3 Hypoglycaemic conditions do not affect the initial rate of glycogen
loss from platelets.
Using the anthrone assay it was established that platelets held under hypoglycaemic
conditions for 24 hours did not lose a significantly greater amount of glycogen when
compared to control platelets (47.2 +/-5.0pg glucose/ml platelets when fresh; 14.7 +/-
6.6pg glucose/ml platelets after 24 hours and 12.7 +/-3.7pg glucose/ml platelets after 24
hours without exogenous glucose; n = 3; PO.Ol between fresh and incubated platelets;
P=0.4 between control and hypoglycaemic platelet samples) (fig. 6.4). Thus,
hypoglycaemia did not promote the loss of glycogen from platelets, consistent with the
hypothesis that glycogen was the main source of glucose for metabolism in platelets
during their in vitro incubation.
6.2.4 Three distinct pharmacological agents partially inhibit glycogen
depletion in platelets.
If glycogen is an important source ofmetabolic glucose it was reasoned that inhibition
of it's catabolism would have negative effects on platelet viability. In order to test this
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Figure 6.1. Micrograph of fixed platelets stained with periodic acid -
Schiff reagent.
Platelets were aged for 24 hours, fixed with 1 volume of 2%
formaldehyde and stained using PAS reagent. PAS positive material can
be readily identified within platelets (arrow); these areas correspond to
the expected size of glycogen fields as seen by transmission electron
microscopy. Bar = 5pm.
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Figure 6.2. Glycogen can be seen associated with the OCS within
freshly isolated platelets.
Freshly isolated platelets were fixed for 1 hour at 37°C with 3%
gluteraldehyde and then processed for transmission electron microscopy.
Micrographs show two platelets from the same donor containing large
fields of glycogen (arrows), some of which is closely associated with what
appears to the be open canalicular system. Micrographs iii and iv are
close-ups of i and ii, respectively.
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hypothesis it was necessary to find inhibitors of glycogen phosphorylase, the major
regulatory enzyme of glycogen catabolism. Caffeine and the novel caffeine analogue,
CP-91149, are known to be direct inhibitors of glycogen phosphorylase (Martin et al.,
1998), however they are thought to act at distinct sites on the enzyme. An alternative
inhibitor, Lithium, reduces glycogen catabolism by blocking the phosphorylation of
glycogen synthase thereby shifting the equilibrium of glycogen metabolism towards
synthesis rather than catabolism. Glycogen synthase and phosphorylase activities are
tightly coupled and it is thought that inhibition of one results in the promotion of the
other, therefore lithium would be expected to exert promotion of synthase activity
whilst simultaneously inhibiting phosphorylase activity (Latsis et al., 2002).
Incubation of platelets for 24 hours at 37°C in the presence of lithium chloride (20mM),
caffeine (20mM) or CP-91149 (lOOpM) incompletely inhibited the loss glycogen
(freshly isolated platelets contained 45.7 +/-1.5|a.g glucose/ml platelets; whereas
platelets incubated in vitro for 24 hours contained 23.2 +/-2.2pg glucose/ml platelets;
whereas platelets incubated in the presence of lithium or caffeine contained 31.7 +1-22
and 30.5 +/-0.2pg glucose/ml platelets, respectively; n>3; P<0.01 between fresh and
incubated platelets; P<0.05 between control and lithium or caffeine supplemented
platelet incubates) (fig.6.5). This data indicates that glycogen breakdown is sensitive, in
part, to inhibition of phosphorylase by the direct action of caffeine or CP-91149 or by
the indirect action of lithium and support the contention that loss of glycogen from
platelets is due to a metabolic process involving phosphorylase activity.
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Figure 6.3. Glycogen is lost from platelets during in vitro storage.
Platelets were aged as PRP for 72 hours. Loss of glycogen was
estimated as the reduction in total platelet carbohydrate by the anthrone
assay against glucose standards of known concentration. *P<0.01; n = 4;
+/-SEM.
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5mM Glucose; No Glucose
time 0 T 24hrs
Figure 6.4. Hypoglycaemic conditions do not affect the rate of loss
of Glycogen from platelets.
Platelets were incubated for 24 hours as a 1:50 dilution of PRP
supplemented with or without 5mM glucose. No significant difference in
the amount of glycogen remaining associated with platelets at 24 hours
was detected. P=0.44; n = 4; +/-SEM.



















Time 0 T 24 hrs
Figure 6.5. Lithium, Caffeine and CP-91149 inhibit the loss of
glycogen from platelets during in vitro incubation.
Platelets were incubated for 24 hours as PRP supplemented with 20mM
LiCh, 20mM caffeine or 100pM CP-91149. All three agents caused an
inhibition of glycogen loss from platelets. *P<0.01 from time 0; **P<0.05
from 24 hour control samples; n = 4; +/-SEM.
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6.2.5 Lithium, caffeine and CP-91149 promote platelet death.
The next question was whether or not inhibition of glycogen catabolism correlated with
increased platelet death. To explore this hypothesis, platelets were incubated under
control or hypoglycaemic conditions with lithium or caffeine and assessed 72 hours
later for viability using the calcein accumulation assay.
Lithium promoted the loss of viability from platelets within 72 hours of incubation
(43.15 +/-4.4 vs 56.7 +/-2.4% dead under normoglycaemic without or with lithium and
48.2 +/-7.4 vs 72 +/-2.6% dead under hypoglycaemic conditions without or with
lithium; P<0.05 for each difference) (fig. 6.6.A). Incubation of platelets with caffeine
gave similar results (32.9 +/-3.2 vs 44.7 +/-5.5% dead under normoglycaemic without
or with caffeine and 37.3 +/-3.0 vs 50.1 +/-4.2% dead under hypoglycaemic conditions
without or with caffeine; P<0.05 for each difference) (fig. 6.6.B).
In a similar experiment platelets were incubated with the novel caffeine analogue CP-
91149 (100pM) for 24 hours (preliminary data indicated that by 72 hours most platelets
were dead) and examined for viability using the calcein accumulation assay (fig. 6.7). It
was found that this agent also had a profound effect upon platelet survival in vitro.
Platelet death at 24 hours was significantly promoted in the presence of CP-91149 (11.4
+/-1.3% versus 23.8 +/-2.4% dead without or with CP-91149, respectively; P < 0.05; n
= 3) and its effects, like that of caffeine and lithium were further promoted by
hypoglycaemia (12.0 +/-1.6% versus 37.6 +/-4.5% dead without or with CP-91149,
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respectively; P < 0.05; n = 3). Thus, three agents having broad pharmacological targets
but sharing an ability to inhibit glycogen phosphorylase are able to promote platelet
death in vitro.
6.2.6 Hypoglycaemia alters mitochondrial integrity.
The data so far are consistent with glycogen content or an ability to utilise glycogen as
being an important determinant of platelet lifespan in vitro. However an apparent
contradiction had arisen regarding the importance of exogenous glucose to platelet
survival; platelets held under hypoglycaemic conditions did not deplete their glycogen
stocks more rapidly than controls but were more sensitive to the effects of caffeine, CP-
91149 and lithium. Furthemore, hypoglycaemia had no effect upon platelet viability as
assessed by the calein-AM accumulation assay (figs. 6.6 and 6.7), even over a five day
period of incubation {n > 3; P=0.99) (fig 6.8). However, it was noted that a discrepancy
had arisen between the calcein-AM and the NAO-accumulation assays. Failure to
accumulate calcein was observed in 8.4 +/-0.8% and 9.3 +/-0.6% of platelets held for 24
hours under normo- and hypoglycaemic conditions, respectively (n=5; P=0.08);
whereas 12.8 +/-1.2% and 22.2 +/-1.8% of platelets failed to accumulate NAO after 24
hours incubation under normo- and hypoglycaemic conditions, respectively (n=5;
P<0.05) (fig. 6.8). This result indicated that hypoglycaemia had affected the integrity of
platelet mitochondria but that this change had not translated into a loss of viability.

































5mM Glucose No Glucose
Figure 6.6. The effect of lithium and caffeine on platelet viability in
vitro.
Platelets were incubated for 72 hours at 37°C as 1:50 dilution of PRP
supplemented with either 5mM or no glucose. Lithium was added to a
final concentration of 20mM. Viability was assessed by the platelets
ability to accumulate calcein-AM. Lithium negatively affected platelet
survival and this effect was exacerbated by hypoglycaemia. n = 3; +/-
SEM *P<0.05 from normoglycaemic control; ** P<0.05 from
hypoglycaemic control.





















Figure 6.7. The effect on platelet viability in vitro of CP-91149 in
conjunction with hypoglycaemia.
Platelets were incubated for 24 hours at 37°C as 1:50 dilution of PRP
supplemented with either 5mM or no glucose. CP-91149 was added to a
final concentration of 100pM. Viability was assessed by the platelets
ability to accumulate calcein-AM or FM4-64. CP-91149 negatively
affected platelet survival and this effect was exacerbated by
hypoglycaemia. n = 3; +/-SE; *P<0.05 from controls; **P<0.05 from
normoglycaemic platelets supplemented with CP 91149.
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Figure 6.8. Hypoglycaemia does not affect platelet lifespan in vitro.
Platelets were aged for 5 days as a 50-fold dilution of PRP supplemented
with or without glucose to a final concentration of 5mM. Platelet viability
was assessed using calcein accumulation assay. No differences between
treatment groups in terms of platelet viability were observed over the 5-
day period. This result suggests that platelets are not obliged to utilise
exogenous glucose for vital processes, n = 5; P=0.988.













Figure 6.9. Hypoglycaemia alters platelets' ability to accumulate
NAO but not Calcein-AM.
Platelets were aged for 24 hours in vitro at 37°C as 50-fold dilution of
PRP supplemented either with or without 5mM glucose and assessed for
viability using NAO or Calcein accumulation assays. As expected, no loss
of viability in response to hypoglycaemia was detected with the calcein
assay (shaded columns), however, the ability to accumulate NAO was
affected by hypoglycaemia. n = 5; *P<0.05 compared to NAO"VEs under
normglycaemic conditions.
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6.2.7 Changes to mitochondrial membrane potential are uncoupled from
platelet death.
The data suggested that hypoglycaemia could promote changes to platelet mitochondria
but that these changes do not necessarily translate into loss of viability. To explore this
possibility platelets were incubated for 5 days and their mitochondrial membrane
potential was assessed using the mitochondrial membrane potentiometric dye JC-1.
Platelet death as assessed by calcein-AM accumulation proceeded at a linear rate over 5
days from less than 1.7 +/-0.5% dead in fresh samples to 15.3 +/-1.7%; 29.8 +/-3.0%;
41.8 +/-2.7%; 66.81 +/-2.4% and 88.9 +/-1.5% death on days one, two, three, four and
five of incubation, respectively (n = 5; P«0.01). This near linear rate of platelet death
was contrasted by the data obtained with JC-1 which indicated that 9.3 +/-1.4% of fresh
platelets had lost their mitochondrial membrane potential and that this progressed as a
hyperbolic kinetic to 37.8 +/-2.6%; 54.6 +/-3.6%; 69.6 +/- 4.3%; 82.8 +/-2.3% and 88.9
+/-1.5% of platelets on days one, two, three, four and five of incubation respectively (n
= 5; P«0.01) (fig. 6.10). This divergence of the kinetics regarding loss of AThn and
viability as assessed by the JC-1 and calcein-AM accumulation assays, respectively,
support the contention that changes to platelet mitochondria are uncoupled from loss of
platelet viability.
Evidence for this conclusion was sought by incubation of platelets with an inhibitor of
electron transport (antimycin) and a protonophore that causes loss of ATTn, carbonyl
cyanide m-chlorophenylhydrazone (mCCCP). The rationale for this approach was that if
mitochondrial function was unimportant for maintenance of platelet viability then these
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two agents would not affect the frequency of platelets able to accumulate calcein-AM.
Incubation of platelets with either antimycin A (10pg/ml) or mCCCP (lOpM) for 24
hours at 37°C did not promote platelet death relative to diluent controls (16.3 +1-2.5%
control; 15.7 +/-2.9% with Antimycin; n = 4; P=0.35 and 14.0 +/-1.7% for control; 13.3
+/-1.3% mCCCP; n = 3; P = 0.3) (fig. 6.11). Confirmation of the ability of antimycin to
cause inhibition of electron transport in platelets (McElroy et ah, 1971; Peerschke,
1999) was confirmed by its ability to reduce fibrinogen binding by 29% (9.2 +/-1.8mfu
and 3.9 +/-0.5mfu for platelets activated in the presence or absence of antimycin,
respectively) and CD62P expression by 57% (12.8 +/-3.5mfu for the control and 9.1 +/-
2.4mfu for antimycin treated platelets; n = 4; P<0.05; for both fibrinogen binding and
degranulation) in response to 5pM ADP (fig. 6.12). The collapse of ATm caused by
mCCCP was reported by JC-1 (49.8 +/-4.5% of platelets had an intact ATm at 24 hours
whereas only 35.9 +/-2.1% had an intact ATm when incubated in the presence of
mCCCP (n = 3; P<0.01) (fig. 6.13).
6.2.8 Antimycin combines with hypoglycaemia to bring about platelet
death.
The data supported the hypothesis that although mitochondrial integrity or function can
be negatively affected by pharmacological agents there is no subsequent promotion of
platelet death. Time course experiments also supported this contention, inasmuch that
the kinetic of the platelets' loss of ATm is different from (and therefore uncoupled
from) loss of viability. It was surprising then to find that incubation of platelets with
lOmM 2-deoxy D-glucose (2DG) (2DG was used to effect hypoglycaemia in full cPRP,
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0 24 48 72 96 120
Hours
Figure 6.10. Platelet death during storage at 37°C is uncoupled from
degranulation and changes to mitochondria.
Platelets were aged for 5 days as PRP and examined for surface
expression of CD62P (A), loss of A^m using JC-1 (B) and retention of
viability as assessed by an ability to accumulate calcein (Both graphs), n
> 5 different donors for each parameter examined.













No antimycin With antimycin
Figure 6.11. Antimycin A has no effect upon platelet viability.
Platelets were aged for 24 hours in the presence of 10pg/ml Antimycin A
and examined for viability using the calcein accumulation. No significant
difference in platelet viability was detected by 24 hours. n=3; P=0.3; +/-
SEM.
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NoADP ; ADP NoADP ADP
B. Degranuiation
Figure 6.12. Activation of aMbp3 and expression of CD62P in
response to ADP is reduced by Antimycin A.
To confirm that Antimycin A had bioactivity platelets (as PRP) were
incubated at 37°C for 1 hour in the presence of either 10pg/ml Antimycin
A or vehicle control (EtOH to a final concentration of 0.1%) prior to
activation in the presence of 2mM CaCI2 with 5pM ADP. The binding of
Alexa488-conjugated fibrinogen to platelets was used to assess integrin
activation (A) and CD62P expression was assessed with phvcoerythrin-
conjugated anti-CD62P antibodies (B). n = 4; *P<0.05 from non activated
control; #P<0.05 between activated in the presence or absence of
Antimycin.

















Figure 6.13. Loss of A'Pm is uncoupled from loss of platelet viability.
Platelets were aged for 24 hours in the absence or presence of 10pM
CCCP and examined for viability using calcein and for loss of A¥m using
JC-1. Although CCCP negatively affected ATm this did not lead to a
change in the frequency of dead platelet by 24 hours. N=3; *P<0.05. ns =
no significant difference between treatments.
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it is transported into cells, phosphorylated and accumulates as 2DG-6-phosphate which
is not metabolised further, therefore glycolytic flux is inhibited) in the presence of
antimycin caused complete loss of their ability to accumulate NAO and a promotion of
death as assessed by calcein-AM accumulation (21.5 +/-2.8% NAO negative for control
platelets at 24 hours; 44.1 +/-5.0%, 22.1 +/-3.7% and 98.0 +/-0.1% NAO negative
platelets incubated with antimycin) (fig. 6.14).
6.2.9 BH3I-2' combines with hypoglycaemia to bring about platelet death.
That antimycin was unable to affect platelet viability on its own but that it showed
synergy with hypoglycaemia appeared, at first, to contradict the lack of importance that
mitochondrial function has regarding the maintenance of platelet viability in vitro.
However, it has been reported that, apart from antimycin's known effects upon electron
transport, the agent can interfere with pro and anti-apoptotic Bcl-2 family member
interactions and lead to the promotion of apoptosis in a murine hepatocyte cell line
overexpressing Bc1-Xl (Tzung et al., 2001). Fortuitously, the research article regarding
the pro-apoptotic effects of antimycin was published back-to-back with an article
regarding small molecule inhibitors of the BH3 domain interaction between pro and
anti-apoptotic Bcl-2 family members (Degterev et al., 2001). The most potent molecule
described, BH3I-2', was therefore used in conjunction with hypoglycaemia in order to
see if it could recapitulate the effects of antimycin.
Incubation of platelets at 37°C for 24 hours with BH3I-2' (20pM) did not result in
increased platelet death according to the calcein accumulation assay (13.3 +/-1.0%
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control; 12.7 +/-1.1% with BH3I-2'; n = 3; P=0.63), however if platelets were
maintained under both hypoglycaemic conditions and with BH3I-2' there was
substantial death within 24 hours (13.3 +/-2.0% control; 69.3 +/-11.0% with BH3I-2'; n
= 3 different donors; P<0.01) (fig. 6.15). Thus, BH3I-2' recapitulated the results
obtained with antimycin.
6.2.10 BH3I-2' dramatically affects the fluorescence emission spectra of
both JC-1 and NAO.
Platelets treated with BH3I-2' always displayed dramatic but unusual changes in their
ability to accumulate JC-1 or NAO. Platelets treated with BH3I-2' and then stained with
JC-1 and examined by cytometry showed a marked shift in both red and green
fluorescence, whereas BH3I-2' treated platelets stained with NAO failed to accumulate
the dye to the same fluorescence intensity as controls. These data initially were thought
to mean that platelet mitochondrial biology had become modified by BH31-2' but it was
unclear why JC-1 fluorescence failed to describe loss of ATm in the normal manner
(loss of red fluorescence and simultaneous gain in green fluorescence). Thus it was
hypothesised that BH3I-2' was directly interfering with fluorescence properties of both
NAO and JC-1.
To explore this possibility JC-1 or NAO were mixed with BH31-2' at the concentrations
used within the assays using platelet free plasma diluted 1:500 with calcium free HBSS
as diluent. The solutions were scanned for emission spectra at the excitation wavelength
used for cytometric analysis (488nm). It was found that the emission spectra of both

















No antimycin With antimycin
Figure 6.14. Hypoglycaemia and antimycin synergise to bring about
platelet death.
Platelets were incubated for 24 hours as cPRP at 37°C with or without
10mM 2DG in the presence or absence of 2pg/ml antimycin. Platelets
were then stained with 100ng/ml NAO or 100nM calcein-AM. A
discrepancy arises in the abilities of calcein AND NAO to report upon
platelet viability under hypoglycaemic conditions. Neither hypoglycaemic
conditions nor the presence of antimycin affected platelet viability
according to calcein-AM accumulation assay relative to controls.
Antimycin with hypoglycaemia acts synergistically to promote loss of
platelet viability, n = 3; *P<0.05; +/-SE.

























Control lOmM 2dG 20microM 2dG&
BH31-2' BH31-2'
5mM Qucose
Figure 6.15. Hypoglycaemia and the pro-apoptotic molecule BH3I-2'
synergise to bring about platelet death.
Platelets were incubated for 24 hours as a 50-fold dilution of PRP with or
without glucose to 5mM in the presence or absence of the pro-apoptotic
molecule BH3I-2' (A). Viability was assessed at 24 hours using calcein
accumulation as a marker of viability. Neither hypoglycaemic conditions
nor the presence of BH3I-2' affected platelet viability compared to
controls, however act synergistically to promote loss of platelet viability. A
similar experiment with platelets in full PRP and using 2DG to induce
hypoglycaemia recapitulated the results using diluted PRP (B) r? = 3;
*P<0.05; +/-SE.
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NAO and JC-1 were significantly changed when in the presence of BH3I-2' (fig. 6.16),
confirming that the agent directly interferred with their fluorescence characteristics and
that the data obtained with these dye combinations could not be relied upon.
6.2.11 Hypoglycaemia leads to changes in platelet calcium^).
To understand why hypoglycaemia made platelets more susceptible to agents that are
capable of shifting cells towards a pro-apoptotic state the intraplatelet calcium
concentration in fresh platelets and platelets incubated for 24 hours at 37°C was
examined using Fluo-3 (fig. 6.17). The rationale for looking at calcium^) was based on
the many links between calcium^), mitochondrial dysfunction and cell death (Lemasters
et ah, 1998; Ermak and Davies, 2002). Strikingly, it was noted that the calcium^) of
platelets did not increase significantly during 24 hours in vitro at 37°C (5.5 +/-0.8mfu
and 6.4 +/-0.9mfu for fresh and incubated platelets, respectively; n = 3; P=0.60). To
confirm that Fluo-3 was capable of detecting changes to platelet calcium^) freshly
isolated platelets were activated with convulxin. CVX-activated platelets exhibited a 6-
fold increase in Fluo-3 fluorescence conpared to unactivated controls (5.5 +/-0.8mfu
and 31.0 +/-0.5mfu for unstimulated and activated platelets respectively; P<0.001; n >
3), indicating that rises in calcium^) are readily detected by this method.
In contrast to this result platelets held under hypoglycaemic conditions (invoked by the
presence of lOmM 2DG) exhibited a 2-fold increase in Fluo-3 fluorescence (from 6.4
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+/-0.9mfu to 11.8 +/-1.6mfu; n = 4; P<0.05) (fig. 6.18), indicative of a change in the
platelets' ability to regulate calcium homeostasis under hypoglycaemic conditions.
Citrated plasma retains a free calcium concentration of approximately 50 to 60pM, thus
it is possible for increases in intraplatelet calcium to be due both to an efflux from stores
and an influx from the plasma. Influx of calcium due to capacitative calcium entry via
store operated calcium channels is known to be inhibited by 2-aminoethoxydiphenyl
borate (2-APB) (Dobrydneva and Blackmore, 2001), however this drug is known also to
inhibit nVsensitive calcium channels (Missiaen et al., 2001). In view of this it was
reasoned that incubation of platelets under hypoglycaemic conditions with wortmannin
(to inhibit HVsensitive calcium channels) and / or 2-APB would resolve the origin of
any intraplatelet calcium rise.
The rise of calcium^) caused by hypoglycaemia could be inhibited by 2-APB but not by
wortmannin (11.8 +/-1.6mfu; 5.6 +/-0.8mfu and 11.6 +/-1.7mfu for 2DG, 2DG with 2-
APB and 2DG with wortmannin, respectively), indicating that IP3-sensitive calcium
channels were not being activated either in controls or by hypoglycaemia. This result is
consistent with the hypothesis that extracellular glucose mediates calcium homestasis in
human platelets. However, inhibition by 2-APB of the increase in calcium^) that was
caused by hypoglycaemia had no effect on the frequency of platelets' able to
accumulate NAO, indicating that the influx of calcium was not responsible for the
increased number of platelets unable to accumulate NAO. The lack of increased calcium
in controls suggests that platelet death in vitro is not the result of calcium(ex) influx or
calcium efflux from internal stores. The effect of 2-APB was to return calcium^) levels
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to controls, suggesting that a calcium efflux from stores did not contribute to the
increased calcium^).
6.2.12 Hexokinase I does not appear to accumulate in the cytoplasm as a
result of hypoglycaemia.
It was hypothesised that mitochondrial integrity had been affected by hypoglycaemic
conditions. It has been reported that 2DG-induced hypoglycaemia can cause production
of reactive oxygen species and oxidation of cardiolipin (Nomura et al., 1999; Nomura et
ah, 2000). Furthermore, due to the recent work demonstrating a role for hexokinase in
the regulation of apoptosis, oxidation of cardiolipin may have been associated with the
dissociation of hexokinase from the mitochondrial outer membrane (Pastorino et al.,
2002; Danial et al., 2003).
Western blot analysis of platelet proteins obtained after sonication and isolation of
cytosolic and membrane-enriched fractions using antibodies to human Hexokinase I
revealed the presence of two major immuno-reactive polypeptides of approximately 100
and 50kDa (fig. 6.19). However there was no qualitative difference in the signal
intensities from platelets incubated overnight under hypoglycaemic conditions
compared to controls incubated with 5mM glucose.
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Figure 6.16. BH3I-2' affects the emission spectra of NAO and JC-1.
The emission spectra of NAO and JC-1 were analysed in platelet-free
solution (cPPP diluted 1:500 with HBSS). The emission spectra were
then re-assessed in the presence of BH3I-2'. The concentrations used
were the same as used for the assessment of platelet NAO accumulation
or AT'm by JC-1. A clear quantitative reduction in the fluorescence
intensity of NAO is caused by BH3I-2'. Furthermore, BH3I-2' alters the
intensity and emission spectrum JC-1.













Figure 6.17. Changes in intraplatelet calcium during in vitro
incubation and in response to various treatments.
Platelets were loaded with Fluo-3 for 30 minutes at 37°C when fresh or
after 24 hours in vitro. Fresh platelets and platelets aged for 24 hours
exhibited similar Fluo-3 fluorescence signals (light and heavy lines in the
histogram) whereas platelets incubated with 2-deoxy D-Glucose (2DG)
had increased Fluo-3 fluorescence signal (grey peak in histogram). As a
positive control fresh platelets were activated with convulxin, which led to
a 2-log order shift in Fluo-3 fluorescence (black peak in histogram).
Quantified data (bar chart) from 3 donors indicated that although calcium
signal could be detected after activation with convulxin there was no
increased cytoplasmic calcium detected by Fluo-3 when platelets had
been incubated for 24 hours, n = 3; +/-SE; *P<0.01; #Not significantly
different from fresh.
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13 2-APB & Wort'
Figure 6.18. Effect hypoglycaemia, 2-APB and wortmannin on the
ability of platelets to accumulate nonyl acridin orange.
Platelets were aged for 24 hours in the presence or absence of 2DG and
various pharmacological agents. Platelets were then assessed for
cytoplasmic calcium and their ability to accumulate 10-/V-nonyl acridine
orange by flow cytometry. The increased calcium signal caused by 2DG
was inhibited by 2-APB but not wortmannin however none of these
treatments had any effect on the platelets inability to accumulate NAO. n
= 4; +/-SE; *P<0.01 from normoglycaemic controls; #P<0.01 from 2DG
treated group & not significantly different from normoglycaemic controls.
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Donor A Donor B
Figure 6.19. Changes to sub cellular localisation of Hexokinase I are
not discernible in response to 2DG.
Platelets were aged for 24 hours in the presence or absence of 2DG,
lysed by hypotonic shock and sonication, centrifuged to form membrane
rich and cytosolic fractions and examined by western blotting using
antibodies to Hexokinase I. Hexokinase is an approximately 100kDa
protein, two immuno-reactive bands can be seen one at ~100kDa and
another at 70kDa. Ponceau stained blot confirmed equal loading of
protein into gels. Hypo = hypoglycaemic samples; Cont =
normoglycaemic samples; S = (cytosolic fraction; P = membrane fraction)
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6.3 Discussion.
Platelets surface express GLUT3 receptors when stimulated by thrombin (Sorbara et al.,
1997) and are sensitive to inhibitors of electron transport such as antimycin during
activation (McElroy et al., 1971; Peerschke, 1999). However, in their resting state most
energy is provided by anaerobic glycolysis (Sorbara et al., 1997). It has been known for
many decades that platelets possess glycogen (Zingoni, 1952) and that glycogen
becomes depleted during activation (Scott, 1967) due to the direct positive effects of
increased calcium^) upon glycogen phosphorylase activity (Gear and Schneider, 1975).
It was therefore hypothesised that platelet viability is maintained by catabolism of
glycogen during in vitro storage.
It was demonstrated that platelets possess large PAS-positive inclusions at the light
microscopic level and that at the TEM level fields of glycogen are present. It was shown
using the anthrone assay that the glycogen content of platelets became reduced during in
vitro storage at 37°C, a finding that is in agreement with other studies (Zingoni, 1952;
Scott, 1967; White et al., 1980). Glycogen was lost from platelets just as rapidly in the
absence of glucose(ex), which is consistent with the hypothesis that the glucose
requirements of platelets are met primarily by the catabolism of glycogen.
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The importance of glycogenolysis to platelet viability was examined using three distinct
pharmacological agents; caffeine, lithium and CP-91149, which have broad range of
pharmacological targets but overlap occurs at the point of glycogen breakdown (Martin
et al., 1998; Zhang et ah, 2003). Lithium is able to promote glycogen synthesis by
blocking the dephosphorylation of GSK3 and it is thought that glycogen synthase and
phosphorylase activities exists in a 'see-saw' state that when one is activated the other
in inactivated, thus facilitating the rapid anabolism or catabolism of glycogen as
required by the body (Latsis et al., 2002; Aiston et al., 2003). Although structurally
similar to caffeine it is believed that CP-91149 acts upon glycogen phosphorylase by
maintaining the enzyme in an inactive dephosphorylated state (Latsis et al., 2002) (see
schematic in fig. 6.20). As expected, all three agents were capable of inhibiting
glycogen breakdown in platelets stored at 37°C for 24 hours, however all were also
toxic to platelets, forging a link between the liberation of glucose from glycogen and the
maintenance of platelet viability. Although it is entirely reasonable that the toxicity
associated with any of these agents was the cause rather than the effect of inhibited
glycogenolysis it is felt that the use of three distinct inhibitors supports the hypothesis
that platelet viability in vitro is maintained by an ability to liberate glucose from
glycogen.
Whether or not the loss of glycogen from platelets stored in vitro, which many groups
have observed, is an artefact of the in vitro environment is not entirely clear. However,
one report regarding platelets held for 72 hours at 22°C reported morphological changes
similar to those reported in this thesis (loss of the ability to aggregate; 'disc to sphere
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transformation' and loss of glycogen). The authors observed that platelets stored for 24
hours and transfused into a thrombocytopenic patient appeared to regain not only their
ability to aggregate but also their glycogen, which increased to control levels within 24
hours post transfusion (Murphy and Gardner, 1971). This ability of stored platelets to
'recuperate' upon transfusion has also been observed by other groups (Vainer et al.,
1976; Rinder et al., 2003) and lends weight to the possibility that the lesion associated
with platelet storage does not reflect the platelets' natural development of senescence
but is rather an artefact of their in vitro environment. It is important to note that
calcium^) was not significantly increased in platelets incubated for 24 hours at 37°C,
thus it appears unlikely that phosphorlyase activity and glycogen catabolism was being
regulated by calcium. In other cells phosphorylase is regulated by PKA, but PKA
activity in platelets could not be implicated in the breakdown of glycogen (see appendix
figure 8.6). Therefore it is possible that the dephosphorylation of glycogen
phosphorlyase (by phosphoprotein phosphatase-1 (PP-1)) is not occuring in vitro and
that phosphorylase activity is constitutively 'switched on'. Examination of the
phosphorylation states of glycogen phosphorylase and the PP-1 is required to explore
this possibility.
A major confounding factor in this research programme is the possible effect of citrate
upon glyocolytic flux. Citrate is an allosteric inhibitor of phosphofructokinase, thus
anticoagulation of whole blood using citrate is theoretically able to inhibit glycolysis,
however reports of citrate usage by platelets are contradictory and not easily compared
due to being performed at different temperatures with platelets from different species.
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Some authors indicate that platelets are unable to utilise exogenous citrate (Tegos and
Beutler, 1979), whereas others suggest that platelets can (Detwiler and Zivkovic, 1970),
or do so at an albeit very slow rate (Cartledge et al., 1997). Considering the fact that
platelets washed from citrated plasma died at a similar rate as those in full citrated
plamsa or diluted plasma (see chapter 3), the effect of citrate in the current research
program upon platelet death may be negligible. Further examination of this possibility
by anticoagulating blood with EDTA and repetition of key experiments is required to
establish if glycolytic flux is normal in cPRP.
The incubation of platelets under hypoglycaemic conditions highlighted a discrepancy
between the calcein and NAO accumulation assays. Consistently within this research
program the NAO and calcein-AM accumulation assays appeared to report the same
event - loss of viability in platelets; however hypoglycaemic conditions increased the
frequency of NAO"VE platelets but had no effect upon the frequency of calcein~VE
platelets. NAO is specific for the mitochondrial lipid cardiolipin but has been reported
to extrude from depolarising mitochondria, suggesting that it is capable of reporting
changes to ATm (Jacobson et al., 2002). It is worth noting that changes to cardiolipin
and ATm have not been shown to occur exclusively of each other in the context of cell
death. The discrepancy suggested that platelets were sensitive to altered environmental
glucose concentrations but that they had little influence upon platelet viability (even
over the extended period of five days). The discrepancy highlighted also the possibility
that changes to mitochondrial AvFm have no direct effect upon the viability of platelets
in vitro. Several further lines of evidence support this conclusion; it was demonstrated
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that over a five-day period of incubation at 37°C the rate death and loss of ATm were
dissimilar from each other, linear and hyperbolic, respectively; mCCCP failed to
promote platelet death and, finally, antimycin failed also to promote platelet death. This
raises the possibility that platelets contain 'get out clause' that allows them to avoid a
mitochondrial driven form of cell death. It also brings into question the use of
prontonophores by some research groups (Bergmeier et ah, 2003) to recapitulate platelet
storage lesion in vitro (especially when it occurs spontaneously).
The hypothetical 'get out clause' protecting platelets from changes to AfFm and / or
cardiolipin is possibly the target of antimycin and BH3I-2'. These agents in their own
right had no significant effect on platelet viability, yet there was considerable synergy
between antimycin or BH3I-2' and hypoglycaemia. It has been demonstrated that
antimycin (Tzung et al., 2001) and BH3I-2' (Degterev et al., 2001) share an ability to
bind the hydrophobic groove of Bcl-2 and Bc1-Xl, thus inhibiting their interaction with
pro-apoptotic Bcl-2 familiy member proteins (such as Bax, Bak and Bik). The
consequence of this (at least for BH31-2'-treated cells) is the promotion of
mitochondrial swelling, loss of ATm and cell death by apoptosis in a Bax-dependent
manner (Feng et al., 2003). Thus, treatment of platelets with these agents may increase
the concentration of free pro-apoptotic Bcl-2 family members in platelets, but that this
increase is not sufficient to promote platelet death. Examination of Bcl-XL binding
partners by immunoprecipitation of platelet lysates using anti-Bcl-XL antbodies may
help resolve whether antimycin or BH3I-2' affect the heterodimerisation of this
molecule with pro-apoptotic members of the Bcl-2 family.
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If an increase in the pro-apoptotic balance within platelets is not sufficient to cause
death what does hypoglycaemia do that facilitates the toxic effects of BH3I-2' or
antimycin?
Evidence of a calcium leak from internal store(s) was provided by the ability of 2-APB
but not wortmannin to block the increase in calcium^ caused by hypoglycaemia.
Although the changes to NAO accumulation caused by hypoglycaemia were not
dependent upon this increased calcium^) it is a fascinating observation that low
environmental glucose appears to be a regulator of calcium homestasis in platelets. The
observation that 2-APB was able to completely block the rise in calcium^) suggests
rapid sequestration of store-leaked calcium was occuring. It is known that certain
organelles utilise locally produced ATP for pumping calcium (e.g. the endoplasmic
reticulum (Xu et al., 1995)) and it is becomingly increasingly clear that mitochondria
have 'privileged' access to calcium released from the endoplasmic reticulum (Srivastava
et al., 1999) and that stress of the ER leading to calcium release can promote loss of
ATm and subsequent cell death (Chae et al., 2004). However, it is known also that cell
death effected by hypoglycaemic stress can been mediated by dissociation of
hexokinase IV (glucokinase) from mitochondria and promotion of apoptotic cell death
(Danial et al., 2003). The mechanism for hypoglycaemia-induced cell death appears to
involve hexokinase dissociation leading to translocation of Bax to the outer
mitochondrial membrane and release of cytochrome C (Pastorino et al., 2002).
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Furthermore, hexokinase II dissociates from mitochondria in glucose-deprived rat
fibroblasts, an event that permits tBid-dependent apoptosis (Majewski et al., 2004).
Taking these observations into account it is hypothesised that platelets rely upon
exogenous glucose to maintain hexokinase at the mitochondrial outer membrane and
support calcium pumping by the DTS. Low glucose^x) promotes a net calcium leak
from the DTS which is buffered by mitochondria. The calcium leak initiates store
operated calcium channel opening. The calcium buffering by mitochondria affects
cardiolipin / AvFm and prevents platelets accumulating NAO. These changes do not lead
to platelet death. An increase in the pro-apoptotic balance within the platelets (e.g. by
antimycin treatment or BH3I-2') leads to promotion of Bax insertion into the
mitochondrial outer membrane due to the loss of hexokinase and subseqent
mitochondrial rupture and platelet death (see figure 6.21).
Examination of hexokinase localisation in platelets treated with lOmM 2DG did not
reveal an accumulation within the cytosol, however repetition of this experiment is
required with confirmation that cytosolic and membrane fractions were suitably pure to
ascertain a difference (e.g. by confirming a pure mitochondrial signal in the membrane
fraction with antibodies to a subunit of cytochrome oxidase). Furthermore a positive
control is required that confirms the accumulation of hexokinase in the cytosol. This
could be done by incubating control lysates with G6P in order to inhibit hexokinase
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activity and promote it's dissociation from mitochondria and subsequently preparing
membrane and cytosolic fractions (Pastorino et al., 2002).
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Ca2+(ex)
Figure 6.21. Hypothetical model for the toxic effects of BH3I-2' and
antimycin.
Platelets incubated for 24 hours under hypoglycaemic conditions display
increased calcium^). This increase is blocked by 2-APB due to inhibition
of store operated calcium channel opening. 2-APB returns calcium(i) to
control levels suggesting that the calcium (leaked from the DTS?)
responsible for initiating SOCC opening is fully sequestered (by the
mitochondria?). Hexokinase dissociates from the mitochondria due to low
glucose(eX). Increasing the pro-apoptotic balance with antimycin or BH3I-
2' allows free Bax to insert into the mitochondrial outer membrane due to
the absence of Hexokinase. This allows substantial and rapid
mitochondrial disruption and platelet death.
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7 CONCLUSIONS
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This thesis aimed to readily identify platelet death and understand why platelets die in
vitro. To perform this work it was necessary to develop a means by which dead platelets
could be readily and rapidly discriminated from live ones. The dyes calcein-AM and
FM4-64 were found to be useful for this purpose and were used extensively as reporters
of platelet viability. It was also found that the dyes could identify platelet
microvesiculation, a process that appears to occur within large aggregates.
Once readily identifiable, changes to the platelet surface could be studied. It was found
that CD42b, an important component of the vWF receptor complex is lost from platelets
at the point of death. The shedding of CD42b was due to metalloproteinase activity.
Metalloproteinase activity was also responsible for an interaction between dead
platelets. The physiological significance of this interaction is not understood.
Macro-autophagy could not be implicated as the means by which platelets died. It is
unlikely that vacuolation represented a form of macroautophagy but it may have been
the result of crinophagy. The results did raise the possibility that autophagic pathways
may have an important role to play in the maintenance ofplatelet function.
Glycogen content of platelets became reduced during in vitro incubation at 37°C.
Inhibitors of glycogen catabolism caused platelet death. Exogenous glucose did not
support platelet viability but did appear to maintain calcium homeostasis and
mitochondrial integrity as evidenced by an inability to accumulate nonyl acridine
orange. Antimycin did not affect the platelets' ability to accumulate NAO and was not
toxic to platelets unless in conjunction with hypoglycaemic conditions. Very similar
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results were obtained with BH3I-2', suggesting that antimycin and BH3I-2' affect the
pro-apoptotic balance within platelets. This pro-death equilibrium is only realised as
death -promoting when platelets are held under hypoglycaemic conditions. A great deal
more experimental work is required to test this hypothesis but it highlights a need to
further understand the role ofmetabolism in the function ofplatelets.
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8 APPENDIX
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Figure 8.1. Low temperatures prime platelets for activation.
Platelet rich plasma was collected from healthy volunteers and incubated
for 10 minutes at the temperatures described in the fugure. Platelets were
transferred to aggregometry tubes, CaCI2 and Thrombin receptor
activated peptide (TRAP6) was added to 2mM and 10pM, respectively.
Bar = 2 minutes, Maximum aggregation was 80units from baseline.
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Figure 8.2. Standard curve for Anthrone assay.
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Figure 8.3. Assay for the accumulation of NAO into live platelets.
Platelets were added to a solution of 500pM NAO at and immediately
placed into the cytometer. Cytometric analysis of platelet fluorescence
was performed for 15 minutes. The accumulation of NAO by platelets
was at equilibrium within 10 minutes (600s). This assay system was
useful for the determination of accumulation rates for other platelet stains
such as calcein-AM and FM4-64.
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Figure 8.4. Transmission electron micrographs of murine splenic
red and white pulp.
Micrographs of platelets within murine splenic red pulp (i to iii) and a
micrograph of white pulp for comparison (iv). Platelets (arrowheads) can
be seen closely associated with a phagocyte with large phagolysosome
(arrow) (i and ii). Other platelets can be seen proximal to erythrocytes
(asterisk). All platelets look normal or with signs of activation (i and ii). No
platelets could be found with a phenotype similar to that seen during in
vitro storage at 37°C.
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Figure 8.5. Gallery of autophagosomes in various organisms.
(A) Autophagosomes (arrow) in the vacuole in the yeast, Saccharomyces
cerevisiae, during nitrogen starvation. (B) Granule-filled vacuole in
platelets (the present research programme). (C) Yellow-fluorescent
protein tagged LC-3 (an autophagosome marker) in ES cells (Mizushima
et a!., 2003). (D) Autophagic vacuoles in Leishmania donovani after
anitmicrobiai peptide treatment (Bera et al., 2003).
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Figure 8.6. Loss of glycogen during in vitro storage is
independent of Protein Kinase A activity.
Platelets were incubated as cPRP for 24 hours in the presence
of the protein kinase A (PKA) inhibitor H-89. A dose-response
curve shows a consistent lack of effect on the loss of glycogen
from platelets, n = 3.
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